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ABSTRACT 
 
HIV-related pain is commonly experienced by people living with HIV/AIDS; it compromises 
function and quality of life and there are no known effective pharmacological therapies. 
Previously, a peer led self-management group was no more effective in reducing pain and 
improving quality of life than controls who received an education book. Thus, the aim of this 
randomised single blinded study was to examine the effectiveness of three non-
pharmacological interventions: a therapeutic relationship alone, a therapeutic relationship 
with education, and a therapeutic relationship with a peer led self-management group on 
pain and other variables. Forty-one HIV-positive participants aged 18 – 50 and currently 
receiving antiretroviral treatment, were recruited from the virology clinic of Charlotte Maxeke 
Johannesburg Academic Hospital. Participants were assessed at baseline and weeks 4,8,12 
and 24. There were no significant changes in pain interference, self-efficacy, depressive 
symptoms or health-related quality of life either between the intervention groups or over time 
but there was a significant decrease in pain severity between the intervention groups. There 
were no changes in physical function between the groups but six components of physical 
function changed over time: loaded and unloaded reach, sit to stand and belt tie improved, 
preferred and fastest walking speed reduced. The study does not support the use of the 
therapeutic relationship, education or self-management for improving quality of life in HIV 
related pain, however, pain severity and physical function did change over time with the use 
of non-pharmacological interventions. 
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Chapter 1 Introduction and Literature Review 
Introduction 
Since the first cases of HIV were reported in the early 1980s, the HIV epidemic has spread 
globally. No region has been more affected than sub-Saharan Africa with 25.8 million people 
living with HIV/AIDS (PLWHA) in this region (UNAIDS; UNAIDS fact sheet 2015). As shown 
in Figure 1.1, more than 10% of the world’s HIV infected population reside here (UNAIDS; 
UNAIDS Gap Report 2014. In this region, South Africa has one of the largest populations of 
people living with HIV/AIDS with 6.8 million being reported in 2013 (UNAIDS, UNAIDS South 
Africa 2013). The co-morbidities, associated symptoms and opportunistic infections that HIV 
brings with it, significantly affect the quality of life and function of those infected. This 
coupled with the level of poverty and lack of healthcare resources available in South Africa 
(Cobbing, Hanass-Hancock and Deane, 2014; Chetty and Hanass-Hancock 2016) make for 
a dire situation. 
Pain has been reported as a symptom of HIV (Norval et al. 2004; Bhengu et al. 2011, 
Harding et al. 2011; Farrant et al.2012) and has been examined in PLWHA in terms of 
aetiology, prevalence and management (Frich  and Borgbjerg 2000; Hitchcock et al.  2008; 
Aouizerat et al. 2010;  Koeppe et al.  2010; Huggins et al. 2012; Maree, Dreyer Wright and 
Makua, 2013; Robbins, Chaiklang, and Supparatpinyo, 2013).Globally it is now agreed that 
the cause of the pain experienced by PLWHA is indeed varied, with the disease process, 
medication side effects, secondary complications, co-morbidities and unexplained aetiology 
often quoted as possible causes of pain in PLWHA according to literature reviews of HIV 
related pain (Marcus et al. 2000; Parker,Stein and Jelsma, 2014). 
A quote taken from a study published in 2013 [‘‘If only there was something that could be 
done.’’] (Maree, Dreyer Wright and Makua 2013, p 99) suggests that the study participant 
believes that pain relief is not possible. This alludes to the possibility that pain management 
is inadequate in PLWHA. This is supported by findings of other studies which report 
inadequate treatment in this population (Narasimooloo, Naidoo and Gaede, 2011; 
Mphahlele, Mitchell and Kamerman, 2012; Farrant et al. 2012; Robbins, Chaiklang, and 
Supparatpinyo, 2013).
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Figure 1.1  Adult HIV Prevalence Rate, 2013
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This literature review will examine relevant research related to the experience of chronic pain 
in PLWHA including prevalence and associated risk factors, the physical and psychosocial 
impact of chronic pain as well as management strategies including pharmacological and 
non-pharmacological approaches.  
1.1 Pain in HIV/AIDS 
Unfortunately, one of the most common symptoms of PLWHA is pain, which is illustrated by 
a number of studies (Norval et al. 2004; Bhengu et al. 2011; Harding et al. 2011; Farrant et 
al. 2012; Peltzer K, 2013). The complaint of pain was the reason for the initial consult with a 
healthcare practitioner which led to the subsequent diagnosis of HIV in the study by 
Mphahlehle, Mitchell and Kamerman (2012). This was reiterated by Wahab and Salami 
(2011) who also reported pain on initial HIV diagnosis in their sample.  
 
1.1.1 Prevalence of pain in people living with HIV/AIDS 
In Table 1.1 studies done predominantly in the United States of America show a prevalence 
of pain of 22% to 91.8% (Frich  and Borgbjerg 2000; Aouizerat et al. 2010; Harding et al. 
2011; Miaskowski et al. 2011, Merlin et al. 2013; Robbins, Chaiklang, and Supparatpinyo, 
2013). A high (91.8%) prevalence of pain was found in a community based sample of 
indigent or homeless people living with HIV/AIDS in San Fransciso (Miaskowski et al. 2011). 
The high prevalence of pain reported could have been influenced by the poor socioeconomic 
living conditions of this population. Table 1.2 shows a number of South African studies and 
one African study which also reflect a high prevalence of pain ranging from 27.8% to 91%. 
The study which reported 91% prevalence was, however, restricted to an inpatient 
population. The high prevalence of pain can therefore be attributed to the fact that all 
participants were ill at the time and the pain reported could have been due to other co-
morbid illnesses or the reason for hospitalisation itself (Narasimooloo, Naidoo and Gaede, 
2011).  
Prevalence of pain noted in a rural cohort was higher than that of an urban cohort in the 
study by Mphahlehle, Mitchell and Kamerman (2012). There were several differences 
between these cohorts, the geographical location of where they resided, and possible 
cultural factors such as differing values and beliefs about HIV or pain and its management. 
The socioeconomic status and educational levels were similar in this cohort. Non-specific 
factors such as interaction with the researcher may have also played a role in the report of 
pain prevalence in this study (Mphahlehle, Mitchell and Kamerman, 2012). In contrast, a 
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Nigerian study found a lower prevalence of pain (27.8%) in an outpatient clinic population. 
The researchers attributed this to an acceptance that pain was a co-morbidity of HIV; 
therefore the participants may have felt that having pain was inevitable when one has HIV 
(Wahab and Salami, 2011). This may be a valid assumption, but would need to be proved by 
further research. The above studies demonstrate the variability of pain prevalence in 
PLWHA but also indicate that pain is a common symptom in PLWHA. 
A systematic review by  Parker,Stein and Jelsma (2014) reviewed data from studies with a 
total of 6814 individuals living with HIV/AIDS. The data were collected between 1993 and 
2011 and the prevalence of pain ranged from 54% to 83% over a three month recall period. 
Pain intensity  was reported to be moderate to severe and a moderate effect on function was 
found. This review supports the studies reviewed above and demonstrates the impact that 
pain has on PLWHA, as well as the high prevalence rates demonstrating that pain is 
commonly experienced by individuals with HIV/AIDS. It is important to note that this review 
included studies done in both high and low income countries and that the prevalence found 
was consistent over time and not affected by the advent of ARV’s (Parker,Stein and Jelsma, 
2014). This demonstrates that prevalence is not affected by socioeconomic status or use of 
ARV’s. 
1.1.2 Intensity of pain in People living with HIV/AIDS 
International and South African studies reviewed reveal that the pain intensity experienced 
by people living with HIV/ AIDS most frequently ranges from moderate to severe. This is 
clearly shown by Table 1.1 and 1.2 where the mean pain intensity ranges from 5 to 8.2 in 
severity on a 10 point scale with 0 being no pain and 10 indicating severe pain. In the 
studies that did not report an average or mean pain intensity, the data were reported as 
falling into mild, moderate, or severe categories with the exception of Frich and Borgberg 
(2000) who described the pain intensity as disturbing. In this longitudinal study participants 
rated their pain intensity on a visual analogue scale according to mild, moderate or severe, 
however, the severity was reported as disturbing or not disturbing. This study also 
demonstrated a high pain prevalence. It is important to note that 79% of participants were in 
ill health and subsequently died by the time the last interview was conducted.The high 
incidence of ill health would then correlate with the high prevalence of disturbing pain found 
in their sample (Frich  and Borgbjerg, 2000).  
In a study, done by Mphahlehle, Mitchell and Kamerman (2015), it was interesting to note 
that the pain intensity decreased from a prevalence of 85% to 54% on follow up visits 6 
months after the initial study.  The researchers also found that 21% of those participants who 
experienced no pain at the initial visit, developed pain 6 months later and 20% of participants 
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with a moderate pain severity developed severe pain. It is worth noting that 40% of 
participants who reported pain initially had no pain at the 6 month follow up. These findings 
show that pain experienced by PLWHA may be unpredictable in nature.  Reasons for the 
changes in prevalence and intensity remain unknown and is an area for future research. 
Pain has been found to significantly affect function in other chronic pain populations 
including patients with cancer, chronic low back pain, arthritis and fibromyalgia (Kravitz et al. 
2011; Gazzi Macedo et al. 2012;  Dailey et al. 2013).  The impact pain may have on the 
individual is significant as demonstrated by Mphahlele, Mitchell and Kamerman (2012) and 
Wahab and Salami (2011) as it was often the reason for seeking consultation with a 
healthcare provider. 
Table 1.1 Prevalence and intensity of pain in PLWHA in countries outside Africa  
 
Authors Sample Location Prevalence 
of Pain 
Pain intensity 
Merlin et al. 2013 1903 outpatients Birmingham, United 
States of America 
37%  23% had moderate pain 
Miaskowski et al. 
2011 
270 community 
based sample 
San Francisco, 
United States 
91.8% 38.1% reported moderate pain 
53.7% had severe pain 
Aouizerat et al. 2010 
 
321 outpatients San Francisco, 
United States of 
America 
55%  82% reported severe pain 
Frich and Borgberg 
2000 
95  inpatients 
and outpatients 
Denmark 74%  51% disturbing pain 
Robbins, Chaiklang, 
and Supparatpinyo, 
2013 
254 outpatients Thailand 22% 49.3% reported moderate to 
severe pain 
 
1.1.3  Effects of pain intensity on function and quality of life in PLHWA 
Pain has significant effects on function, quality of life and productivity. Studies assessing 
these factors in PLWHA are summarised in Table 1.3.  
Function 
An increase in pain severity has been linked to a decrease in functional activity as measured 
by Mann et al. (2015) who used the Euroqol 5D and brief pain inventory to assess physical 
function. Mann et al. (2015) restricted the population to those PLWHA who suffer from 
neuropathic symptoms and not necessarily chronic pain in general, therefore, the results 
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cannot be generalised. Pain was also independently associated with increased impairment 
in mobility, self-care and usual activities in a large American study in a population of PLWHA 
(Merlin et al. 2013). These studies suggest that the suffering experienced by PLWHA who 
have chronic pain affects all aspects of their daily lives and function. This is supported by 
several studies in Table 1.3 (Hughes et al. 2004; Astoro et al. 2007; Van As et al. 2009; 
Balderson et al. 2013; Merlin et al. 2013; Galantino et al. 2014).   
It can be seen clearly from Table 1.3 that none of the studies used an objective physical 
outcome measure.  Subjective measures such as the Short form health survey 36, Euroqol 
5D, Brief Pain Inventory, Medical Outcomes Study- HIV Health Survey, World Health 
Outcomes International Classification of Function checklist, were used in the respective 
studies (Hughes et al. 2004; Astoro et al. 2007; Van As et al. 2009; Aragonés- López et al. 
2012; Merlin et al. 2013; Balderson et al. 2013;  Galantino et al. 2014; Mann et al. 2015). 
These are all subjective self-report measures with the exception of the World Health 
Organisation International Classification of Function checklist which utilises observation (Van 
As et al. 2009).   
Van As et al. (2009) also used other standardised methods of measurement such as 
goniometry and the Oxford scale of measurement of muscle strength. While all of the above 
measures will give an indication of physical function, they are not as specific to actual 
performance of physical tasks when compared to the Simmonds battery (Simmonds et al. 
1998; Simmonds MJ, 2002; Simmonds, Novy and Sandoval, 2005). This is a battery of 
physical tests that measure speed of movement, co-ordination, strength and endurance. The 
tests are measured through observation, timing of tasks and measurement of distances 
achieved by participants and have been used in the current study (Simmonds MJ, 2002). As 
demonstrated above, most studies in PLWHA with pain use a subjective measure of physical 
function to determine impairment, thus reporting on deficits in physical functioning may not 
correlate which the actual physical function of study participants. The review by Parker,Stein 
and Jelsma (2014) demonstrated that pain interference with function was of a moderate level 
which supports the findings of studies reviewed above (Parker, Stein and Jelsma, 2014). 
Quality of Life  
Quality of life, increased depression, anxiety and poor self-efficacy have been also been 
linked to chronic pain in HIV (Merlin et al. 2014). This quote taken from a qualitative study on 
patient perspectives of pain and HIV underlines how debilitating the problem of pain can be 
for an HIV infected individual to bear: 
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 [“Well, I’ve just got enough problems dealing with HIV, and trying to get myself clean, and 
then you throw in the pain on top of that, well, that’s just something I don’t need, right now. 
And it’s just I mean; you can only take so many hard licks from one day, before you just 
gotta give up. And, if you got that damn pain sitting there, just gnawing, it’s like somebody’s 
gnawing on a bone, and you got that sitting there”] (Merlin et al 2014, p 4).  
People living with HIV experience significant difficulty dealing with everyday life in terms of 
managing a chronic disease and several studies have reported on reduced quality of life in 
PLWHA (Hughes et al. 2004; Astoro et al 2007; Van As et al. 2009; Merlin et al. 2013). 
Factors in these populations associated with a decreased quality of life included mental 
functions, sensation and pain, digestive problems, neuromuscular function, mobility, usual 
activities , mood, age, opportunistic infection, ARV treatment for more than 3 months and 
CD4 count of less than 200cells/mL (Hughes et al. 2004; Astoro et al. 2007; Van As et al. 
2009; Merlin et al. 2013) . Two studies, however, report a relatively high quality of life 
(Aragonés-López et al. 2012; Balderson et al. 2013).  Aragonés-López (2012) cite the Cuban 
healthcare system outlined below as reasons for the higher level of quality of life in their 
cohort. Mandatory treatment in a sanitorium was a Cuban government policy in 1986 which 
has since changed to include optional treatment in a sanitorium. This now entails various 
national HIV programmes including training on how to live with HIV, socioeconomic and 
social support,  close disease monitoring and good access  to treatment (Granich et al. 
1995; Gorry C, 2011). The reasons cited by the authors seem plausible given the 
comprehensive and structured healthcare programme available to those PLWHA in Cuba. 
The second study was carried out in a population who had been living with HIV/AIDS for a 
longer period of time (Balderson et al. 2013)  which may account for the increased quality of 
life as these individuals most likely have learnt how to cope with living with HIV over time 
and developed significant support mechanisms in this time as well. 
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Table 1.2 Prevalence of pain, pain intensity and pain sites in Africa 
Authors Sample Location  Prevalence of Pain Pain intensity Most common Pain Sites 
Peltzer K 2013 735 treatment naive 
outpatients 
Kwazulu Natal 
South Africa 
Overall pain prevalence reported as 
common but no data available. 
 
Not reported Headache 32.1%,joint pain 
23.6% ,22.9% reported chest 
pain, 15% reported muscle 
aches, 11.9% abdominal pain  
on initial assessment 
Mphahlele, Mitchell 
and Kamerman, 2012  
521 ambulatory out 
patients  
396 attending an 
urban clinic, 125 
attending a rural 
clinic. 
 South Africa. At the time of assessment                      
Rural -72% reported pain Urban -  56% 
reported pain    
At the time of HIV diagnosis                  
Rural-76% reported pain Urban – 60% 
reported pain  
Sought consult for pain resulting in HIV 
diagnosis                                                       
Rural – 73% Urban 92% 
The median pain 
intensity was 5 
(moderate intensity). 
Most common pain sites 
identified were head, chest, and 
abdomen.  
In addition genital pain in rural 
sample and feet in urban 
sample. 
Bhengu et al. 2011 
 
149 outpatients  
 
Kwazulu Natal 
South Africa 
54 % reported pain.  
19% who reported pain also reported 
numbness. 
Not reported 32% reported headaches 
22% reported types of pain 
Narasimooloo, Naidoo 
and Gaede, 2011 
 
100 inpatients Kwazulu Natal 
South Africa. 
91 % of the sample reported pain.  Mean- Worst pain 8.2 
(severe) 
Mean – average pain 
6.8 (moderate) 
Not reported 
Farrant el al. 2012 385 outpatients 
 
South Africa 51% of the sample reported pain. Not reported Numbness or tingling in hands 
or feet 61%, no other sites 
reported 
Harding et al. 2011 224 outpatients 
192- South Africa 
32- Uganda 
South Africa, 
Uganda 
82.6 % reported pain Not reported Not reported 
K W Wahab and A K 
Salami, 2011 
79 outpatients Nigeria 27.8% 
26.6% reported pain at the time of HIV 
diagnosis 
Moderate 10% 
Severe 15% 
44% lower limbs 
38.1 % head, neck and 
abdomen 
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Table 1.3 Effects of pain on quality of life and function 
Author Location Sample 
HIV-SN or a cross 
section of PLWHA 
ARV status 
Quality of Life 
Outcome 
measure 
Quality of Life Functional 
Impairment 
Outcome measure 
Functional Impairment 
Van As et al. 2009 South Africa 45 ambulatory outpatients 
PLWHA 
73.3% on ARV’s 
26.7% ARV naïve 
None Not reported WHO ICF Checklist, 
dynamometry 
Oxford muscle testing 
and goniometry 
Limitations in mobility, interpersonal 
relationships and general tasks and 
demands 
Aragonés-López et 
al. 2012 
Cuba 354 outpatients PLWHA 
100% on ARVs 
MOS-HIV health 
survey 
questionnaire 
Higher scores for 
quality of life on the 
MOS-HIV health 
survey 
MOS-HIV health 
survey questionnaire 
Not reported on specifically. 
Balderson et al. 
2013 
United states 
of America  
452 outpatients 
PLWHA 
100% on ARV’s 
SF 36 Health status 
decreased when pain 
severity increased 
SF 36 Poor physical functioning when chronic 
illness was present. 
Mann et al. 2015 United states 
of America  
103 outpatients with HIV-
SN 
ARV status not reported 
EQ 5D 
 
Not reported EQ 5D 
BPI 
Increased pain severity associated with 
increased activity impairment 
Astoro et al. 2007 Indonesia 107outpatients 
PLWHA 
31.8% on ARV’s 
68.2% ARV naïve 
SF 36 Poor quality of life in 
62.6% of the sample 
SF 36 Physical function and mental function 
affected 
Merlin et al. 2013 United states 
of America 
1903  outpatients 
PLWHA 
ARV status not reported 
EQ 5D Not reported EQ 5D Impairment in mobility, self-care and 
usual activities 
Hughes et al. 2003 South Africa 123 PLWHA – ARV naive 
108 control group-
community participants-
HIV status unknown 
EQ 5D Health Related 
Quality of Life is 
severely 
compromised in 
PLWHA 
EQ 5D Health Related Quality of Life is 
severely compromised. Pain, mobility 
and usual activities are major problems 
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1.1.4 Sites of Pain in People living with HIV/ AIDS 
As can be seen from Table 1.1 and 1.2, people with HIV associated pain experience pain at 
multiple sites including the extremities, gastrointestinal, head, neck, chest , muscles and 
joints. (Frich and Borgbjerg, 2000; Maritz et al. 2010; Bhengu et al. 2011; Miaskowski et al. 
2011, Wahab and Salami, 2011; Farrant et al. 2012; Nasimango et al. 2012; Maree, Dreyer 
Wright and Makua, 2013). Whilst some studies haven’t reported pain sites due to the lack of 
use of a specific pain outcome measure (Aouizerat et al. 2010; Narasimooloo, Naidoo and 
Gaede,  2011; Merlin et al. 2013), those that do, often choose the brief pain inventory to 
obtain this data. There seems to be no specific cause for the variation in pain sites, as these 
vary from chest pain to generalised body pain with no proven link to any specific medication, 
viral load or other variables (Frich and Borgbjerg, 2000; Bhengu et al. 2011; Mphahlele, 
Mitchell and Kamerman,  2012; Farrant et al. 2012; Nasimango et al. 2012; Maree, Dreyer 
Wright and Makua, 2013). This may be due to the complexity of chronic pain.
As mentioned previously, chronic pain is a complex phenomenon. There are several 
components that contribute to an individual’s perception and experience of chronic pain. 
These include the biological aspect of the neurophysiology that occurs when one 
experiences pain, the psychological component of the emotions attached to the experience 
of pain and the social aspect where the environment and social interaction with others 
influence the individual’s experience of chronic pain. Ultimately pain is an output from the 
brain based on the threat value perceived by the brain and the inputs vary significantly as 
shown by figure 1.2 below. As the pain becomes more chronic, central sensitization of the 
nervous system increases and this results the pain producing pain and other symptoms 
(motor, immune, endocrine) in an effort protect the body (Butler D S, 2000; Moseley GL, 
2003; Moseley GL, 2007; Moseley and Flor 2012; Siddall and Cousins 2004). A detailed 
review of the mechanisms of chronic pain has not been included in this review as this is 
beyond the scope of this literature review. 
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Figure 1.2 Inputs that affect pain perception taken from Moseley G L: Reconceptualising Pain 
According to Modern Pain Science. Physical Therapy Reviews. 2007; 12: 169–178. 
 
In PLWHA aspects such as the stigma of HIV (Van Olmen et al. 2012; Cobbing, Hanass-
Hancock and Deane, 2014; French et al. 2015; Parsons, Bond and Nixon, 2015; Denis P 
2016) and the social isolation this brings contribute to the pain experience. Factors that 
complicate pain in PLWHA in Africa are poor access to healthcare and good healthcare 
facilities, cost of transportation to clinics and low socioeconomic status (Plazy et al. 2015; 
Camlin et al. 2016; Chetty and Hanass-Hancock 2016). The impact of psychosocial factors 
on pain in PLWHA can be illustrated by evidence that spiritual alternatives to medical 
management such as traditional healing (Camlin et al. 2016) impact on the treatment 
choices of the person living with HIV/AIDS. In addition, it has also been reported by PLWHA 
that when they complain of pain they are seen as lazy and their pain is not acknowledged as 
“real” (Maree, Dreyer Wright and Makua, 2013) which may have a psychosocial impact on 
the individual. Additionally there are various potential risk factors that have been linked to 
pain in PLWHA. 
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1.1.5 Risk factors for pain in HIV/AIDS 
Potential risk factors have been identified by several studies(Schiffto et al. 2002; Hitchcock, 
Meyer and Gwyther, 2008; Koeppe et al. 2010; Maritz et al. 2010; Harding et al. 2011; 
Miaskowski et al. 2011; Wahab and Salami, 2011; Mphahlele, Mitchell and Kamerman, 
2012).  As pain is a complex cortical construct, the multiple risk factors are biopsychosocial 
and include age; sex; disease markers; education and other biopsychosocial variables.  
Age 
Increased age was identified by two studies in Table 1.4 as being a risk factor for the 
development of pain in PLWHA (Koeppe et al. 2010; Mphahlele, Mitchell and Kamerman, 
2012;). Increased age has been shown to be a risk factor for chronic pain in a number of 
studies in other populations with chronic non cancer pain and musculoskeletal pain 
(Björnsdóttir, Jónsson and Valdimarsdóttir, 2013; Inoue et al. 2015; Croft and Mayhew, 
2015; Nahin R L, 2015). The association of pain with increasing age may be related to co-
morbidities such as the development of age related joint pain. However, this should be 
confirmed with further research in PLWHA using an age-stratified sampling design. 
Sex 
Female gender has been identified by several studies as a risk factor for the development of 
chronic pain in PLWHA (Koeppe et al. 2010; Miaskowski et al. 2011, Harding et al. 2011, 
Mphahlele, Mitchell and Kamerman, 2012). This finding is not restricted to PLWHA as 
females have been identified as being at higher risk to develop chronic pain (Munce and 
Stewart, 2007; Björnsdóttir, Jónsson and Valdimarsdóttir, 2013 Alhalabi, Alhaleeb and 
Madani, 2015; Deeny et al. 2015).The prevalence of chronic pain in females can be 
associated with psychosocial factors such as depression, coping strategies, catastrophising 
and stress (Munce and Stewart 2007, Bartley and Fillingim, 2013). Reviews on gender 
differences in pain confirm a higher prevalence of pain in women for a variety of reasons 
such as sex hormones, endogenous opioid mechanisms, genetic factors, pain coping , 
catastrophising, anxiety and gender roles (Bartley and Fillingim 2013, Melchior et al. 2016). 
One of the studies in Table 1.4 identified male gender as a potential risk factor (Hitchcock, 
Meyer and Gwyther, 2008). However, this finding does not correlate with research in the field 
of chronic pain currently. Possible reasons for this finding were not discussed by the authors. 
The female participants were much younger than the male participants in this study which 
may have been a confounding variable. The authors did not publish details of the male to 
female ratio or the age ranges present so it is difficult to draw any conclusions as to the 
reason why their results conflicts with the other studies. 
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Disease markers 
A lower CD4 count or higher viral load was identified as a risk factor in two of the studies in 
Table 1.4 (Hitchcock, Meyer and Gwyther, 2008; Maritz et al. 2010) and a third study Schiffto 
et al. 2002 identified a history of AIDS diagnosis which can be linked to a lower CD4 count 
as a risk factor. Other studies have reported that the viral load does not play a significant 
role in the aetiology of the pain which does not give a clear picture of what predisposes an 
individual living with HIV/AIDS to develop chronic pain (Farrant et al. 2012; Mphahlele, 
Mitchell and Kamerman, 2012, Norval D A, 2004).  However, one should take into account 
that a lower CD4 count can be related to other co-morbidities which may result in pain, as 
the individual has a poorer health status due to the higher viral load. A study by Singer et al. 
(1993) conducted over two years reported that pain was related to disease progression and 
reported an increase in new pains related to headaches and peripheral neuropathy. This 
study did not report on the level of pain intensity experienced by the participants, therefore, it 
is difficult to comment on the progression of pain in this study. The systematic review on 
pooled data of 6814 PLWHA showed mixed results with evidence linking disease markers to 
pain and other studies showing no link to the CD4 count (Parker, Stein and Jelsma, 2014). 
The use of disease markers as a risk factor for pain remains to be proven; therefore, one 
cannot make assumptions about the link with chronic pain in PLWHA. It is possible that 
disease markers may have no influence on pain. 
Education 
 Studies in Table 1.4 report on the association of educational levels and chronic pain in 
PLWHA (Miaskowski et al. 2011; Mphahlele, Mitchell and Kamerman, 2012; Robbins, 
Chaiklang, and Supparatpinyo, 2013). A lower level of education seems to be related to the 
development of chronic pain; this may be attributed to a lower level of insight into the 
medical condition of HIV due to poor health literacy and may include a lack of knowledge 
about the disease. This may also be influenced by poor access to healthcare resources. 
Other studies have reported an association between lower levels of education and chronic 
pain in cohorts with back pain (Schmidt et al. 2007) and chronic pain (Zarei et al. 2012). 
Reasons cited are the lack of knowledge of disease and treatment; therefore, the 
participants do not attend to their health timeously and in an appropriate manner. This may 
be the case for PLWHA as well but has not been proven in research. More research is 
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needed using a longitudinal study design with larger sample sizes to determine if education 
is indeed a risk factor for pain in this population. 
Other risk factors 
The other risk factors that have been highlighted such as tobacco use, length of time since 
diagnosis (Koeppe et al. 2011), tuberculosis treatment (Hitchcock, Meyer and Gwyther, 
2008) and length of time on ARV’s (Robbins, Chaiklang, and Supparatpinyo, 2013) have not 
been verified by other studies and may be associated with HIV related pain. Most of the 
studies reviewed have been cross sectional in nature, and further research using longitudinal 
studies with large samples would be necessary to establish if this is indeed the case.  
The study data by Koeppe et al. (2011) should be considered robust due to its longitudinal 
nature and the fact that it looked at a large sample size in a variety of settings. However, this 
study examined prolonged analgesic use as an indicator of pain experienced instead of a 
pain specific outcome measure such as the brief pain inventory. The finding that anti-
depressant use is a risk factor for pain should be viewed cautiously as anti-depressants are 
often used to manage chronic pain in this population and the fact that these individuals were 
also prescribed analgesia is not surprising. Therefore, it cannot be assumed that the use of 
antidepressants and by implication the presence of depression is a valid risk factor for the 
development of pain. 
The studies reviewed above show that various risk factors have been shown to be 
associated with pain in PLWHA such as age, female gender and lower educational levels. 
These have also been identified to be risk factors in populations with chronic pain. Disease 
markers remain an area of controversy as research reported does not demonstrate beyond 
doubt the association between pain in PLWHA and the disease marker. Therefore, disease 
markers and other risk factors identified above will require further research with longitudinal 
studies that look at these specific risk factors. 
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Table 1.4 Risk factors for HIV related pain
Authors Sample Location Risk factors identified 
Hitchcock et al. 2008 354 outpatients 
Public hospital clinic 
Pretoria, South Africa Higher incidence of neuropathic pain in males 
 Lower CD4 counts 
Treatment for tuberculosis 
Koeppe et al. 2011 931 outpatients  
Private, public and university 
based clinics 
United States of America Lower CD4 counts  
History of opportunistic infections  
Length of time since HIV diagnosis (4years or more) 
Increased age 
Tobacco use  
Higher incidence of pain in females  
Use of anti-depressants or anxiolytics 
Public or no health insurance 
Mpahlehle et al. 2012 521 ambulatory outpatients 
Urban and rural clinics 
South Africa Decreased pain linked to ARV’s –rural cohort 
Age –urban cohort 
Miaskowski et al. 2011 270 community based sample San Francisco, United 
States 
CD4 count not associated with pain severity 
Lower level of education 
Female gender 
Harding et al. 2011 224 outpatients,192- South 
Africa 
32- Uganda 
South Africa, Uganda Female gender 
 
Wahab and Salami,  
2011 
79 outpatients Nigeria Not related to stage of HIV infection 
Robbins, Chaiklang, and 
Supparatpinyo, 2013 
254 outpatients Thailand Time on ARV treatment 
Lower education level 
Positive depression screening 
17 
 
 
Table 1.5 Under treatment of pain in HIV 
Authors Location Sample (only those 
participants 
reporting pain) 
Pain locations Appropriate Treatment Outcome 
measure 
Conclusion 
Mphahlele et al. 
2012  
South Africa 198 ambulatory 
outpatients reported 
pain out of 512 
participants 
Headaches, chest 
pain, abdominal pain 
and feet pain 
No analgesia-Rural 29% Urban 43%  
 
Appropriate strength analgesic 
medication Rural 0% Urban 8% 
Standardised 
interview 
Significant under treatment for both 
cohorts. Prescribed inappropriate or no 
medication to treat pain 
Narasimooloo, 
Naidoo and 
Gaede, 2011 
South Africa 91 inpatients  Not reported 30%-No analgesia for pain relief         
 
Pain 
management 
index and 
medical chart 
review 
Significant under treatment of pain. 
Farrant el al 2012 South Africa 197 outpatients Not reported Poor pain/symptom management 
measured according to the burden of 
symptoms reported 
None 
reported. 
Pain found to be inadequately treated 
Maree, Dreyer 
Wright and 
Makua 2013 
South Africa 436 outpatients Headaches, chest 
pain, mouth, limb 
pain and foot pain 
40% of sample still experienced pain 
despite taking medication prescribed 
60% reported that the amount of 
medication given was insufficient to 
last till the next clinic visit 
Structured 
interview 
Staff at the clinic lacked knowledge of 
pain and appropriate pain management 
Frich and 
Borgberg 2000 
Denmark 84 inpatients and 
outpatients 
Headaches, 
gastrointestinal tract 
and extremities 
77% of patients reported that 
treatment of pain was inadequate at 
baseline interview. 
Pain 
management 
index and 
medical chart 
review 
Inadequate treatment of pain that 
improved over time of the study. 
Robbins, 
Chaiklang, and 
Supparatpinyo, 
2013 
Thailand 69 outpatients Not reported 86% reported inadequate pain 
management according to scores of 
less than zero on the pain 
management index. 
Pain 
management 
index 
Inadequate treatment and the WHO 
guidelines were not followed. 
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1.2  Management of chronic pain in people living with HIV/AIDS 
 
In this section I will be reviewing the pharmacological and non-pharmacological approaches 
to chronic pain management in HIV. The literature on the under treatment of pain is 
summarised in Table 1.5. Several studies reviewed have looked specifically at neuropathic 
pain as this is prevalent in PLWHA.  
Some of the studies reviewed in Table 1.5 have pointed to the fact that pain reported by 
participants was undertreated. However, the lack of specific standardised outcome 
measures or lack of detail in methodology reporting how this data were collected, reduces 
the robustness of these results (Narasimooloo, Naidoo and Gaede, 2011; Farrant et al. 
2012; Mphahlele, Mitchell and Kamerman, 2012). Despite the lack of standardised outcome 
measures, several papers have reported under treatment of HIV related pain in Africa and in 
other countries (Frich and Borgbjerg, 2000; Narasimooloo, Naidoo and Gaede, 2011; Farrant 
et al. 2012; Mphahlele Mitchell and Kamerman, 2012; Robbins, Chaiklang, and 
Supparatpinyo, 2013; Maree, Dreyer Wright and Makua, 2013).  
Mphahlehle (2012) and colleagues reported that no analgesia was given to 29% of the rural 
cohort and 43% of the urban cohort suffering from pain in their study. This study also 
reported that the appropriate strength analgesic medication was not reported by any rural 
participants and only 8% of urban participants reported that the analgesia provided was of 
appropriate strength (Mphahlele, Mitchell and Kamerman, 2012). Similarly, in a study of 
inpatients with HIV/AIDS 30% of participants suffering from pain received no analgesia 
(Narasimooloo, Naidoo and Gaede, 2011). Further, Maree, Dreyer Wright and Makua, 
(2013) reported that 40% of the cohort still experienced pain despite taking prescribed 
medication  while 60% reported that the amount of medication given was insufficient to last 
till the next clinic visit. The similarity of findings in the studies reviewed above reveal that 
there may be a need to improve the medical management of pain experienced by PLWHA in 
South Africa.  
 
1.2.1 Pharmacological Management  
Due to the nature of HIV related pain having multiple aetiologies, prescribing the correct 
pharmacological intervention may be difficult as the aetiology is not always known. In South 
Africa the majority of treatment available to PLWHA who experience significant pain is 
currently restricted to pharmacological interventions. This is in keeping with the global view 
examined in reviews on management of HIV related pain (Phillips et al. 2010; Kamerman 
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and Mitchell, 2011; Parker,Stein and Jelsma, 2014; Finnerup et al. 2015). In addition, the 
pharmacological management of HIV related pain appears to prioritise the treatment of 
neuropathic pain. 
The review by Kamerman and Mitchell (2011) advises the use of published guidelines to 
manage neuropathic pain in HIV. In the absence of population appropriate evidence based 
guidelines for the management of neuropathic pain, the reviewers recommend the World 
Health Organisation (WHO) analgesic step ladder approach to chronic pain (Kamerman and 
Mitchell, 2011). This recommendation is supported by the other reviews which recommend 
specific analgesic medication according to clinical trials and research reviewed (Finnerup et 
al. 2015).  
Finnerup et al. (2015) recommended tricyclic antidepressants, serotonin noradrenalin 
reuptake inhibitors, pregabalin and gabapentin as first line treatment for neuropathic pain. 
Tramadol, lidocaine and capsaicin patches were weakly recommended as second line 
treatment and a weak recommendation for strong opioids and botulinum toxin A was made. 
Finnerup et al. (2015) concluded that HIV neuropathic pain was found to be more difficult to 
treat than other types of pain from the research examined. The authors also outlined that 
large placebo responses, modest drug efficacy and the variability in diagnostic criteria for 
neuropathic pain contribute to the weakness of recommendations for treatment of 
neuropathic pain. 
The South African guidelines for neuropathic pain also advise the first line use of gabapentin 
or pregabalin, amitriptyline or other tricyclic antidepressants and serotonin noradrenalin 
reuptake inhibitors such as duloxetine and venlafaxine (Chetty et al. 2012). Thereafter a 
combination of these drugs is recommended as second line treatment, and tramadol 
followed by strong opioids is recommended as a third line of treatment. The South African 
guidelines for neuropathic pain also highlighted the lack of South African data for 
pharmacological management of painful HIV neuropathy (Chetty et al. 2012).  The national 
development plan presented by the South African Department of Health in 2015 includes the 
goal of ensuring all PLWHA have adequate access to treatment and ARV therapy but there 
is no specific mention of the treatment of pain experienced by PLWHA (Department of 
Health 2014). 
Opioids 
According to Koeppe et al (2010), the use of medication and specifically opioids is not 
effective in the management of pain in individuals with HIV (Koeppe et al. 2010). However, 
the use of opioids in HIV related pain is controversial with research undecided on whether 
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the use of opioid drugs is efficacious. This is demonstrated by a Cochrane review which 
concluded that the analgesic effect of opioids in neuropathic pain is questionable with 
enough research proving that it works and just as much research showing that it is not that 
effective McNicol, Midbari and Eisenberg (2013). A review funded by the neuropathic pain 
special interest group of the International Association for the Study of Pain looked at studies 
and clinical trials that were published and unpublished as well as the possible bias in the 
reporting of study outcomes. This review recommended opioids only as a third line 
medication in the management of neuropathic pain (Finnerup et al. 2015).  
Clinical guidelines by the American Pain Society and the American Academy of Pain 
Medicine recommend the use of opioids in chronic non cancer pain of moderate to severe 
intensity that is affecting quality of life and daily function. This recommendation is 
accompanied with a caution that the potential benefits of opioid prescription should outweigh 
the potential harmful effects of possible addiction or overuse (Chou et al. 2009). Chronic 
pain in HIV falls into the category of non-cancer chronic pain; however, these guidelines do 
not specifically address HIV related pain. 
Therefore, the research does not seem to support the use of opioid medication for HIV 
related pain. The guidelines reviewed, however, concentrate mostly on neuropathic pain in 
PLWHA and ignore other types of pain experienced by PLWHA. Neuropathic pain in PLWHA 
has been identified by researchers as a common symptom. This could be related to the fact 
that historically, ARV’s used early on in the HIV epidemic produced the side effect of 
neuropathic pain. More studies are required that look at the use of opioids in the 
management of chronic pain in PLWHA to establish if this is a viable management option. 
Amitriptyline 
Amitriptyline is a tricyclic antidepressant that has been used to treat chronic neuropathic pain 
with some efficacy (Finnerup et al. 2015; Moore et al. 2015). A comparative study that 
looked at the efficacy of amitriptyline when compared to pregabalin in chronic low backache 
(Kalita et al. 2014) found that amitriptyline performed better in the reduction of pain and 
disability.  However, the results of this study are questionable due to the small sample size 
and lack of a placebo arm (Kalita et al. 2014). Dinat et al. (2015) looked at the use of 
amitriptyline in neuropathic pain in HIV as it is the first drug of choice for the treatment of 
diabetic neuropathy and post herpetic neuralgia, according to the WHO guidelines (World 
Health Organisation, 2016) (World health organisation 2016). The results showed that 
amitriptyline is no better than placebo at treating neuropathic pain in HIV (Dinat et al. 2015). 
An updated Cochrane review supported these findings by reporting that there is only low 
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quality evidence available that amitriptyline is significantly better than placebo in treating 
neuropathic pain. The authors concluded that there is a possible overestimation of treatment 
effects in previous research done (Moore et al. 2015).  
A Maltese study looked at the management of chronic orofacial pain with the prophylactic 
use of low dose amitriptyline. The study reported good results with resolution of pain in 
45.5% of the mid facial pain participants and 23% in migraine sufferers. The participants 
were followed up for 3 years which strengthens the veracity of these results. Some of the 
participants, however, were treated with amitriptyline and other tryptans as well as non-
steroidal anti-inflammatories. The results can therefore not be fully attributed to the use of 
low dose amitryptiline and further research in this population may be warranted to establish 
the drug efficacy reported by this study (Agius, Jones and Muscat, 2014). 
 Amitryptiline is used in the management of chronic pain in other conditions such as low 
back pain and orofacial pain with efficacy (Kalita et al. 2014; Agius, Jones and Muscat, 
2014), thus it may have benefit in treating chronic pain in PLWHA. The study on neuropathic 
pain does not demonstrate efficacy in PLWHA but perhaps more studies are necessary in 
this population to establish drug efficacy (Dinat et al. 2015). Amitryptiline may be a useful 
modality to manage other types of pain in PLWHA, however, research needs to focus on HIV 
related pain not only neuropathic pain in PLWHA.  
Anticonvulsants 
Anticonvulsants have been recommended as a treatment option in neuropathic pain (Chetty 
et al. 2012; Finnerup et al 2015) with literature of varying strengths supporting these 
recommendations. 
The study by Kalita et al. (2014) demonstrated that the anticonvulsant pregabalin did not 
yield better results in reducing pain and function in individuals with chronic back pain than 
amitryptiline. This serves to emphasize that pregabalin may be beneficial for neuropathic 
pain but is perhaps not the drug of choice for all types of chronic pain. A study that examined 
the use of anticonvulsants in neuropathic pain, however, showed that gabapentin and 
nortriptyline in combination reduced pain and improved sleep significantly which led to a 
slight improvement in quality of life. These drugs in combination had better efficacy than 
when used alone in this trial (Gilron et al. 2009). A Cochrane review in 2013 looked at the 
use of anti-epileptic medication in neuropathic pain and fibromyalgia (Wiffen et al. 2013). 
This review supported the use of pregabalin and gabapentin in neuropathic pain in diabetic 
neuropathy and post herpetic neuralgia with second tier level evidence. It also 
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recommended the use of pregabalin in fibromyalgia and central neuropathic pain (Wiffen et 
al. 2013). 
The review reported a lack of second tier evidence for the use of anti-epileptic medication in 
HIV peripheral neuropathy. It was interesting to note that none of the other anticonvulsant 
drugs were found to be useful in management of neuropathic pain (Wiffen et al. 2013). So 
evidence does seem to indicate that anticonvulsants have a place in the management of 
pain, more specifically neuropathic pain, which may be relevant to the population of PLWHA 
who suffer from painful peripheral neuropathy although evidence for efficacy in this 
population seems to be limited. Once again more research is necessary in HIV related pain 
that does not focus on neuropathic pain alone. 
Cannabis 
The use of cannabinoids in the management of chronic pain has been controversial, mostly 
due to the fact that it is an illegal narcotic in most countries and the side effects of cognitive 
and motor dysfunction that occur when used for a prolonged period of time (Finnerup et al. 
2015). However, there is evidence in favour of the use of cannabinoids or cannabis in 
chronic pain management, especially for pain that does not respond to other medication 
(Boychuk et al. 2015). An Australian study looked at a cohort of community based 
participants suffering from non-cancer pain and found that 16% had used it for pain relief 
and a further 24% would use it for pain relief if they were able to access the drug 
(Degenhardt et al. 2015). The average amount of pain relief from cannabis use reported by 
these participants was 70% while pain relief from usual medication was only 50%. However, 
these results are compounded by a high prevalence for recreational cannabis use in this 
study with 43% of participants reporting that they had used the drug previously for 
recreational purposes (Degenhardt et al. 2015). There were also significant concomitant 
factors present which could have been confounding variables such as the presence of 
mental illness, substance abuse, higher pain interference and higher use of opioids over a 
longer period of time (Degenhardt et al. 2015).  
The use of smoked cannabis in painful HIV sensory neuropathy has been tested and found 
to be beneficial with a 34% reduction in pain when compared to placebo. The authors do 
note, however, that the relaxing effects, reaching a “high” or “unblinding” could have 
attributed to the reduction in pain (Abrams et al. 2007). The intervention took place over five 
days with no follow up period, which also questions the long term efficacy of the cannabis for 
neuropathic pain. These results were supported by another short term study (follow up 
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period of two weeks post intervention) where the participants reported 30% pain relief when 
compared to placebo (Ellis et al. 2009). 
As demonstrated above, efficacy of pharmacological interventions in the field of chronic pain 
is inconclusive. In the field of HIV related pain most studies have been restricted to 
neuropathic pain. This is only one type of pain experienced by PLWHA and there is a need 
for further research in this population. Research done shows that there generally isn’t good 
efficacy for neuropathic pain because placebo has been shown to work as well as 
pharmacological agents(Moore et al. 2015; Dinat et al. 2015) However, some agents such 
as cannabis have shown positive results (Ellis et al. 2009; Degenhardt et al. 2015) for 
chronic and neuropathic pain. Generally, the evidence is weak (Finnerup et al. 2015) but 
recommendations have been made for first line treatment of neuropathic pain with tricyclic 
antidepressants, serotonin noradrenalin reuptake inhibitors, pregabalin and gabapentin with 
moderate levels of evidence. There is thus a clear need for further research and alternative 
pharmacological options for the management of chronic pain in HIV as studies have focused 
on neuropathic pain in this population while ignoring other types of HIV related pain. 
 
1.2.2 Biopsychosocial approach to chronic pain 
Chronic pain is multi-factorial in any situation and this is further complicated in PLWHA by 
aspects such as the stigma of HIV as mentioned previously (Van Olmen et al. 2012; 
Parsons, Bond and Nixon, 2015; French et al. 2015; Denis P 2016). As outlined previously, 
the socioeconomic factors and access to healthcare in South Africa add to the complexity of 
the chronic pain experience of PLWHA in this country (Cobbing, Hanass-Hancock and 
Deane, 2014; Plazy et al. 2015, Camlin et al. 2016, Chetty and Hanass Hancock, 2016). 
Alternatives to traditional medical management such as traditional healing (Camlin et al. 
2016), often play a role in the South African context. Others perception of pain can also play 
a role as reported by Maree, Dreyer Wright and Makua (2013) where complaints of pain 
were not perceived as real. 
A biopsychosocial approach to other forms of chronic pain has long been advocated as an 
effective pain management approach (Siddall and Cousins 2004; Cheatle M D 2016).This 
involves a holistic view of the individual using a three way approach to manage chronic pain. 
This includes a biological approach to manage the physiological aspects of chronic pain 
such as pain intensity, a psychological approach to manage the emotional aspects of pain 
such as catastrophising and depression and a social approach which looks at the individuals 
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social environment and interaction which provides the context in which the chronic pain is 
occurring (Siddall and Cousins 2004; Cheatle M D 2016).  
 A review of management for chronic pain in HIV proposed that the biopsychosocial 
approach is the best option (Marcus et al  2000). Whilst this might be the case in HIV 
management in other countries/continents, it is far from being the case in Africa/South Africa 
where medical management is mostly used. This is illustrated by the studies in Table 1.5 
describing management of HIV related pain (Narasimooloo, Naidoo and Gaede 2011; 
Farrant et al. 2012; Mphahlele, Mitchell and Kamerman, 2012; Maree, Dreyer Wright and 
Makua, 2013; Chetty and Hanass Hancock, 2016). 
The management options for managing pain in this population should include interventions 
for the biological, psychological and social aspects of pain. This would then ideally include 
both pharmacological and non-pharmacological approaches, the latter including self-
management and interdisciplinary programmes. 
 
1.2.3 Non-Pharmacological Management 
Non-pharmacological interventions have been largely neglected in PLWHA globally and in 
South Africa (Kamerman and Mitchell, 2011; Parker,Stein and Jelsma, 2014). The standard 
practice currently is management through medication (Kamerman and Mitchell, 2011; 
Parker,Stein and Jelsma, 2014). Evidence pertaining to the use of non-pharmacological 
treatment in the management of chronic pain in PLWHA is sparse. However, more 
researchers are starting to look at non-pharmacological interventions as pharmacological 
interventions have been shown to have inconsistent rates of efficacy in the management of 
pain as shown above in the section on pharmacological management (Koeppe et al. 2010; 
Moore et al. 2015; Dinat et al. 2015). A few non-pharmacological approaches will be 
reviewed below but it is important to note that there are many non- pharmacological 
approaches available for the management of chronic pain and it is beyond the scope of this 
literature review to examine all of them.  
Cognitive behavioural therapy and group therapy 
Cognitive behavioural therapy (CBT) has been used as a treatment modality in individuals 
with chronic pain in the past (Thorn and Kuhajda, 2006; Haraldseid, Dysvik and Furnes, 
2014; Furnes, Natvig and Dysvik, 2014) and remains a treatment modality of choice in many 
multidisciplinary pain clinics. Studies have reported benefits including reduced pain intensity, 
pain interference, improved mental health, socialisation, pain related functioning, acceptance 
of pain and lifestyle changes (Thorn and Kuhajda, 2006; Cucciare, Sorrell and Trafton, 2009; 
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Huggins et al. 2012; Trafton et al. 2012; Haraldseid, Dysvik and Furnes, 2014)  . In South 
Africa, the South African Neuropathic Pain guidelines (Chetty et al. 2012)  recommend CBT 
as a non-pharmacological intervention for neuropathic pain based on a review of evidence 
that showed modest efficacy for chronic pain (Turk et al. 2010). 
 The efficacy of cognitive behavioural therapy in a population of PLWHA suffering from HIV 
related pain has shown a reduced pain intensity of two points on a numeric rating scale 
(NRS), a clinically significant improvement in pain according to the Initiative on Methods, 
Measurement, and Pain Assessment in Clinical Trials (IMMPACT) recommendations 
(Dworkin et al. 2008). Reduced pain anxiety, pain interference in overall functioning and 
improvement in mental health symptoms such as mood, and an improvement in pain 
acceptance have also been demonstrated (Huggins et al. 2012; Trafton et al 2012). The 
cohort and intervention was the same for three studies (Huggins et al. 2012; Cucciare, 
Sorrell and Trafton, 2009; Trafton et al. 2012), with the researchers using different 
questionnaires focussing on different outcomes. The intervention was carried out on 
outpatients at 3 primary care  clinics in San Francisco. The fact that three studies were 
carried out in the same cohort using the same intevention may indicate that CBT has not 
been widely used with PLWHA  who suffer from chronic pain. The sample size was small  60 
for the studies by Trafton (2012) and Cucciare (2009) and 45 for the Huggins (2012) study 
which restricts the reported results to this cohort alone. The attendance at the CBT group 
was also poor with only 35% attending the total CBT sessions (Huggins et al. 2012; Trafton 
et al. 2012). Therefore, significant changes reported may not have occurred due to the CBT 
intervention alone, although participants in one of the studies rated their satisfaction with 
CBT very highly (Trafton et al 2012). The high participant satisfaction may indicate that even 
a small number of CBT sessions are beneficial. However, in this context there was no 
control group present, therefore, findings may not be as valid as confounding variables and 
other factors may have played a role in the outcomes reported. 
 Satisfaction with CBT as an intervention is portrayed well in the words of this study 
participant who said [‘‘Most of the group participants dug deep and shared, there were a lot 
of tough stories, and then you see you are not the only one to struggle.’’] (Haraldseid, Dysvik 
and Furnes, 2014, p 16). This statement suggests benefits of group interactions. Social 
support, a warm group climate, a sense of fellowship and trust which consequently leads to 
a deeper level of sharing and an improvement in the daily lives of participants are of value in 
the intervention (Haraldseid, Dysvik and Furnes, 2014). Studies have shown that benefits of 
group interaction, support, trust and a sense of fellowship are important aspects of 
participating in a therapeutic group (Mundell et al. 2012; Furnes, Natvig and Dysvik, 2014). 
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This is highlighted by this quote taken from the study by Mundell et al. (2012) [“I made 
friends and seeing those women I realized that I was not the only one, it gave me courage 
and confidence to live my life.”] Improved mental health, lifestyle changes, improved 
socialisation were some of the benefits reported (Mundell et al. 2012, p 6).  
It is still debatable whether cognitive behavioural therapy is the answer to pain management 
in PLWHA. The benefits of cognitive behavioural therapy have not been found to last longer 
than 6 months in this population. Studies with longer follow up periods are required to 
establish the long term benefits of CBT (Evans and Fishman, 1997; Molassiotis et al. 2002; 
Huggins et al. 2012; Trafton et al. 2012). In a case study by Thorn and Kuhajda, (2006), it is 
reported that CBT groups can run for up to 3 years with the same participants, however, 
there is a lack of research to prove that this is current accepted practice for CBT and chronic 
pain. This would appear to be a resource intensive approach to treatment which may not be 
appropriate in a South African setting.  
A study comparing CBT to peer support counseling (PSC) found the benefits of peer support 
counseling lasted longer than CBT (Molassiotis et al. 2002). The changes noted at 3 months 
in the CBT group were not present at 6 months post intervention while the PSC group had 
significant changes noted in quality of life and psychological variables. This suggests that 
CBT may need to be an ongoing therapy rather than a once off programme although the 
effectiveness of this approach needs further research. The cost implications may restrict the 
use of ongoing CBT. These study results (Molassiotis et al. 2002) may also suggest that a 
group which is facilitated by a peer may be more successful than one run by a healthcare 
professional and may be worth exploring in further research. These results are supported by  
Lorig, Ritter and González (2003) who reported that the use of  peer leaders are beneficial 
when using a self-management programme due to the modelling of behaviour that occurs, 
the increased availability of peer leaders versus healthcare professionals and the fact that 
peer leaders speak the language of participants (Lorig, Ritter and González,2003).  
Evans et al. (2003) compared CBT and individual psychotherapy in a group of PLWHA who 
suffered from painful peripheral neuropathy. She reported a significant reduction in pain 
intensity and pain interference of at least two points on the numeric rating scales. However, 
the high attrition rate from this study of 45.9% lead to the researcher concluding that 
psychological interventions such as CBT and psychotherapy may not be viable or feasible in 
this population. This casts some doubt on whether CBT or other psychological interventions 
are effective interventions that can produce long term results in PLWHA, particularly in 
resource poor settings. 
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Mindfulness based Practice  
Mindfulness based practices have long been advocated in the field of chronic pain 
management. Some examples of the mindfulness based practice approaches such as 
meditation, hypnosis and relaxation therapy are reviewed below. 
Hypnosis  
Hypnosis has been assessed as a treatment modality in several populations suffering from 
pain such as chronic low back pain (Tan et al. 2015), work related musculoskeletal disorders 
(Roja et al. 2013), dysmenorrhea (Shah et al. 2014), burn patients (Patterson et al. 1992)  
and multiple sclerosis (Jensen et al. 2016). Results vary with some reports of significant 
reductions in pain intensity ratings (Roja et al. 2013; Tan et al. 2015; Jensen et al. 2016) and 
no significant differences when compared to other interventions (Shah et al. 2014). This may 
be due to the heterogeneity of diagnoses and types of pain in the study cohorts as well as 
the type of hypnotic intervention delivered which ranged from self-hypnosis to cognitive 
hypnotherapy (Roja et al. 2013; Shah et al. 2014; Tan et al. 2015; Jensen et al. 2016). 
Hypnosis has also been used to manage pain in PLWHA demonstrating a significant 
reduction in pain (4 points on the total McGill pain questionnaire score) and an improvement 
in quality of life and depressive symptoms 3 weeks post intervention (Dorfman et al. 2013). 
Unfortunately, the reduction in pain was only reported to have lasted 7 weeks post 
intervention when the last follow up assessment was done. The study design made it difficult 
to reliably ascertain that these changes were due to the hypnosis (Dorfman D 2013). A 
randomised controlled trial is necessary to determine if hypnosis can be used to effectively 
manage pain in this population, however, due to the very nature of hypnosis this is difficult to 
achieve as is the case with most rehabilitation modalities. 
Meditation  
Meditation is another therapeutic modality used in chronic pain with some positive results 
reported, including the reduction of anxiety and depression, increased pain acceptance and 
feelings of control over pain (La Cour and Petersen, 2014), reduction of pain perception 
(Bakhshani et al. 2016) and reduction of stress, symptom severity and sleep disturbance 
(Cash et al. 2015). These studies were stronger than the hypnosis studies as they all 
included a control group but had small sample sizes which may have affected the 
significance of the reported results. Efficacy of meditation or mindfulness has been 
demonstrated in cohorts of PLWHA (Nicholas et al. 2007; Duncan et al. 2012). Nicholas et 
al. (2007) reported that meditation was scored second highest for efficacy from all the 
complementary medicine strategies for self-management of peripheral neuropathy 
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symptoms in PLWHA, while Duncan et al. (2012) demonstrated that mindfulness meditation 
reduced the frequency of symptoms at 3 and 6 month follow up and reduced the associated 
stress experienced at 3 months. Therefore, meditation may have some possible benefit in 
management of pain in PLWHA; however, this requires further research using randomised 
controlled trials which compare different interventions. 
Relaxation Therapy 
Relaxation therapy has been advocated in the treatment of chronic pain for chronic 
headache and fibromyalgia sufferers. There are several types of relaxation therapy including 
guided imagery, muscle relaxation and autogenic training which can also include 
diaphragmatic breathing.  
A systematic review on the use of relaxation therapy in fibromyalgia and chronic fatigue 
syndrome concluded that there was a moderate effect on acute pain when guided imagery 
was used. There is no agreement on the content of visualisation that should be used in the 
techniques and no indication of the benefit of the technique in chronic pain. The studies 
reviewed had conflicting results on the long term benefits. The review included data on 650 
fibromyalgia sufferers and 88 chronic fatigue sufferers with a range of relaxation therapy 
techniques using randomised controlled trials. Blinding was not possible and the review 
reported that it was difficult to ascertain the effects of relaxation therapy as many studies 
included it as a component of a multimodal therapy programme, thus the authors only 
included those trials which used the relaxation therapy on its own (Meeus et al. 2015). The 
duration of relaxation therapy varied from one session to four weeks. Techniques and 
protocols varied as well which is possibly the reason that results conflict. The risk of bias in 
these studies is high as the therapist cannot be blinded from the study participants due to 
the nature of the technique. 
A second review on guided imagery in an arthritis and rheumatic disease population 
demonstrated that guided imagery is beneficial in decreasing pain, anxiety and fibromyalgia 
symptoms, improving self-efficacy, mobility and psychological well-being. The review 
covered a sample of 287 participants and was restricted to the guided imagery technique 
alone. The study concluded that there was an unclear risk of bias due to lack of blinding and 
the use of self-report measures alone to measure study outcomes. The duration of the 
techniques also varied and longer follow up would be necessary to establish permanence of 
the results reported (Giacobbi et al. 2015). 
A study done on chronic tension type headache patients compared the effects of relaxation 
therapy, acupuncture and physical training in a cohort of 90 headache sufferers and 88 
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matched healthy participants. Their results indicated that physical training was significantly 
better in reducing symptoms than acupuncture (p=0.036) after three months. At 6 months 
there was no significant difference in the symptom profile between the three intervention 
groups indicating that any changes that may have occurred at three months were not 
permanent. Relaxation therapy was found to significantly improve sleep and vitality when 
compared to acupuncture (p=0.04) at the six month follow up assessment. However, this 
was restricted to a particular component of the symptom profile and did not have an overall 
effect when the total symptom profile was calculated (Soderberg et al. 2011). The 
intervention period ranged from two to three months and 10 -12 sessions for each technique. 
This variability in the length of intervention may have been a confounding variable, however, 
the techniques were fairly standardised and delivered by the same group of experienced 
therapists which adds to the reliability of the results. The study did not use a pain specific 
outcome measure, therefore, the impact of the relaxation therapy technique on pain cannot 
be commented on. The risk of study bias is high due to the lack of blinding as mentioned 
previously. Despite this there seems to be merit in this technique that would require further 
research. 
Relaxation therapy has been used in the HIV population but mainly for stress management 
and the examination of any possible effect on immune status. A study using relaxation 
therapy as part of a cognitive behavioural intervention reported better emotional coping and 
quality of life but these were modest findings which the authors admit are not definitive 
(McCain et al. 2008). An improved immune status was reported in the results but could not 
be linked to any change in stress levels. The study participants were not highly stressed pre-
intervention so it was difficult to establish whether the effects were linked to stress reduction. 
Another study on 150 HIV positive women also looked at the effect of relaxation therapy as 
part of a cognitive behavioural stress management programme. The authors reported a 
significant reduction in cortisol post guided imagery, however, confounding variables such as 
duration of relaxation therapy, lack of data about practice outside the study, varying times of 
collection of the saliva for analysis and the limited follow up (only during study period of ten 
weeks) cast doubt on the integrity of these results (Jones et al. 2014). 
The reviewed research  has mixed results which is possibly due to the lack of a standardised 
protocol for these techniques and the variety of relaxation therapeutic techniques used 
(McCain et al. 2008; Jones et al. 2014; Meeus et al. 2015; Soderberg et al., 2011; Giacobbi  
et al. 2015). It is also difficult to achieve blinding in these studies due to the nature of the 
technique which requires interaction with the health care practitioner thus the risk of study 
bias is high. There are indications that relaxation therapy has benefits but its role in the 
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management of chronic pain requires further research using randomised controlled trials 
with standardised interventions and longer follow up periods to establish permanence of any 
effects observed. There is also a lack of research with this modality in PLHWA who 
experience chronic pain. The above research demonstrates that this may be a useful 
modality in pain management for this population. 
Acupuncture and Massage therapy 
Acupuncture and massage therapy have been studied widely in a number of chronic pain 
populations (Scharf et al. 2006; Suarez-Almazor ME, 2010; Field et al. 2015; Damapong et 
al. 2015; Wamontree et al. 2015, Ji et al. 2015, MacPherson et al. 2015; Shin et al. 2015). 
For massage therapy, the results indicate reductions in pain intensity and tissue hardness 
(measured with a tissue hardness meter which gives a reading of percentage of tissue 
hardness) and an increased range of motion (Damapong et al. 2015). However, many of 
these studies reported results after short term follow up periods of one to four weeks only 
with the exception of three studies that had follow period of 12 weeks( Suarez-Almazor et al. 
2010), 26 weeks (Scharf et al. 2006)  and 12 months (MacPherson et al. 2015) respectively.  
The longevity of the shorter study results cannot be commented on (Field et al. 2015; 
Damapong et al. 2015; Wamontree et al. 2015). The heterogeneity of the different treatment 
techniques used in these studies also do not allow for adequate comparison of all the data 
collected in these studies. Acupuncture has also been researched in several chronic pain 
populations with conflicting results of improvement of pain or no significant differences in 
outcomes used in the studies (Scharf et al. 2006; Suarez-Almazor et al. 2010; MacPherson 
et al. 2015; Shin et al. 2015; Ji et al. 2015). 
Acupuncture and massage therapy were compared to the usual biomedical approach in a 
study that used focus groups and interviews to establish participants’ views on treatment 
benefits (Ho and Robles, 2011) in a cohort of PLWHA who were experiencing peripheral 
neuropathy. It was surprising to note in this study that even though the study participants 
reported temporary pain relief from the complementary modalities received, they believed 
that these modalities were a good long term option for pain relief, even to the extent of 
discontinuing their ARV medication for periods of time as they felt the complementary 
options were more beneficial (Ho and Robles, 2011). This is a concerning finding as the 
discontinuation of ARV’s would lead to the development of ARV resistance over time and a 
possibility of disease progression depending on the amount of time the ARV was 
discontinued.  
Another study in a group of 46 individuals living with HIV in the United States of America 
compared massage, acupuncture and a combination of massage and acupuncture to a 
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control group who did not access these treatments. The subjective experiences of the 
participants revealed that acupuncture and massage whether used individually or combined, 
reduced pain, improved energy levels, decreased anxiety and improved sleep. The control 
group did not exhibit these changes (Henrickson M, 2001).This study did not use 
standardised outcome measures. Outcome measures included a numeric rating scale to rate 
the impact of treatment, a 19 item questionnaire used to rate the perception of treatment 
impact and CD4 counts that were measured at baseline and post treatment. The lack of 
standardised outcome measures such as the BPI or Becks Depression Inventory makes the 
results questionable as only subjective reports of symptom relief via telephonic interview 
were used to gather this data and no significant changes were noted in the CD4 counts 
taken (Henrickson M, 2001).  
A Canadian mixed methods study in 194 PLWHA revealed that massage was one of the 
most common choices among participants (Mulkins et al. 2014). At the 18 month follow up 
visit 81% reported the use of a massage therapist and 15% reported the use of an 
acupuncturist. The results showed an improvement in pain, energy, stress and overall well-
being, however, these were not attributed to a specific modality and therefore one cannot 
draw the conclusion that massage therapy was responsible for the changes in health status 
noted. It is important to note the possible impact of the “care effect” that these type of 
interventions produce where the individual feels that the manner in which they are treated is 
much warmer and that the service provider cares about how they feel. This is demonstrated 
by the following quote taken from this study: [“I spend most of my days alone but I know I 
can come here and find someone who is going to listen to my issues and try their best to 
help me. That means so much to me..... Susi (Reiki practitioner) knows where I am coming 
from. She has been treating me for a while now and I know she is healing me. She literally 
lifts weight off my shoulders”] (Mulkins et al. 2014,p 220). 
The studies cited above reveal that CAM and specifically hypnosis, meditation, relaxation 
therapy, acupuncture and massage therapy are being used by PLWHA for various health 
benefits such as the management of fatigue, stress, neuropathy and other symptoms 
(Henrickson M, 2001; Nicholas et al. 2007; Mcain et al. 2008; Ho and Robles, 2011; 
Dorfman et al. 2013; Mulkins et al. 2014, Jones et al. 2014) The efficacy of such modalities 
in providing pain relief has not been established and more rigorous studies are required 
using a randomised control trial design that uses a control group which does not receive the 
intervention.  
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Electrotherapy 
There are several electrotherapy modalities available to treat pain. These are 
transcutaneous electrical nerve stimulation (TENS), laser, interferential therapy, shortwave 
diathermy and ultrasound. There is insufficient evidence that demonstrates efficacy of some 
of these modalities in pain; however, TENS has been used widely in the management of 
acute and chronic pain. TENS was thus chosen as the electrotherapy modality to focus on 
for this review.  TENS is the modality recommended by guidelines and a significant amount 
of research has been done in the field of chronic pain using this modality (Dailey et al. 2013; 
Lauretti, Chubaci and Mattos, 2013; Pallett et al. 2014; Koke et al. 2015 ).  
The electrotherapy modality of TENS has often been touted as a good pain management 
tool in chronic pain as it activates inhibitory pathways while decreasing central excitatory 
mechanisms (Dailey et al. 2013).The long term benefits of TENS however remain to be 
proven in research (Dailey et al. 2013 Lauretti, Chubaci and Mattos, 2013; Pallett et al. 2014 
Koke et al. 2015). A significant reduction in pain of two points or more on a visual analogue 
scale (Koke et al. 2015) and a significant difference in pain and fatigue with movement 
(Dailey et al. 2013)  have been reported in a chronic pain population of fibromyalgia patients.  
However, the data collection methods used in this study may have influenced the results. 
The six minute walk test used as an outcome of function was performed prior to measuring 
pain. This may have resulted in decreased stiffness which subsequently could have resulted 
in decreased pain (Dailey et al 2013).   
The use of TENS during active movement was recommended in a review by Vance et al. 
(2014) on the use of TENS for pain control. The review further stated that dosage, 
placement of electrodes and tolerance to TENS were issues that warranted further 
investigation in research. Other factors found to be independently associated with continued 
TENS use at the six month follow up assessment are; higher expectations of pain relief, 
neuropathic pain and absence of severe pain (Koke et al 2015). This may imply that an 
expectation regarding pain relief could affect outcomes of pain relief from TENS and that 
pain severity may play a role in determining efficacy of TENS in the management of chronic 
pain (Koke et al 2015). It is useful to note that those suffering from neuropathic pain were 
found to have continued the TENS treatment at the six month follow up assessment (Koke et 
al 2015). This may indicate that they found the treatment beneficial and this may be a 
management option for PLWHA who suffer from neuropathic pain. However, the long term 
efficacy of TENS in chronic pain remains unproven (Dailey et al. 2013; Lauretti, Chubaci and 
Mattos, 2013; Koke et al. 2015).  
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An observational study by Pallett et al. (2014) looked at compliance with TENS and the 
effect of TENS on pain intensity in patients with chronic low back pain. Pain intensity was 
measured at 4 time points on a daily basis, before, during, and at the end of treatment and 
30 minutes after. Only 1 study participant complied fully with the TENS protocol and 20% 
showed good compliance. The majority of participants (77%) showed partial adherence to 
study protocol. However, 42% of participants responded to TENS treatment with a more than 
30% reduction in pain intensity which is clinically significant according to IMMPACT 
recommendations (Dworkin et al. 2008). Of these only 29% utilised TENS for the 
prerequisite hour (Pallett et al. 2014). The researchers concluded that perhaps the 
inconsistency of efficacy that is reported in research for TENS can be attributed to 
participants not following the protocol of use correctly. This would mean that TENS is an 
effective pain management modality if used appropriately. Adherence is an aspect difficult to 
control as the implementation of pain management with TENS is mostly patient administered 
and relies on good patient education and compliance for correct implementation.  
Studies reviewed in this section also differed in the treatment parameters set for use of 
TENS and due to a lack of standardisation in protocol, the comparison of the treatment 
outcomes is difficult. The periods of application and follow up varied ranging from seven 
days to four weeks of application and zero to six months for follow up post intervention. This 
makes it difficult to judge the long term efficacy of TENS reported as well as the optimum 
treatment time (Lauretti, Chubaci and Mattos, 2013).The use of TENS also carries a 
significant cost and may not be accessible to those with a lower socioeconomic status. This 
is unfortunately the case with a large number of PLWHA in South Africa. The use of TENS 
as a viable modality for pain management in PLWHA in South Africa is possibly not a 
realistic option. 
The treatment modalities reviewed above are passive in nature and do not promote active 
engagement in an individual living with HIV/AIDS. Therefore, self-management of the 
disease may be compromised in individuals who use these modalities as treatment. They 
may be using passive coping strategies as opposed to active coping strategies to cope with 
their disease and symptoms. Passive coping strategies have been shown to demonstrate 
poorer long term outcomes in chronic diseases. Several studies reviewed under self- 
management and exercise sections below show that once individuals engage in active 
coping and management strategies of their chronic disease, their management of symptoms 
and health status improved. Another barrier to the use of these modalities is the costs of 
these modalities which restrict use to those who can afford the treatment. Access to this type 
of treatment is also not freely available in the rural areas of South Africa due to availability of 
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experienced therapists in these areas. We have a lack of healthcare resources in South 
Africa thus optimum service delivery is compromised. Using a self-management approach 
with active coping strategies will help to alleviate the burden on an already strained 
healthcare system. In addition this approach is cost effective as the affected individual 
spends less time attending treatments by different healthcare providers. 
Education 
Patient education, particularly pain neuroscience education, has recently been demonstrated 
to be an effective therapeutic tool in the management and prevention of pain (Furnes, Natvig 
and Dysvik, 2014). Education self-management programmes have been researched in the 
HIV population for many years (Gifford et al. 1998; Gifford and Sengupta 1999; Webel A R, 
2010). Understanding how to manage the symptomatology, side effects and possible co-
morbidities that accompany the diagnosis of HIV is vital to good medical management of the 
disease process for both the healthcare practitioners and PLWHA. Webel (2010) tested the 
efficacy of education alone on symptom management and medication adherence in PLWHA. 
No significant changes were found in medication adherence or quality of life outcomes. The 
weakness of this study, however, may lie in the scripted intervention. Whilst it standardised 
the process of education, scripted interventions do not allow for spontaneous group 
interaction and communication. Furthermore, at baseline the group had various co-
morbidities which included depression and diabetes; all participants were female with four 
transgender females present (Webel A R 2010). These may have been confounding 
variables that could have influenced the study results. The participants also reported a low 
number of symptoms at baseline (0.49) on the HIV Sign and Symptom Checklist, thus a 
further reduction in symptoms may not have been reflected due to a floor effect. The 
qualitative comments of the participants, however, showed that they did experience benefits 
from the education as demonstrated by the two quotes below: 
[“I like the program because I have learned more ways to control any negative symptoms I 
have.”]  suggesting a gain of useful knowledge and [“I meet other women who are just like 
me and we learn about each other; they bring experience and they bring lots of information 
about HIV.”] which confirms the therapeutic nature of a group educational intervention 
(Webel A R, 2010, p 1033).  
Two of the studies using education in PLWHA involved the same intervention called the 
positive self-management program (PSMP). The methodology differed in that one was a 
qualitative study using telephonic interviews with 24 participants who had undergone the 
programme (Gifford and Sengupta, 1999) while the other was a pilot of a randomised trial 
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done with 71 participants randomly allocated to a control group of usual care and the PSMP 
(Gifford et al. 1998). The qualitative study revealed positive feedback by participants similar 
to Webel’s (2010) results. Five main themes were identified, these were: contracting which 
included setting of goals, use of the resource manual provided, support experienced by 
group members, knowledge and experience available in the group and a change of attitudes 
and behaviours (Gifford and Sengupta, 1999). Once again the study participant’s comments 
revealed how helpful they found the intervention for goal setting: 
[“I guess probably the fact that even though you’re really ill and you might have a 
life-threatening illness, you can still set goals and those goals don’t have to be 
long-term goals. They can be short-term goals, but they kind of give you hope and 
give you something to work for. I thought that was beneficial.”]. (Gifford and Sengupta, 1999, 
p 124).The benefits of the group communication with a group of participants who share a 
common illness are also demonstrated by the following statement: 
[“You know, it’s like everybody comes to this [PSMP] at a different point and is at 
a different stage [of their illness], but we’re able to build understanding and communication 
through that’] (Gifford and Sengupta,1999, p 126). The quantitative study reported a 
decrease in symptom severity and improved self-efficacy for control of symptoms in the 
intervention group while the control group (usual care) experienced an increase in symptom 
severity and a decrease in self-efficacy over a three month period (Gifford et al.1998).  
 
These studies are supported by other research that shows that education may be effective 
as part of a self-management programme to improve symptom severity including pain and 
self-efficacy in chronic pain populations including PLWHA (Lorig et al. 1999; Lorig et al. 
2001; Kravitz et al. 2011; Nkhoma, Seymour and Arthur, 2015).   
Exercise 
Exercise contributes to overall well-being by improving cardiovascular fitness, flexibility, 
muscle strength and endurance (Cassato and Churilla, 2009; Pedersen and Saltin, 2015) 
and has also been found to reduce the risk of chronic low back, neck and shoulder pain 
(Nilsen, Holtermann and, Mork, 2011). In addition to preventing health conditions, exercise 
and graded physical activity has also been shown to reduce pain scores in a chronic pain 
population (Gazzi Macedo et al. 2012; Tse, Wan and Ho,  2011). A study by Tse, Wan and 
Ho (2011) showed a reduction in pain scores on a 10 point scale of 2 points with a significant 
increase in range of motion (p<0.01) following an eight week exercise programme (including 
stretching, strengthening exercises and massage) in a cohort with a 73% prevalence of 
chronic pain. The reduction in pain was attributed to the exercise programme; however, the 
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massage component may have been a confounding variable in this study (Tse, Wan and Ho,  
2011). A comparative study between motor control and graded exercise programmes which 
included stretching, strength and cardiovascular training supported Tse, Wan and Ho’s  
(2011) finding in a population of chronic low back pain outpatients attending physical therapy 
in Australia (Gazzi Macedo et al. 2012). Although no differences were found between the 
control and experimental groups, all study participants experienced a significant reduction of 
two points on the numeric rating scale for pain, a reduction of disability and an increase in 
function as measured by the 24-item Roland-Morris Disability Questionnaire and 36-Item 
Short-Form Health Survey at 12 month follow up (Gazzi Macedo et al. 2012). The study 
results may be due to the effects of research study participation. This is due to the fact that 
both the control and experimental group improved regardless of the exercise intervention. 
The non-specific effects of any therapeutic relationship that may have developed between 
study participants and the researchers cannot be ruled out as a confounding variable. 
The use of exercise as a non-pharmacological intervention has been demonstrated to 
improve the health of people suffering from chronic conditions such as diabetes and 
hyperlipidaemia (Pedersen and Saltin, 2015). HIV has evolved into a chronic disease much 
like diabetes due to the advent of antiretroviral drugs (Van Olmen et al. 2012). Early reports 
suggest that improved cardiovascular fitness, self-efficacy, weight, body composition, 
fatigue, health related quality of life and life satisfaction are benefits of exercise in HIV 
populations (Fillipas et al. 2006; Gomes et al. 2010; Smith BA, 2001. Two systematic 
reviews by the same group of researchers looked at aerobic and progressive resistive 
exercise and found  exercise to be safe and beneficial for PLWHA in terms of improved 
cardiopulmonary fitness, body composition, psychological status (O'Brien et al. 2010) and 
improved weight and strength (O'Brien et al. 2008) respectively. 
These reviews are supported by Gomes et al. (2010) who used an exercise programme that 
included cardiovascular, strengthening and flexibility exercise  three times a week on 
alternate days over a period of 12 weeks in PLWHA. The study outcomes showed no 
significant changes in the CD4 count compared to baseline measurement but a significant 
increase (p=0.002) in  self-reported life satisfaction using the Life Satisfaction Index (Gomes 
et al. 2010) . Further, Fillipas et al. (2006) compared aerobic and resistive exercises twice 
weekly to a walking home programme over a period of six months. The study outcomes 
showed an increase in self-efficacy, cardiovascular fitness, overall health and cognitive 
function for the exercise group when compared to the baseline scores and the control group 
scores (Fillipas et al. 2006). These results are further supported by a Zimbabwean study 
which looked at the effect of a 12 week progressive resistive exercise programme on health 
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realted quality of life in a cohort of PLWHA. The results showed a significant improvement in 
scores on the Euroqol 5D visual analogue scale for the intervention group (Mkandla; 
Myezwa and, Musenge, 2016).The long term efficacy of the interventions used in the above 
studies could not be established as the participants were not followed up post intervention 
(Fillipas et al. 2006; Gomes et al. 2010).  Mkandla; Myezwa and Musenge (2016)  also 
reported a high drop out rate of 60% which may have influenced the study results (Mkandla; 
Myezwa and Musenge, 2016). 
Home programmes may be used to ensure carryover of benefits obtained during exercise 
programmes run in the clinic i.e the home programme will follow on from a supervised 
exercise programme done in therapy. Unsupervised exercise has been shown to be less 
effective than supervised exercise. This was demonstrated by the Fillipas et al.(2006) study 
results where an unsupervised home based walking programme had poorer outcomes than 
the supervised exercise group in spite of the high rate of exercise adherence  by both 
groups.  
The various studies discussed in the section above show that exercise has several benefits 
for individuals suffering from chronic pain and from HIV. Therefore, this may be a viable, cost 
effective intervention for the management of pain in PLWHA. 
Self-Management  
Self-management, in the context of a long-term medical condition, is defined as: [“Self-
management is about giving people living with long-term conditions the tools, skills and 
support they need to improve their own wellbeing.”] (selfmanagement uk 2015). Self-
management may be an effective way of delivering a number of interventions to an individual 
in a manner that saves on resources and time spent. These skills can be initially taught by a 
trained peer leader or healthcare provider in a group setting. The individual then takes 
responsibility for their own disease management with home programmes or home based 
tasks which help them to put these skills into practice (Lorig et al. 1999). As discussed 
earlier, group therapy may be beneficial as it allows engagement in a group of peers which 
helps individuals suffering with the condition (such as pain or HIV or both) due to the 
support, trust and feeling that someone else understands their experience (Molassiotis et al. 
2002; Haraldseid, Dysvik and Furnes, 2014; Furnes, Natvig and Dysvik, 2014) . 
Lorig (1999) and colleagues originally presented the concept of self-management in a 
population of individuals suffering from a variety of chronic diseases (Lorig et al. 1999). This 
model has since been tested in a variety of settings with a number of chronic conditions such 
as arthritis, cancer, diabetes, heart and lung disease and HIV (Gifford et al.1998; Lorig et al. 
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2001; Gitlin et al. 2008; Kravitz et al. 2011). The positive effects achieved are not always 
maintained, for example the reduction of pain was not sustained post intervention when 
measured at 6 and 12 weeks in the study by Kravitz (2011) in a cohort of cancer pain 
sufferers. This could possibly also be due to the fact that the intervention was done in one 
visit and the follow up period was short. 
Self-management has been used successfully to manage chronic pain in PLWHA and has 
been shown to reduce symptom severity and improve self-efficacy (Millard, Elliott and 
Girdler, 2013; Parker, Jelsma and Stein, 2016a). These results have shown short term 
efficacy as most studies used a 3 month follow up period as reviewed by Millard, Elliott and 
Girdler (2013), however, not all studies have rendered positive results. A small pilot study 
showed no significant changes in pain, fatigue and psychological symptoms (Gifford et al. 
1998). The small sample sizes as well as the voluntary nature of the study (participants were 
recruited through public service announcements and advertisements) have contributed to 
some study bias and the lack of specificity of the pain outcome measure may have 
contributed further to this (Gifford et al. 1998). Another study in a cohort of chronically ill 
individuals (suffering from lung disease, heart disease or arthritis) also showed no significant 
effects for the chronic disease self-management programme developed by Lorig (1999) and 
colleagues. The researchers concluded the good healthcare that the control group received 
as usual care may have impacted on the study outcomes. These participants were also 
recruited through public advertisement though some were invited personally through 
outpatients’ clinics (Elzen et al. 2007). 
A framework for the components of a self-management programme in PLWHA has been 
proposed by studies reviewed (Lorig et al. 1999, Parker, Jelsma and Stein, 2013, Parker, 
Jelsma and Stein 2016a; Webel A R, 2010). The suggested components of a programme 
include education on HIV, nutrition, exercise, goal setting, action planning and problem 
solving in a group setting (Webel A R, 2010; Parker, Jelsma and Stein 2016a). 
An  example of a South African HIV self mangement programme is The Positive Living 
Programme (PLP) which was developed by Parker, Jelsma and Stein (2016a). It comprises a 
6 week self-management programme that is accompanied by a detailed education manual. 
The programme is facilitated by a peer leader who  was trained by the researcher. The 
training involved facilitation of a self-management group according to the information in the 
manual. The information in the manual covers a variety of topics pertinent to PLWHA. Self- 
management, exercise, symptom management, pain management, stress management and 
nutrition are outlined in the manual and faciltated by the peer leader during group sessions 
that are held on a weekly basis. Emphasis is placed on goal setting, problem solving and 
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active engagement of all participants to ensure the development of active coping strategies 
in management of HIV  as well as pain. The programme is based on the chronic disease 
self- management programme  developed by Lorig (1999) and colleagues and the 
subsequent studies on this model of self-management (Lorig  1999; Lorig et al. 2001). HIV is 
a chronic disease as discussed earlier in this review, thus it makes sense that a chronic 
disease self- management framework would be beneficial in managing the symptoms of HIV 
which include pain. 
The programme was initially tested in a group of amaxhosa women in an urban setting and 
found to be beneficial in reducing pain severity, interference and improving self-efficacy, 
health related quality of life and depressive symptoms (Parker, Jelsma and Stein, 2016 a). 
The programme was compared to the education manual alone and both the control and 
experimental groups improved thus it is not clear what facilitated the improvement in 
participants. The study also had a short follow up period of 16 weeks. Further research is 
required to establish permanance of the effects and the link between the reduction in 
symptoms and the PLP.  
The use of Peer Leaders in self-management groups 
The use of peer leaders in facilitation of self-help groups is supported by research. Peer 
leaders have often been used in a variety of self-management programmes for chronic 
diseases such as diabetes, hypertension  and HIV ( Foster et al. 2007; Webel A R 2010; 
Mosack et al. 2012; Tang et al. 2014; Parker,Stein and Jelsma, 2014; Liu et al. 2015; Lorig, 
Ritter and González,2003). They are often utilized to address cultural and languange 
barriers in specific patient cohorts and to provide models to group participants or peers of 
how to manage medical conditions sucessfully(Parker,Stein and Jelsma, 2016a; Lorig, Ritter 
and González, 2003). There have been varying results in research reported which may to 
due to the different formats used in self-management groups. An example of this is Webels’ 
(2010) study which used a scripted intervention. This could be  identified as a possible 
confounding factor as it did not allow peer leaders to interact freely with group participants to 
facilitate learning. 
 A Chinese study reviewed earlier by Molassiotis et al. (2002) compared group CBT to a 
peer support counselling group and found that the peer support group’s psychological well 
being improved and was maintained at three months following the intervention while the CBT 
group participants had short term improvements that did not last post intervention 
(Molassiotis  et al. 2002). The follow up period for this study was limited to three months 
which does not demonstrate whether this would be an effective intervention in the long term. 
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Long term effects were demonstrated by another study which compared peer leaders and 
community health workers in a diabetes self-management programme. The study found that 
the participants in the peer led group had improvements in health outcomes that were 
sustained at 18 months when compared to the other intervention group. The authors argued 
that participants may have identified more strongly with a peer leader as the peer leader is 
suffering from the same medical condition and has to face similar daily challenges (Tang et 
al. 2014). This is a valid point and is specifically relevant in PLWHA who have to deal with 
the additional burdens of stigma and disclosure of their HIV status. The intervention in this 
study was, however, biased towards telephone based interaction as participants had 
difficulty travelling to the group sessions. One can therefore not assume that the same 
effects would be possible in a group face to face intervention which is the format for most 
peer led self-manangement programmes. 
A cochrane review on the use of peer led self-manangment programmes in 7442 participants 
concluded that there is insufficient evidence to support an improvement in outcomes for 
longer than six months. Studies reviewed did show improvements in pain, disability, fatigue, 
depression, self-efficacy, self-reported exercise and reduced health distress but none of 
these were evaluated long term and the effects although significant were small. There was 
also no evidence to demonstrate that peer led interventions were superior to profession led 
interventions (Foster et al.  2007). Limitations of the review are that the majority of 
participants were women aged between 40-65 years so results should be restricted to this 
cohort and the research reviewed may be outdated as it was all prior to 2007. Further 
research is necessary to establish the efficacy of using peer leaders in self- management 
interventions. The obvious benefits of cost effectiveness and reduced strain on healthcare 
resources is particularly relevant in the South African context (Cobbing, Hanass-Hancock 
and Deane, 2014; Chetty and Hanass Hancock, 2016) where healthcare resources are 
limited for  the population requiring healthcare. 
The role of the therapeutic relationship in treatment 
The reduction in pain intensity and interference in participants has often been attributed to 
non-specific effects or the placebo effect in the chronic pain population according to 
pharmacological studies (Moore et al. 2015; Dinat et al. 2015). Numerous drug trials for the 
treatment of neuropathic and chronic pain have failed to demonstrate drug efficacy due to 
placebo responses (Moore et al. 2015; Dinat et al. 2015; Fallon et al. 2015; Malik et al. 
2015).  
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The effect of a therapeutic relationship on pain has been investigated previously and found 
to be distinct from the placebo effect (Kaptchuk et al. 2008). Studies reviewed earlier on 
complementary medicine demonstrated that patients who feel “cared for” within a therapeutic 
environment experience pain relief (Mulkins et al. 2014). This is supported by a study that 
examined the therapeutic alliance between physiotherapists and patients with chronic low 
back pain. Results showed that using an enhanced therapeutic relationship resulted in an 
average decrease of pain by 3.1 points on a numeric pain rating scale (Fuentes et al. 2014). 
This is a significant finding as it demonstrates that the use of empathy, warmth, caring and 
understanding within a therapeutic relationship can result in profound clinical effects such as 
the reduction of pain (Fuentes et al. 2014). 
Pain associated with HIV also appears to be reduced when patients feel that somebody 
cares (Parker, Jelsma and Stein,2016a). The reduction in pain could be attributed to the 
“care effect” of having someone who cares about your pain and how you are feeling. In this 
study the participants were given the chance to attend a peer led group where they received 
support from fellow group members and the peer leader. The control group in this study did 
have access to the education manual; however, they did not receive active facilitation of the 
information in the manual.  The results showed a significant decrease in pain in both control 
and intervention groups when compared to the usual care that the participants had received 
in the 15 months prior. In addition, there was an improvement in health-related quality of life, 
symptoms of depression and self-efficacy once pain had improved, in both groups. The role 
of the therapeutic relationship is unclear in this study as the control group had access to the 
education manual in addition to interaction with the research assistant with whom a 
therapeutic relationship was developed and thus the effect of the therapeutic relationship 
alone was not isolated. 
The role of social support given by a healthcare provider may have an effect on the 
individual’s health related quality of life (Fuentes et al. 2014). This effect may help to partially 
counteract the negative support or social undermining that individuals experience due to 
stigma and social isolation associated with HIV (Maree, Dreyer Wright and Makua 2013; 
Parsons, Bond and Nixon, 2015; Denis P 2016).The role of the therapeutic relationship is 
thus important in providing support to those PLWHA who suffer from chronic pain as this 
additional support from a healthcare provider may assist in alleviating pain in these 
individuals. This has to be established in studies that examine more specifically the effect of 
the therapeutic relationship on pain. Ideally this needs to be done in a randomized controlled 
trial to establish if it is indeed the therapeutic relationship that is responsible for the changes 
reported by the studies above. 
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1.2.4 Conclusion 
Pain is highly prevalent in PLWHA and is responsible for a high level of morbidity as it 
significantly affects quality of life and function (Hughes et al. 2004; Astoro et al. 2007; Van 
As et al. 2009; Balderson et al. 2013; Merlin et al. 2013). As the treatment of HIV has 
evolved, HIV is now viewed as a chronic disease (Van Olmen et al. 2012) that can be 
managed medically through the use of ARV’s. However, management of pain experienced in 
this population is still problematic. There are a few studies that demonstrate that usual 
medical interventions have failed to manage pain effectively (Abrams et al. 2007; Frich and 
Borgbjerg, 2000; Koeppe et al. 2010; Dinat et al. 2015) . 
There is a dire need to address the problem of pain in the HIV population as it has been 
shown to negatively affect quality of life (Hughes et al. 2004; Astoro et al. 2007). Self-
management through the use of non-pharmacological interventions outlined above such as 
exercise, education and problem solving may be the answer with evidence that these 
approaches work in other chronic disease populations (Lorig et al 2001, Foster et al. 2007; 
Webel A R 2010; Millard, Elliott and Girdler, 2013; Furnes, Natvig and Dysvik, 2014; 
Parker,Stein and Jelsma, 2016a). 
However, healthcare resources are often limited (Cobbing, Hanass-Hancock and Deane, 
2014) due to the overloaded public healthcare system that most HIV sufferers have access 
to in South Africa (Cobbing, Hanass-Hancock and Deane, 2014; Chetty and Hanass 
Hancock, 2016 ). An innovative and cost effective approach is necessary when considering 
the management of chronic pain for PLWHA in South Africa. It is therefore important to 
establish whether a relatively resource intensive peer-led programme of self-management 
(Positive Living programme) recommended by Parker, Jelsma and Stein 2016a is more 
effective than simple educational resources or a therapeutic relationship. 
This prospective study examined whether these approaches of  peer led self-management 
or education  were effective interventions for reducing pain intensity as a primary outcome 
and also improving the secondary outcomes of health related quality of life, self-efficacy, 
physical function and depressive symptoms in PLWHA who have chronic pain. 
The aims and objectives of this study were therefore to measure the effects of: 
 a therapeutic relationship compared to 
 education together with a therapeutic relationship compared to  
 a peer-led intervention (Positive Living programme) (Parker R E 2013, Parker, 
Jelsma and Stein 2016a) together with a therapeutic relationship,  
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In an urban cohort of PLWHA who suffer from chronic pain with respect to the following 
outcomes: 
1. Pain severity measured with the Brief pain inventory (BPI) 
2. Pain interference measured with the Brief pain inventory (BPI) 
3. Depression measured with the Beck Depression Inventory II (BDI) 
4. Self-efficacy measured with the Stanford Chronic disease 6 – item self-
efficacy scale  (SE6) 
5. Health related quality of life measured with Euroqol 5D (EQ 5D)and 
6. Physical function measured with the Simmonds battery 
 
The null hypothesis of the study is: There will be no differences in pain severity or pain 
interference, health related quality of life, self-efficacy, depression and physical function in 
the participants in any of the three allocated intervention groups. 
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Chapter 2 Methods 
2.1. Research Design and overview  
This study was conducted at the Virology Clinic at the Charlotte Maxeke Johannesburg 
Academic Hospital. This is an outpatient clinic that is open weekdays from 8am to 1pm. The 
clinic services the geographical area around the Charlotte Maxeke Johannesburg Academic 
Hospital.  Attendance at the clinic is approximately 95 patients per day. The study was 
conducted from August 2014 to December 2015.  A sample of 70 participants was recruited 
from the queue at the Virology Clinic. People waiting in the queue to see the doctors were 
asked if they had pain over the last 3 months and if so, if they would be willing to participate 
in the study. Participants were taken individually to a consulting room in the clinic where the 
study was explained in more detail by the research assistants who spoke the local 
languages and assisted in obtaining informed consent. On confirmation that they met the 
inclusion and exclusion criteria and understood the nature of the study, written informed 
consent was obtained. The research assistants had worked in the clinic on previous 
occasions and were familiar with how the queuing system worked. They identified the 
patients on either side of the participating patient and their place was kept when they left the 
queue to participate in the interview for consent purposes. Thereafter they returned to the 
queue and came back to the study room for their baseline assessment when they had 
finished with their doctors appointment. On follow up visits the patients arrived to see only 
the research assistants for reassessment therefore there was no need to keep places in the 
doctors’ queue for them. 
Ethical clearance was obtained from the Human Research Ethics Committee (Medical) of 
the University of Witwatersrand. The ethical clearance number is M140877 (Appendix A). 
The trial was registered with the Pan African Clinical Trial Registry (PACTR) and the 
registration number is PACTR201410000902600 (Appendix B).  The study followed an 
experimental comparative group design which included components of randomization and 
blinding.   
2.2 Sample Size Calculation 
The sample was calculated using the improvement  of 3 points for pain severity in the brief 
pain inventory questionnaire with an alpha value of 0.5 to give the study a power of 90% if a 
sample of 20 per group is used thus a total sample size of 60 was required. The effect size 
was obtained from the previous study done (Parker, Jelsma and Stein 2016a, Parker RE 
2013). The sample calculation table is attached (Appendix C). Due to the drop out of 
participants, a modification and extension application was submitted to the Human Research 
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Ethics Committee (Medical) of the University of Witwatersrand to recruit an extra ten 
participants (Appendix D)   
2.3 Randomisation of the sample 
The researcher (DD) allocated participants to the three different intervention groups based 
on a randomization table obtained from a random number sequence generator at. 
https://www.random.org (Appendix E). A random number sequence was generated from 1-
60 and 61-70 for allocation to three Groups namely: education, peer led self-management 
group and therapeutic relationship (Appendix E).  Using these group allocations each 
participant was allocated a study number to ensure confidentiality and this number specified 
which group they were then allocated to. DD then set up appointments for the week 0 
assessment and interventions depending on this allocation.  An extra 10 participants were 
recruited later on in the study to counteract the effect of the large dropout of participants 
experienced. A second randomization table was generated for a further ten participants from 
61 to 70. 
2.4 Blinding of the sample 
DD was responsible for ensuring blinding throughout the study. The research assistants 
were blinded to the group allocation of each participant. This was maintained by informing 
the participants and research assistants alike not to discuss group allocation or interventions 
with each other. All questions and queries with respect to interventions and the information 
provided in the education manuals were addressed by DD. The research assistants did not 
have access at any point in the study to the random number sequence table and specific 
group allocations. Furthermore, the research assistant’s role was restricted to the 
administration of follow up assessments which were standardized and the same for all 
participants regardless of group allocation. 
Recruitment of participants took 3 months pre-intervention. Once sufficient participants were 
recruited to run a peer led group a start date was booked and the participants allocated to 
this group were called to come in for the week 0 assessment prior to the start of the peer led 
intervention. All groups were assessed at week 0 and reassessed at week 4, week 8, week 
12 and week 24 (Figure 2.1). Group 2 underwent a 6 week group intervention between 
weeks 0 and 8.   
Each of the components in Figure 2.1 below i.e. recruitment and screening, interventions 
and follow ups will be dealt with now.  Randomisation has been outlined earlier. 
2.5 Screening procedure  
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DD and research assistants used the screening question taken from the Brief Pain Inventory: 
“Throughout our lives most of us has had pain from time to time such as minor headaches, 
sprains and tooth aches. Have you had pain other than these everyday kinds of pain during 
the last week?” to establish which of the patients qualify to participate in the study. This 
question was modified to include the “last 3 months” not “last week” as the study 
investigated chronic pain not acute pain. Anybody answering this question positively was 
invited to participate in the study.  They were then given detailed information on the study 
(Appendix F) and informed consent (Appendix F) was obtained by the research assistants.   
 
 
Figure 2.1 Study Design 
 
2.6 Criteria for selection   
The inclusion criteria for the study were as follows:  
1. Age of participant had to be between 18 -40 years old 
2. A confirmed diagnosis of HIV infection 
3. On a stable highly an active antiretroviral treatment (HAART) regimen ≥ 6 months 
4. ≥3 month history of pain 
Recruitment and screening  
Randomisation 
Group 1 : Therapeutic 
Relationship 
Group 2: Education  
Manual issued at week 0 
Group 3 : Peer Led Self 
Management   
Group held wk1 to wk7 
Follow up at 4,8,12 & 24 weeks 
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5. First  and second language isiZulu speakers 
The reason for including only those participants on a stable HAART regimen was to ensure 
that all participants were medically stable and on appropriate treatment with no other co-
morbidities that could be confounding factors in the study.  
A 3 month or more history of chronic pain was necessary to ensure that the participants who 
were recruited to the study were experiencing chronic pain (Merskey and Bogduk, 1994). 
Participants were required to complete questionnaires and potentially complete an 
intervention that included an exercise component, participants were excluded if: 
1. they had any mental incapacity (defined as an inability to comprehend basic  
questions or information given about the study during recruitment)   
2. they were non-ambulatory participants who did not fulfil ACSM Health/Fitness Facility 
Pre- participation Screening Questionnaire criteria (Appendix G)    
Prior to study commencement DD, peer leaders and the research assistants all underwent 
training in the administration of the interventions, study methodology, research 
questionnaires and physical assessment batteries used. 
2.7 Training 
2.7.1 Researcher  
I underwent training in Cape Town with my co-supervisor, A/Prof R Parker, the developer of 
the Positive Living manual (Appendix H) and the group intervention protocol, prior to 
commencement of the peer-leader training. The training took place over two days.    
2.7.2 Peer leaders 
Two peer leaders (one male, one female) were sourced from the Treatment Action 
Campaign organization. This is a non-profit organization run mostly by volunteers which 
works toward improving the healthcare of PLWHA in South Africa. The peer leaders were 
selected after interviewing several candidates for suitability. The peer-leaders were trained 
by DD for a total 32 hours over a two week period prior to the study commencement. This 
included training on the content of the Positive Living manual as well as facilitation of group 
interaction with the group members. Emphasis was placed on using a facilitatory approach 
during the groups rather than a didactic one.  
2.7.3 Research assistants  
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The research assistants underwent the Good Clinical Practice course for non-clinical support 
staff run by the Wits Health Consortium. The course was based on clinical practice 
guidelines and training in the process of clinical trials and the course content can be viewed 
on http://www.academicadvance.co.za/Portals/0/GCP%20Basic%202016.pdf . 
Thereafter DD commenced training of the research assistants in administration of all 
outcome measures. This involved training them in practicing the administration of the 
questionnaires on each other and two work colleagues who spoke English as a second 
language. DD also trained the research assistants on the administration and recording of 
time taken to complete the Simmonds battery of physical tests. This was also done to ensure 
inter-rater reliability. Once the research assistants were confident in the administration of all 
questionnaires and the Simmonds battery of physical tests the recruitment of study 
participants’ commenced. The scoring of all questionnaires and data capture of the results 
was done by DD. 
2.8.  Study roles 
The roles of the researcher (DD), research assistants and peer leaders are described below.  
2.8.1  Researcher 
 DD was responsible for the following tasks: randomization, study management, blinding of 
research assistants, training of research assistants and peer leaders, data capture and 
analysis. The randomization of participants to the intervention groups was carried out by DD 
once the research participants had been recruited and screened by the research assistants. 
This was done using a random number generator which was discussed earlier under 
randomization. DD was responsible for the management of the study, training of the 
research assistants and peer leaders, payment of transport costs, allocation of appointments 
and refreshments as well as ensuring that the research assistants were blinded to the 
specific group allocation of each participant. DD collated, captured, analyzed and prepared 
the data for publication.  
2.8.2 Research assistants 
The recruitment and initial screening of participants for participation was carried out by the 
research assistants. The week 0 assessment and all subsequent follow up assessments 
were also carried out by the research assistants who were blinded to the specific group 
allocation of each participant. Unfortunately, due to the workload of the research assistants 
they were not able to always see the same participant for follow up appointments as there 
were other studies running concurrently as mine.  
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2.8.3 Peer leaders 
The peer leaders were recruited and underwent training in the peer led self-management 
group which is detailed in this chapter. The peer led self-management group lasted for 6 
weeks and occurred between weeks 0 and 8. This was overseen and monitored by DD to 
ensure that the groups were run correctly. The supervision was done through briefing prior to 
sessions and debriefing after each session held. Peer-leaders were compensated for their 
time with an hourly stipend of R52.75.   
2.9   Data Collection 
A baseline measurement was administered to all participants at week 0. Thereafter, 
reassessment occurred during follow up visits at week 4, 8, 12 and 24 shown in figure 2.2. 
We recruited 50% of the peer led intervention participants, started the group intervention and 
then recruited the next 50% for the second peer led intervention group. All participants were 
recruited and randomly allocated as per the random number allocation tables described 
above. All research participants received reimbursement for travel and airtime to ensure that 
they could call DD in-between appointments if necessary. DD allocated the funding on every 
visit and sent reminder messages via cell phone to all participants a day before their 
appointments. 
2.9.1 Measurement tools 
The outcome measures used in the study were as follows: 
1. The Brief Pain inventory (Short Form) (Appendix I) 
2. Becks Depression Inventory II (Appendix J) 
3. Euroqol-5D (Appendix K) 
4. Stanford Chronic disease 6 – item self-efficacy scale (Appendix L) 
5. Simmonds battery of physical tests (Appendix M) 
These assessments were administered by the research assistants and will be discussed   
individually below with respect to their suitability for use in this study.  
The Brief Pain Inventory (Short Form) (Appendix I) 
The Brief Pain Inventory (BPI) is a self-report questionnaire that measures pain intensity and 
pain interference (Cleeland CS 1989). The BPI was originally developed for use in cancer 
pain and has since been validated for use in chronic non-cancer pain (Tan et al. 2004, Daut 
RL 1983).  It is derived from an earlier questionnaire the Wisconsin Brief Pain Questionnaire 
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(WBPQ) (Daut RL 1983). It is an easy to understand scale that takes a fairly short amount of 
time to complete (10 minutes). The pain intensity questions  use a numerical rating scale 
from 0 to 10, where 0  is labelled as “no pain” and 10 is labelled as “pain as bad as you can 
imagine”. The questions rate the participant’s worst and least pain in the last 24 hours, 
average pain and pain right now at the time of assessment. The participant then records the 
treatment or medication taken for the pain and rates how much relief these provide. Once 
again a scale from 0% to 100% is used where 0% indicates “no relief” and 100% indicates 
“complete relief”. The pain interference items follow the same format using a numerical scale 
where 0 is labelled “does not interfere” and 10 is labelled “completely interferes”. General 
activity, mood, walking ability, normal work, and relations with other people, sleep and 
enjoyment of life are the domains assessed for pain interference.  Severity of pain is graded 
as follows: mild pain ranges from severity level 1 to 4, moderate pain ranges from 5 to 6    
and severe pain ranges from 7 to 10 according to the scoring criteria of the BPI. 
Since its development, the BPI has been used in a number of studies on HIV related pain 
(Merlin et al. 2012, Evans et al. 2003; Smith M Y, 2002, Uebelacker LA , 2015) including a 
few South African  and African studies (Nkhoma , Seymour and Arthur, 2015, Wahab  and 
Salami  2011). The WBPQ, the precursor to the BPI, was validated in three indigenous 
South African languages, namely, Isizulu, Setswana and Xitsonga. In addition it was also 
validated for use in second language english users(Mphahlele, Mitchell and Kamerman, 
2008). When one compares the WBPQ and the BPI there are minimal differences.  “Least” 
pain severity was added to the BPI and the interference by pain is described  using visual 
analogue scales where as the WBPQ used a categorical rating  scale and did not have a 
“least “ pain severity category. In addition, the WBPQ asked about the type of pain  and 
effectiveness of pain treatment and the patients perception of the cause of pain  where the 
BPI asks about medication use and  a rating of effectiveness is used (Cleeland CS, Brief 
Pain Inventory User Guide, 2009). Mphahlele, Mitchell and Kamerman (2008) found that the 
internal consistency of the items was good with the Cronbach alpha co-efficient ranging from 
0.80 to 0.88 for pain intensity across the different languages.  The study also found the 
Cronbach alpha co-efficient for pain interference ranged from 0.73 to 0.94.  This study was 
completed in both urban and rural cohorts in a South African HIV positive population 
(Mphahlele, Mitchell and Kamerman, 2008). The BPI was also translated and validated for 
use in the isiXhosa language in an HIV positive population ( Parker, Jelsma and Stein 
2016b). For the current study  the English and Isizulu versions of the BPI were used. 
Average pain severity was not included in my calculation of the pain severity score. A 
previous validation study of the BPI (Mpahlehle, Mitchell and Kamerman, 2008) showed that 
‘average’ pain intensity did not translate well in isiZulu and that the term average pain 
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translated to ”medium”, “pain in between” or “mild” pain (Mpahlehle, Mitchell and Kamerman, 
2008). Thus the average pain severity reported by amaZulu participants would not be an 
accurate reflection of their average pain (where average is the patients rating of pain that is 
felt for most of the time) and this would impact on the validity of the pain severity score 
making it an unreliable measure. In my study I therefore excluded average pain intensity 
when calculating the pain severity score to ensure a more reliable measure of pain severity. 
The scale has demonstrated ability to detect improvement over time (Tan et al. 2004). It was 
chosen as it has been validated for use in chronic non cancer pain, has been used and 
validated in HIV studies, therefore, is appropriate for the study population chosen. The 
IMMPACT recommendations on outcome measures in chronic pain found  that the pain 
interference scale of the BPI met the criteria for assessment of clinically significant 
differences in  physical function (Dworkin et al. 2008). This lends weight to my choice of this 
outcome measure in this study. 
Other instruments such as the Mcgill pain questionnaire (Main C J, 2015) were considered, 
however, the McGill pain questionnaire may not be understood well by participants who are 
using English as a second language (Main C J, 2015). A second limitation is it has not been 
translated into South African languages used in this study. Furthermore, The Mcgill pain 
questionnaire does not examine interference with daily activity which the BPI does. 
Therefore, the BPI was selected over the Mcgill pain questionnaire as the outcome measure 
of choice to measure pain intensity and severity. Permission to use the Brief Pain inventory 
was obtained prior to use in the study from Dr. Charles S. Cleeland.  
Beck Depression Inventory (Appendix J)   
The Beck Depression Inventory (BDI) is a self-report questionnaire that looks at depressive 
symptoms and has been revised several times (Beck et al. 1961). This study used the Beck 
Depression Inventory Version II which is the third version of the BDI (BDI-II manual 1996) 
English and Zulu versions. The items included are designed to correspond to the DSM IV 
diagnostic criteria for depression and it was originally validated on a population of psychiatric 
patients and normal adults (Beck et al. 1961). The BDI consists of 21 groups of 4 items that 
have a numeric rating of 0-3 rendering a total score of 63.  The items are ranked from 0 to 3 
on a Likert scale according to the degree of symptom   severity experienced with 0 being no 
symptom and 3 being a severe degree of symptom severity. Item 16 and 18 pertaining to 
sleep patterns and appetite respectively have a 7 point scale to detect changes in behaviour 
to aid in diagnosis. The total score is divided into ranges for minimal (0-13), mild (14-19), 
moderate (20-28) and severe depression (29-63) (BDI-II manual 1996).The participants 
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report how they are feeling right now and the questionnaire consists of the following 
symptoms / behaviour associated with depression: mood, pessimism, a sense of failure, a 
lack of satisfaction, feelings of guilt, a sense of punishment, self-dislike, self-accusation, 
suicidal tendencies, crying, social withdrawal, indecisiveness, distortion of body image, work 
apathy, sleep difficulties, fatigue, loss of appetite, weight loss, loss of libido, preoccupation 
with somatic symptoms  and irritability (Beck et al. 1961). 
The BDI has been used in the chronic pain population (Beck and Steer, 1988; Kerns RD, 
2004) and the IMMPACT recommendations (Dworkin et al. 2008) are for the use of the BDI 
to identify clinically significant differences in emotional functioning in chronic pain 
participants. Whilst Kerns (2004) reported that the BDI II may inflate depressive symptoms in 
people with chronic pain as it was not developed for use in chronic pain (Kerns RD, 2004), a 
consensus meeting addressing the use of outcome measures in chronic pain identified that 
small changes on the BDI were clinically meaningful (Dworkin et al. 2008). With its robust 
psychometric properties the BDI is recommended as an appropriate outcome measure of 
emotional functioning in chronic pain. It is suggested that three criteria could be used to 
measure clinically important change in participants who have chronic pain: the BDI score is 
considered normal if <10; if a shift occurs to a less severe category e.g. moderate to mild; if 
there is a change of 5 points on the BDI score(Dworkin et al. 2008). 
The BDI II has been validated for use in a population of PLWHA (Lipps GE, 2010). It has 
also been used in studies with HIV related pain (Evans et al. 2003; Keltner et al. 2012) and 
in South African studies of PLWHA (Govender and Schlebusch, 2012; Nel and Kagee, 2013; 
Breet et al. 2014) though the studies were not pain related. The BDI II has been translated 
into isiZulu (Govender and Schlebusch, 2012) which makes it a good choice for this study as 
it allows for easier administration to participants in the South African setting where Zulu is 
spoken as a first or second language. As it has been used previously in studies with HIV 
related pain as well as South African PLWHA the English and Zulu versions of the BDI II was 
chosen as the outcome measure of depression this study. Permission was applied for and 
granted through www.pearsonclinical.co.uk.   
Euroqol-5D (Appendix K) 
The Euroqol 5D is a self-report questionnaire that measures the health related quality of life 
(HRQOL) of an individual (Brooks R 1996, Buxton et al. 1990). It has 5 dimensions which 
measure physical, social and psychiatric aspects. These aspects are assessed by rating 
mobility, self-care, usual activities, pain or discomfort, and anxiety and depression according 
to a 3-point scale that ranges from no problem to extreme impairment or severity. Thereafter 
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the participant then has to rate their state of health on a visual analogue scale from 0 to 100 
with 0 being the “worst imaginable state of health” and 100 being the “best imaginable state 
of health” (Buxton et al. 1990).  
This outcome measure was developed in Europe with several European countries 
participating in its development; however, its simple nature easily allows use in a variety of 
settings. The questionnaire was originally developed to complement other HRQOL 
instruments and give an indication of state of health (Buxton et al. 1990). The EQ 5D is short 
and easy to complete as it can be completed within 5 minutes. If compared to other health 
related quality of life scales such as the SF36, the EQ 5D yields information about quality of 
life in a much shorter and simpler format (Nilsson et al. 2007). This is helpful when the EQ 
5D is used in populations that are second language English speakers or has to be translated 
for use in a different language as the terminology used in the questions is simple. This is 
also beneficial when used in a group that has a lower level of education such as the study 
participants in this study. Nilsson et al. (2007) found that a higher percentage of respondents 
found the EQ 5D easier to use than the SF36 and that satisfaction with both instruments was 
rated equally (Nilsson et al. 2007).  
 The Euroqol 5D has been validated for use in both an HIV (Wu et al. 2002) and chronic pain 
population (Hurst et al. 1997, Soer et al. 2002). It has also been used in previous studies on 
HIV related pain (Keltner et al.2012; Merlin et al. 2015). The EQ 5D was translated into 
isiXhosa (Mkoka et al. 2003) and validated in an urban Xhosa speaking population (Jelsma 
et al.2004). The EQ 5D was then used to assess HRQOL in a South African isiXhosa 
speaking population of PLWHA (Hughes et al. 2004). The questionnaire has been translated 
into isiZulu; however, no published validation studies could be found. IsiZulu is similar to 
IsiXhosa as they have a common root language (Nguni) and are thus likely to have 
similarities in their culture (Valchev et al. 2011).  The EQ5D could thus be used with Zulu 
speakers as well. The above data and previous studies demonstrate that the EQ 5D is a 
user friendly outcome measure to assess HRQOL and has been translated into the South 
African languages used in this study. These were the reasons the English and Zulu versions 
of the EQ 5D was picked as the assessment of choice to measure HRQOL. 
Stanford Chronic disease 6 – item self-efficacy scale (Appendix K)  
The Stanford Chronic disease 6 – item self-efficacy scale (SE 6) is a self-report scale that 
looks at the measurement of self-efficacy in 6 domains (Lorig et al. 2001). These are: 
fatigue, physical discomfort or pain, emotional distress, symptoms or health problems, self-
management tasks or activities and medication use. The scale is rated using a visual 
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analogue scale that ranges from “1 (not at all confident) to 10 (totally confident)” (Lorig et al. 
2001). The original scale had 33 items in 10 subscales but this was reduced to 6 items 
(Brady T J, 2011). All six items are added and the mean is calculated by dividing the total by 
six. This is then used as the self-efficacy score (Lorig et al. 2001).  
This scale was developed by the Stanford Patient Education Research Centre from a 
number of self-efficacy scales developed for their chronic disease self-management 
programme. It was tested on 605 subjects with a variety of chronic diseases initially with a 
Cronbach alpha score of 0.91 (Lorig et al. 2001). A recently published study looked at the 
reliability and responsiveness of the SE6. The authors concluded that the scale could be 
used to assess self-efficacy in a number of chronic disease populations (Ritter and Lorig, 
2014) which is relevant to this study of chronic pain in HIV. In addition, a review by Miles et 
al. (2011) noted that this scale along with the Pain Self-Efficacy Questionnaire (PSEQ) and 
the Chronic Pain self-efficacy Scale (CPSS) were suited for use in the chronic pain 
population. The SE6, was recently used in a South African study of HIV related pain (Parker, 
Jelsma and Stein 2016a) and has been used in studies of various chronic conditions 
(Griffiths et al. 2005; Lester, Stepleman and Hughes, 2007; Gitlin et al. 2008; Dal Bello-Haas 
et al. 2010; Freund et al. 2013) and spinal cord injury (Pang et al.2009) in various 
populations. Since HIV is now considered a chronic disease (as noted in Chapter 1), this 
scale was chosen to measure self-efficacy in the research participants in this study.  The 
English and Zulu versions of the SE6 were used for this study.   
Simmonds battery of physical tests (Appendix L)  
The inclusion of physical exercise in the Positive Living manual and as part of the peer led 
group intervention links to possible improvements in physical function thus the Simmonds 
battery was chosen as an objective measure of physical function. The Simmonds battery 
consists of 9 subtests or physical tasks that the research participant must complete 
(Simmonds et al.1998). These include 3 walking tests ( preferred speed test, fastest speed 
test and measurement of distance walked in 6 minutes), loaded and unloaded reach tests, 
belt tie, sock test, a reach up test and a sit to stand test. These are described in the table 
below (Table 2.1) the test battery was initially validated on a sample of low back pain 
participants and a group of healthy pain free participants (Simmonds et al. 1998).  
The Simmonds battery has not been used in any published African studies using a HIV pain 
cohort but has been used in a study of ambulatory PLWHA who attended an outpatient 
facility in the United States of America (Simmonds, Novy and Sandoval, 2005). No published 
African studies in PLWHA to date could be found which included an objective measure of 
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function. The battery was included in my study’s outcome measures to provide an objective 
measurement of the research participants’ physical function which allowed comparison to 
self-reported physical function from the other outcome measures used.   
At the time of data collection we noted that a separate study on a similar intervention with 
osteoarthritis patients found no significance differences between groups for the ability to don 
the sock or the time taken to don the sock during the sock test (Saw, M 2015). It was then 
decided that the sock test would be excluded from the battery when administering the 
Simmonds battery in my study. The removal of the test did not have an effect on the scoring 
of the test or the interpretation of the results as each subtest is scored and evaluated 
independently of each other. 
Table 2.6 Description of Simmonds Battery 
Simmonds Battery 
Subtest Description  Assessment 
Preferred walking speed Participants walk 15 metres at their preferred 
walking speed.  
Average speed of walking 
Fastest  walking speed Participants walk 15 metres at their fastest 
walking speed. 
Speed of walking 
Distance walked in 6 
minutes 
Participants walk for 6 minutes measured in 15 
metre laps. 
Endurance and strength 
Loaded reach  Participants stand adjacent to a wall where a 
tape measure is placed horizontally at shoulder 
height. The participant reaches forward as far as 
possible holding a 4 kilogram weight horizontally 
at shoulder height. 
Endurance and strength 
Unloaded reach  Participants stand adjacent to a wall where a 
tape measure is placed horizontally at shoulder 
height. The participant reaches forward as far as 
possible with no weight at shoulder height. 
Range of motion of  upper 
limbs 
Belt tie Participants sat in a chair and were timed as they 
wrapped a standard crepe bandage 
approximately 1 metre in length around their 
waist. 
Co-ordination and speed of 
movement 
Sock Participants sat in a standard chair and were Co-ordination and speed of 
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timed as they put on 1 loose fitting sock. movement 
Reach up The participant faced a wall and reached as high 
as they could with both hands which was 
measured in centimetres. 
Range of motion of upper 
limbs 
Repeated sit to stand Participants were timed as they sat down and 
stood up twice a rest period was given between 
the first and second test. An average of both 
tests was used. 
Speed, co-ordination and 
range of motion  
 
 
2.10  Interventions 
My study used three different interventions namely, the therapeutic relationship, education 
and a therapeutic relationship and the peer led self-management group which included 
education and a therapeutic relationship. These will be described further below. 
2.10.1  Group 1 – Therapeutic relationship 
This group of participants were assessed at week 0 then returned for follow up at week 4, 8, 
12, and 24. In these appointments the outcome measures were repeated and the research 
assistant also asked culturally-appropriate questions, such as asking after the health of their 
family. During training of the research assistants, the researcher discussed the importance 
of forming a good relationship with participants by asking about their health and family prior 
to the commencement of the administration of questionnaires. A friendly, warm, open and 
empathetic manner of communication was encouraged by the researcher and this was 
continually refreshed and discussed with the research assistants throughout the data 
collection period. This was done in an effort to build and maintain a therapeutic relationship 
with all participants so that the effects of this relationship could later be seen in the study 
results. 
2.10.2. Group 2 – Education group   
This group included the therapeutic relationship explained above, with additional access to 
the educational material in the form of the Positive Living manual (Appendix M). The 
participants allocated to this group received educational material in the form of the Positive 
Living manual (Appendix M). The manual was given to these participants at week 0 after the 
baseline assessment by DD, to avoid any bias on the part of the research assistants who 
administered the assessments. This manual was translated into isiZulu and isiXhosa prior to 
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the start of the study and was also offered in English. The translation of the manual was 
done through the use of a reputable national translation company. The translation was 
carried out following a standard procedure with two independent language translators 
completing the forward translation of the manual into isiZulu and then two other language 
translators completing the backward translation into English. Thereafter a consensu meeting 
was held to discuss and agree on any discrepancies that arose in this process. 
 The manual contains education about self- management, exercise, stress management, 
nutrition, relaxation and symptom management and has been used previously (Parker R E 
2013, Parker, Jelsma and Stein 2016a ).To ensure that blinding remained, if the participant 
wished to ask questions on the information contained in the booklet they were directed to DD 
or to their treating health care professional i.e. doctor or nurse at the clinic.    
2.10.3 Group 2- Peer led self-management group  
The intervention included the therapeutic relationship explained above and a peer led 
multimodal group intervention. Participants were also given the Positive Living manual at 
week 1 of the intervention. This intervention was run over a period of 6 weeks and consisted 
of weekly peer led sessions with a group of participants. The sessions are outlined in the 
figure below (Figure 2.3). The sessions are based on the information in the Positive Living 
Manual (Appendix H) described above and given to the education group. The difference 
between the education and peer led group was that the information was facilitated by peer 
leaders in the peer led group.  
The study on which the peer led group was based found that when the programme was 
reviewed, concerns were expressed by the reviewers (who were recruited from the 
community) about groups with mixed sexes. The reasons given for these concerns were that 
aspects such as sexuality were not discussed in a mixed sex group as it is not culturally 
appropriate (Parker R E 2013). Thus there was a need for single sex groups and two-peer 
leaders, one of each gender.        
During the first session there was a discussion about the importance of confidentiality within 
the group and all participants signed an additional consent form that included consent to 
physical activity, consent to non-disclosure of information during the group, agreement to 
attend the weekly group session and the follow up appointments required for assessment.  
The aims of the programme were to educate participants about self-management and 
facilitate the use of a self-management programme by participants. This would help 
participants manage their chronic pain, symptoms of HIV and any psychosocial 
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manifestations such as stress or depressive symptoms through the use of non- 
pharmacological interventions.       
This group of participants was assessed at week 0 which occurred in the week of the first 
peer led group then returned for follow up at weeks 4, 8, 12, and 24.  
The intervention consisted of weekly sessions of two hours each shown Figure 2.2 below 
and explained in detail thereafter. They were taken through the manual with facilitation by 
the peer-leaders. The facilitators were briefed prior to each session and debriefed after every 
session by DD, to ensure that the peer leaders facilitated the groups according to the 
protocols they were trained in.  
The first week’s topics of self-management and exercise explained the steps of self-
management, the importance of exercise, what type of exercise to do and how to develop an 
action plan and achieve goals set each week. A simple exercise routine was demonstrated 
by the peer leader which was composed of 20 minutes of exercise. This was made up of 10 
different exercises which included stretching and aerobic exercises such as marching on the 
spot. These exercises were repeated at each weekly session and participants were 
encouraged to do the exercises at home as part of their exercise goals.   
Week 2 covered symptom management in general and then looked at specific symptoms 
and signs that PLWHA may suffer from. Action charts and checklists were used to help the 
participant understand the severity of the symptom experienced and whether this required 
the intervention of a healthcare professional or could be managed at home.  
In week 3 stress management was examined and this included a long and short relaxation 
session that the participants were encouraged to do at home. The relaxation session was 
administered by the peer leader within the session thereafter it was included at the end of 
every group session. The script for the relaxation therapy was included in the education 
manual so that participants could use this to practice the technique at home. The practicing 
of the relaxation session within the group was done to facilitate the participants learning 
about the technique and becoming more skilled at it. 
Pain management was the topic of week four with guidelines and suggestions of how to 
manage one’s pain. Good nutrition and the safe storage and preparation of food were 
covered in week 5.  
The last week was used to help participants plan for the future and ensure that they 
continued to use the self-management skills they had learnt so that they could manage their 
HIV and chronic pain experienced (Parker R E 2013, Parker, Jelsma and Stein 2016a ). 
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Each week included a feedback session that focused on goals that had been set in the prior 
session pertaining to that week’s topic, for example for session one- exercise – to walk every 
day at home for 10 minutes.  The achievement of the goal was rated and if the goal was not 
achieved discussion around reasons for this and how these could be addressed differently 
next time was discussed.  
Once the group had finished the six week programme the individual participants were asked 
to fill in a feedback questionnaire (Appendix N) given to them by DD. All participants were 
asked if they understood the questionnaire and DD and the peer leader were present if 
anyone required help understanding the questions, however, none of the participants 
requested assistance and all completed questionnaires were done independently by the 
participants. This questionnaire included the following questions:  
1. What did you like about the course?  
2. What didn’t you like about the course? 
3. Was there anything more you would like to learn that wasn’t in the course? 
4. What did you like about the workbook? 
5. What didn’t you like about the workbook? 
6. Is there anything you would like to add or change in the workbook? 
The information was then collated and the most common comments were noted. Each 
participant was also awarded a certificate of attendance at the end of the six week 
programme. 
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Figure 2.2 Outline of weekly sessions in the Positive Living Programme 
Self 
management & 
exercise 
•Self management 
steps 
•A good action 
plan 
•Types of exercise 
•Barriers to 
exercise 
•Exercise 
programme 
•Goal setting 
Managing 
symptoms of 
HIV 
•Review of 
previous goals 
•Fast checklist for 
new or worsening 
symptoms 
•Respiratory 
problems 
•Depression  
•Gastrointestinal 
problems 
•Headaches 
•Eye Problems 
•Skin problems 
•Urinary problems 
•Other common 
problems 
•Exercise session 
•Goal setting 
Stress 
Management 
•Review of 
previous goals 
•Managing stress 
•Causes of stress 
•Relaxation 
•Sleep 
•Communication 
with health carer 
•Goal setting 
•Exercise session 
•Relaxation 
session 
Pain 
•Review of 
previous goals 
•Causes of pain 
•Non 
pharmacological 
treament options 
•Medication 
•Goal setting 
•Exercise session 
•Relaxation 
session 
Nutrition 
•Review of 
previous goals 
•Balanced diet 
•Types of food 
•Managing eating 
problems 
•Storage of food 
•Exercise session 
•Relaxation 
session 
A successful self-
manager 
•Achievements 
•Future action 
plans 
•Useful resources 
•Exercise session 
•Relaxation 
session 
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2.11   Data Analysis 
Once the data had been collected from the participants I entered the data onto an electronic 
data base system called Research Electronic Data Capture (RedCap 6.14.1 - © 2016 
Vanderbilt University). This system allowed easy capture of the data collected onto an 
encrypted website that was password protected. Once the data had been entered it was 
exported to Microsoft Excel. The data were cleaned in order to prepare for statistical 
analysis. The statistical analysis was done using GraphPad version 6 (Graphpad, California) 
and R version 3.1.2 (R Core Team 2016). Normally distributed data were described using 
mean and standard deviations. Non-normally distributed data were described using median 
and range.  Univariate analyses of dichotomous variables were carried out using a chi 
square test, parametric, continuous variables were compared using a one way Anova and 
non-parametric, continuous variables were compared with a Krushkal Wallis test. 
There was missing data as participants did not attend all follow up visits. As a result, and 
because repeated measures needed to be taken into account, two way ANOVAs could not 
be used for multivariate analysis. A mixed model linear regression was used to fit a null 
model, which was then compared to models of the effects of group, time and group and time. 
When significance was found a correction for multiple comparisons was carried out using the 
Holm Bonferroni method.  If models remained significant they were compared to each other 
using an ANOVA. If one model was no better than another, the simplest model i.e. the model 
with the fewest terms was chosen. 
Prior to the linear regression, diagnostic tests were used to assess normality and 
heteroscedasticity of the data including histograms, quantile-quantile plots and graphing 
residual plots (Appendix O). Non-normally distributed data were transformed using log 
transformation or square root transformation as appropriate when non-normally distributed 
data couldn’t be transformed successfully, a Friedman test was used to determine effects 
over time and a Kruskal Wallis test was used to determine effects between groups for the 
self-efficacy, sit to stand, reach up and belt tie tests to establish significance.  
A p value of <0.05 was considered significant. Data were represented graphically using 
means and standard errors of mean. 
I completed all univariate analysis. The mixed-model regression was carried out by A/Prof 
Peter Kamerman from the School of Physiology. Statistical procedure followed was an 
intention to treat analysis. 
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Chapter 3  Results 
 
3.1 Sample flow and demographic data at baseline 
The flow diagram below in figure 5 shows the flow of the sample from recruitment to the 
week 24 follow up visit. Initially 70 participants were approached, four were excluded 
(reasons given in flow chart below), 66 participants were recruited, a further 25(37%) of the 
sample were excluded from statistical analysis due to not returning for follow up after week 4 
and not arriving for the first group session in the peer leader group. As a result there were 
data for 41 participants at week 0. At week 24, 28 participants remained with the majority of 
these allocated to the therapeutic relationship group (13). Some participants missed follow 
up visits but returned for the next follow up visit. 
 This loss to follow up over the 24 week period amounted to 32% of the sample (13/41) at 
baseline. This has been attributed to the finding of employment, relocation to other provinces 
and a loss of contact with participants. The total attrition from the initial sample recruited is 
therefore 58% as 38 participants were lost to follow up from the initial 66 participants. 
Various measures were undertaken to prevent the loss to follow up. Participants were sent 
reminder sms’s for appointments and called when they did not arrive on the day. In addition 
they were called afterward to allocate a second appointment date and time and two contact 
numbers were taken at recruitment stage to ensure that the researcher could contact the 
participants. The only avenue not explored was the use of home visits when the participants 
did not arrive or were not contactable by numbers provided. This is an option that should be 
considered for future research undertaken in this setting. 
I will describe the baseline characteristics and demographics of the sample outlined in 
Figure 3.1 below before explaining the results of the comparison of all variables and the 
results of the statistical tests used.   
The participants of all groups at baseline assessment were fairly homogenous in 
composition as demonstrated in the table (Table 3.1) below. They were mostly composed of 
women with no significant difference in the gender composition between groups. The 
majority of the sample had a secondary school level of education and was unemployed. No 
significant difference was found for nadir CD4 counts, viral loads, time since diagnosis of 
HIV or ARV treatment. Most participants were on first line antiretroviral treatment. 
Scores on the BPI, EQ5D, BDI and SE6 were also found to be fairly homogenous with no 
significant differences between groups at baseline assessment prior to interventions.  
63 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
Figure 3.1 Flow diagram depicting research study
Wk 24 (N=28) - total study sample 
Analysed (n=10) 
wk 0=10 
wk4=10 
wk8=10 
wk 12=9 
wk 24=7 
 
Analysed (n=15) 
wk 0=23 
wk4 =14 
wk 8=8 
wk 12=11 
wk 24=8 
 
Analysed (n=16) 
wk 0=16 
wk4=13  
wk8=14  
wk 12=15 
wk 24=13 
Drop out over study period (n= 15) 
Did not attend group (n=12) 
Ill health (n= 1) 
Lost contact (n=2) 
Drop out over the study period (n=15) 
Lost to follow-up at baseline (n= 8) 
Employed (n=2) 
Relocated (n= 3) 
Lost contact (n=2) 
Dropout over study period (n=8) 
Lost to follow-up at baseline (n= 5) 
Employed (n=1) 
Relocated (n= 1) 
Lost contact (n=1) 
 
Allocated to therapeutic relationship group (n= 21) 
Received allocated intervention (n= 16) 
Did not return for follow up (n= 5) 
Allocated to education group (n=23) 
Received allocated intervention (n=23) 
Did not return for follow up (n=8) 
Allocated to peer leader group (n=22) 
Received allocated intervention (n=10) 
Did not receive allocated intervention (n=12) 
 
Randomized (N=66) 
77777070)70) 
Assessed for eligibility (N= 70) 
Excluded (n= 4) 
Not meeting inclusion criteria (n=1) 
Declined to participate (n= 2) 
Died (n=1) 
 
 
 
Enrollment 
Allocation 
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Table 3.1 Baseline characteristics of the sample 
Age, sex, occupation, educational level, viral load and treatment is displayed using 
means and standard deviations [mean (SD)]. 
Variables Therapeutic 
Relationship 
Education Peer Leader p values 
Age in years             
 
41(6) 37(5) 36(6) 0.79e 
Sex       
Female          
Male 
 
12 (75) 
4 (25) 
  
12(80) 
5(20) 
 
6(60) 
4(40) 
 
0.46d 
Occupation      
Employed* 
Unemployed** 
 
 
9 (56) 
7(44) 
 
  
5(33) 
10(67) 
 
3(30) 
7(70) 
 
0.35d 
Educational Level 
None 
Primary 
Secondary 
Tertiary 
 
0 
0 
a16(100) 
0 
 
1(7) 
3(20) 
b11(73) 
0 
 
0 
0 
10(100) 
0 
 
 
0.05e 
Viral load copies/mL c  
LDL 
>LDL 
Missing data 
 
11(69) 
  5(31) 
 
12(80) 
  0 
  3(20) 
 
7(70) 
3(30) 
 
0.34e 
Treatment  
1st line ARV 
2nd line ARV 
3rd line ARV 
 
13(81) 
  2(13) 
  1(6) 
 
14(93) 
  1(7) 
  0 
 
8(80) 
1(10) 
1(10) 
 
0.77e 
EQ5D VAS, BDI scores, SE-6 scores, CD4 nadir and time since diagnosis is 
displayed using medians and ranges [median (range)]. 
 
Time since diagnosis in 
years  
 
8 (1-12) 
 
6 (1-15) 
 
6(2-14) 
 
0.61f 
CD4 Nadir in cells/mm3 250(12-569) 125(11-366) 249(3-325) 0.16f 
 
EQ5D VAS 60(20-90) 70(50-90) 60(20-80) 0.14f 
BDI 17(8-25) 27(4-43) 20(4-49) 0.20f 
SE-6 9(0-10) 9(0-10) 9(7-10) 0.91f 
*Employed – consists of part time, temporary and full time employment,**Unemployed – 
consists of unemployed, those on disability grants (n = 2) and student (n = 1), 
a
 Included 2 participants with Early Childhood Development course, 
b
 Included 3 participants 
with courses done after secondary school, 
c
 Included missing data for 4 participants.
  
d
Chi square test used to determine significance between groups,
  e 
One way Anova was 
used to determine significance between groups, 
f 
Krushkal Wallis was used to determine 
significance between groups 
 
65 
 
3.2  Baseline pain characteristics 
The focus of this study was on non-pharmacological interventions for chronic pain in PLWHA 
thus it was important to examine the results of the BPI in detail. The baseline pain 
assessment results are outlined below (Table 3.2) and show that all groups had similar 
scores for pain severity and interference at baseline.  The scores for pain severity ranged 
from a mild to severe level of 2 to 7. Pain interference was found to be moderately affected 
across all groups. Regarding analgesic use 44% reported no medication, 32% used 
paracetamol, 12% using amitriptyline, 5% ibuprofen, 2% aspirin and 5% other medication. 
For the 56% (23/41) using analgesics, pain relief reported from medication on average was 
rated as 39% on the BPI numeric rating scale where 0% indicates no relief and 100% 
indicates complete relief. Two sites of pain were commonly reported by participants with the 
most number of pain sites reported being seven. The five most common sites participants 
experienced pain were the feet (42%), chest (24%), lumbar (24%), ankles (24%), head 
(20%) and abdomen (18%). There were no significant differences found for the pain 
characteristics at baseline as shown below in table 3.2. 
Table 3.2 Characteristics of pain experienced at baseline 
Worst, least and current pain severity scores and all pain interference scores are 
displayed using medians and ranges [median (range)].  
Variables Therapeutic 
Relationship 
Education Peer Leader p values 
Pain severity 5 (2-7) 5(2-6) 5(3-6) 0.09 
Pain interference 
(average score)  
General activity 
interference 
Mood 
Walking 
Work 
Relationships 
Sleep 
Enjoyment 
 
5(0-8) 
 
 
6(0-10) 
8(0-10) 
4(0-9)  
4(0-9) 
5(0-9) 
5(0-10) 
5(0-7) 
 
6(0-10)  
 
 
6(0-10) 
7(2-10) 
5(0-10) 
5(0-10) 
6(0-10) 
8(0-10) 
5(0-10) 
6(0-9)  
 
 
7(2-10) 
7(0-10) 
5(0-10) 
5(0-8) 
4(0-10) 
7(0-10)  
3(0-10) 
 
0.60 
 
 
0.43 
0.86 
0.61 
0.59 
0.19 
0.32 
0.66 
Pain relief 40(0-70) 45(10-90) 30(0-80) 0.44 
Pain sites are displayed using a count and percentage [x(y %)].  
Total pain sites  
Head    
Chest   
Abdomen 
Lumbar 
Ankle   
Feet 
2(1-6)  
3(19)  
2(13) 
2(13)  
3(19) 
5(31) 
6(38) 
2(1-7)  
4(27) 
6(40) 
4(27) 
4(27) 
3(20) 
6(40) 
1(1-6)  
2(20) 
1(10) 
1(10) 
1(10) 
3(30) 
5(50) 
0.32 
Krushkal Wallis test used to calculate p value for all pain variables recorded in this table. 
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3.3  Pain Severity data 
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Figure 3.2 Comparison of pain severity scores 
 
A cumulative link mixed-model ordinal regression was used to test for the effects of group, 
time, and group and time on pain severity.  Each model was compared with a null model. 
There was no difference over time, however, a significant difference (p<0.05) was found for 
the scores of pain severity between the therapeutic relationship and education groups. This 
significance survived testing for multiple comparisons using the Holm Bonferroni test 
(p>0.05). 
Therefore, the results show that there was a difference in pain severity between the 
therapeutic relationship and education groups at week 8 and this was maintained at week 
24.  
 
 
 
 
 
 
 
Intervention 
TR=Therapeutic relationship 
E=Education 
PL=Peer leader 
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3.4 Pain Interference Data 
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Figure 3.3 Comparison of Pain Interference scores  
 
A cumulative link mixed-model ordinal regression was also used to compare the effects of 
group, time, and group and time on pain interference. Each model was compared to a null 
model. The effect of group, and group and time was not significant. There was an effect of 
time on pain interference scores (p<0.05) but this did not survive testing for multiple 
comparisons using the Holm Bonferroni test (p>0.05).  
Therefore, the results show that across all three interventions no significant difference was 
found for pain interference between groups or over time. 
 
 
 
 
 
 
 
 
 
TR=Therapeutic relationship 
E=Education 
PL=Peer leader  
 
 
 
Intervention 
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3.5   Depressive symptoms 
The data from the three intervention groups for depressive symptoms were tested for 
normality and found to be slightly skewed. The data were transformed using a square root 
transform which helped normalise the data (Appendix O).  
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Figure 3.4 Comparison of depressive symptoms 
 
Following the transformation of the data, a linear mixed-model regression was used to test 
for the effects of time, group, and time and group on BDI scores. The initial analysis showed 
a significant difference (p<0.05) over time which did not survive the multiple comparisons 
test using the Holm Bonferroni test (p>0.05). The time and group and time models were no 
better than the null model. 
Therefore, the results show that across all interventions no significant difference was found 
for depressive symptoms between groups or over time. 
 
 
 
TR=Therapeutic relationship 
E=Education 
PL=Peer leader 
Intervention 
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3.6 Health Related Quality of Life Data  
The data from the three intervention groups for EQ5D VAS was tested for normality and 
found to be slightly skewed. As the data were not normal they were analyzed using a general 
additive mixed-model (GAMM) with inflated beta distribution (Appendix O).   
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Figure 3.5 Comparison of health related quality of life 
A Likelihood ratio test was performed. There was an effect of group and time on EQ5D VAS 
scores (p<0.05), however, this did not survive the multiple comparisons test using the Holm 
Bonferroni test (p>0.05).  
Therefore, the results show that across all three interventions and over time there were no 
significant differences in health related quality of life.  
  
TR=Therapeutic relationship 
E=Education 
PL=Peer leader 
Intervention 
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3.7  Self-efficacy 
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Figure 3.6 Comparison of self-efficacy 
The data from the three intervention groups for the SE-6 scores was not distributed normally 
and attempts to transform the data were unsuccessful.  
Therefore, a Kruskal Wallis test was performed to establish group differences and no 
significance was found between groups (p>0.05). A Friedman test was performed to 
establish significance over time and no significance was found (p>0.05). 
Therefore, the results show that across all three interventions and over time there were no 
significant differences in self-efficacy. The clustering of scores near the top end of the scale 
suggests a ceiling effect.  
 
3.8 Data from the Simmonds Battery of Physical tests 
 
The data from the three intervention groups for all subtests of the Simmonds battery were 
compared across group and over time. The p values were calculated and two subtests were 
found to be not significant when compared to baseline, however, six subtests outlined below 
were found to be significant. 
 
 
TR=Therapeutic relationship 
E=Education 
PL=Peer leader 
Intervention 
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3.8.1 Preferred Walking Speed Subtest 
The data from the three intervention groups for preferred walking speed was tested for 
normality and found to be slightly skewed. The data were transformed using a square root 
transform which helped to normalise the distribution of data (Appendix O) 
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Figure 3.7 Comparison of preferred walking speed 
A linear mixed-model regression was used to compare the effects of time, group and group 
and time on preferred walking speed. There was a significant effect of both time and group 
and time (p< 0.05) on preferred walking speed. These associations survived the multiple 
comparison test using the Holm Bonferroni test (p<0.05). The models were assessed to see 
which was best. There was no significant difference between the models so the simplest 
model was used, which identified the effect of time to be most important. Therefore, the 
results show that there was a significant time effect, independent of intervention group, for 
preferred walking speed. The preferred speed of walking decreased from week 0 to week 24 
across all groups. 
 
3.8.2  Fastest Walking Speed Subtest 
The fast walking speed data was examined for normality and found to be skewed. This was 
not significant and no further adjustment of data were undertaken (Appendix O).   
 
 
TR=Therapeutic relationship 
E=Education 
PL=Peer leader 
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Figure 3.3 Comparison of fastest walking speed 
The initial linear mixed-model regression showed a significant difference (p<0.001) over time 
which survived the multiple comparisons test. 
There was a significant effect of both time and group and time on fastest walking speed 
(p<0.001). These associations survived the multiple comparison test using the Holm 
Bonferroni test (p<0.05). The models were assessed to see which was best. There was no 
significant difference between the models so the simplest model was used, which identified 
the effect of time to be most important.  The fastest speed of walking decreased over time, 
independent of which group participants were in. 
I compared the subjective data from the BPI reported by participants on walking interference 
using a student t test and found that there was no significant difference between week 0 and 
24 for walking interference i.e. the walking interference did not get worse over time.  This did 
not correlate with the objective data above from the preferred walking and fast walking 
speed subtests. 
 
 
 
 
TR=Therapeutic relationship 
E=Education 
PL=Peer leader 
Intervention 
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3.8.3 Distance walked in six minutes subtest 
The distance walked in 6 minutes data were examined for normality and found to be slightly 
skewed, this was not significant and no further transformation of data were undertaken 
(Appendix O).  
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Figure 3.9 Comparison of distance walked in 6 min 
 
Using linear mixed model regression the effects of time, group and group and time were 
assessed no significant effects were found (p>0.05). 
The results therefore show that across all three interventions no significant difference was 
found for distance walked in six minutes at weeks 0, 4, 8, 12 and 24 between groups and 
over time. 
 
3.8.4 Unloaded Reach subtest 
The unloaded reach test data was examined for normality and found to be skewed. A log 
transformation was used to normalize the data (Appendix O). Following transformation, 
linear mixed model regression showed that there was a significant effect of both time and 
group and time (p< 0.001) on the unloaded reach scores. These associations survived the 
multiple comparison test using the Holm Bonferroni test (p<0.001). The models were 
assessed to see which was best. There was no significant difference between the models so 
TR=Therapeutic relationship 
E=Education 
PL=Peer leader 
Intervention 
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the simplest model was used, which identified the effect of time to be most important. 
Therefore, the results show that there was a significant time effect (p<0.001), independent of 
intervention group, for unloaded reach. The unloaded reach increased from week 0 to week 
24 across all groups.  
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Figure 3.10 Comparison of unloaded reach test 
 
3.8.5 Loaded Reach subtest 
The data for the loaded reach test were fairly normally distributed. A log transformation was 
used so that the data matched the data from the unloaded reach test (Appendix O).  
 
 
 
 
TR=Therapeutic relationship 
E=Education 
PL=Peer leader 
Intervention 
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Figure 3.11 Comparison of loaded reach test 
 
Following transformation, linear mixed model regression showed there was a significant 
effect of both time and group and time (p< 0.001) on the loaded reach scores. These 
associations survived the multiple comparison test using the Holm Bonferroni test (p<0.001). 
The models were assessed to see which was best. There was no significant difference 
between the models so the simplest model was used, which identified the effect of time to be 
most important. Therefore, the results show that there was a significant time effect 
(p<0.001), independent of intervention group, for loaded reach. The loaded reach increased 
from week 0 to week 24 across all groups.  
Linear mixed model regression showed a significant difference (p<0.001) over time which 
survived the multiple comparisons test using the Holm Bonferroni test. 
There were significant differences for the loaded reach test over time which indicated that 
the participants reached further over time from week 0 to week 24. 
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3.8.6 Reach Up Subtest 
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Figure 3.12 Comparison of reach up test 
 
The data from the three intervention groups for the reach up test was not distributed 
normally and attempts to transform the data were unsuccessful.  
A Kruskal Wallis test was performed to establish group differences and no significance was 
found between groups (p>0.05). A Friedman test was performed to establish significance 
over time and no significance was found (p>0.05). 
The results therefore show that across all three interventions there was no significant 
difference was found over time for the reach up test from week 0 to 24.  
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3.8.7  Sit to stand subtest 
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Figure 3.13 Comparison of sit to stand test 
The data from the three intervention groups for the sit to stand test was not distributed 
normally and attempts to transform the data were unsuccessful.  
A Kruskal Wallis test was performed to establish group differences and no significance was 
found between groups (p>0.05). A Friedman test was performed to establish significance 
over time and a significance was found (p>0.001). 
This significance did survive the multiple comparisons test (p>0.001) using the Dunn’s test. 
The results therefore show that across all three interventions there was a significant 
difference over time for the sit to stand test from week 0 to 24. The participants performed 
this test faster as shown in the graph above. 
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3.8.8 Belt tie Subtest 
W
e
e
k
 0
w
e
e
k
 4
W
e
e
k
 8
W
e
e
k
 1
2
W
e
e
k
 2
4
0
1
2
3
4
5
A s s e s s m e n t tim e s  (w e e k s )
B
e
lt
 t
ie
 (
s
)
TR
E
P L
 
 
Figure 3.14 Comparison of belt tie test 
The data from the three intervention groups for the belt tie test was not distributed normally 
and attempts to transform the data were unsuccessful.  
A Kruskal Wallis test was performed to establish group differences and no significance was 
found between groups (p>0.05). A Friedman test was performed to establish significance 
over time and a significance was found (p>0.001). This significance did survive the multiple 
comparisons test (p>0.001) using the Dunn’s test. 
The results therefore show that across all three interventions there was a significant 
difference over time for the belt tie test from week 0 to 24. The participants performed this 
test faster as shown in the graph above. 
 
3.9 Feedback from group participants 
 
In addition to the quantitative data collected, participants who attended the peer led groups 
were given an opportunity to fill in questionnaires evaluating the group. This questionnaire is 
attached in Appendix N. Themes were identified and displayed in Table 3.3. 
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Table 3.7 Comments from feedback questionnaire 
 
Question: What did you like about the course?  
 
Participant 36: “I liked everything about the course especially about how to 
manage my health, stress etc. I really liked this book” 
Participant 35: “ It also taught us to manage our chronic illness” 
Participant 22 ”And how to deal with things that I face at home and in my 
life” 
Participant 53 ”Everything because it taught me about managing myself 
something’s I didn’t know and things that I was not keen to ask my doctor 
and specially to know my medication” 
Participant 51: ”I just like everything about the course, I learn how to 
manage myself” 
Participant 57: “I got many things how I must keep myself, health and to 
teach other people” 
 
Participant 35: “ I like that it was education, the ideas that we got from 
others, we were able to talk about challenges that meet on the way” 
Participant 22: “ It make me meet new people, how to work as a group” 
Participant 4: “I liked the ideas we get there and the people that we met they 
were friendly” 
Participant 40: “ It make me feel better than before , I like to share things 
with other people” 
 
Question: What did you like about the work book? 
 
Participant 11: “It took me to a different level, it made me understand that 
this disease can be managed” 
Participant 35: “Everything about it and it makes me alert of things that I 
should do in the future” 
Participant 22: “It keeps me going and makes me know how to plan or do 
things. I can keep it and use it anytime when I want to” 
Participant 4: “ It was very smart I learnt everything, that I can manage 
myself to the symptoms I get each and every time and my disease” 
Participant 51: “To manage my life, I just learned how to manage my life” 
 
Participant 36: “I liked the fact that it had everything I needed exercises etc.” 
Participant 57: “ This book gives me more information about people who get 
HIV, it contains good information about HIV and how to stop pains if you 
got” 
 
Participant 53: “It showed me that I can learn more and become an 
ambassador for HIV and teach schools, churches and underprivileged 
people” 
 
In response to the question “What didn’t you like about the course?” all participants 
answered nothing and gave feedback that the course was too short. 
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In response to the question ” Was there anything more you would like to learn that wasn’t in 
the course?” the participants answered that everything was covered and that they did not 
feel anything else was needed. 
In response to the question” What didn’t you like about the workbook?” Most participants 
answered nothing, with one participant indicating that the book should include more 
information. 
In response to the question” Is there anything you would like to add or change in the 
workbook?” Most participants answered “no” with one participant requesting information on 
safe sex and family planning and another asking for more information on HIV/AIDS.  
3.10 Conclusion 
In conclusion the study found significant differences for the pain severity scores between the 
therapeutic relationship group and education group. Significant differences were also found 
for the loaded reach, unloaded reach, sit to stand, belt tie, preferred walking speed and 
fastest walking speed subtests of the Simmonds battery. The loaded and unloaded reach, sit 
to stand and belt tie scores improved, while the preferred and fastest walking speed test 
scores reduced.  These differences are all outlined above with graphs and summaries of the 
p values found. There were no significant differences found for pain interference, depressive 
symptoms, health related quality of life, self-efficacy or any of the other subtests on the 
Simmonds battery. 
In addition the comments obtained from the peer leader group participants show that all 
participants found the group and information manual beneficial. 
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Chapter 4  Discussion and Conclusion 
4.1 Introduction 
 
In this study I set out to examine whether three non-pharmacological interventions would be 
effective in managing chronic pain in PLWHA and if so, which was the most effective. These 
three interventions were: 
 the use of a therapeutic relationship alone,  
 the use of a therapeutic relationship with an educational resource or  
 the use of a therapeutic relationship with a peer led self-management intervention 
plus the educational resource.  
The primary outcome was pain severity and the secondary outcomes were pain interference, 
self-efficacy, and health related quality of life, depressive symptoms and physical function. 
The results showed significant differences for the pain severity scores between the 
therapeutic relationship group and education group. Significant differences were also found 
for the loaded reach, unloaded reach, sit to stand, belt tie, preferred walking speed and 
fastest walking speed subtests of the Simmonds battery. The loaded and unloaded reach, sit 
to stand and belt tie scores improved, while the preferred and fastest walking speed test 
scores reduced.   
It is important to note that the high attrition rate of 58% resulted in the study being 
underpowered and this possibly contributed to the lack of significance found in the results. 
Thus all results reported must be seen in this light and any significant results reported 
cannot be construed as substantial findings due to this limitation. This limitation is discussed 
in further detail later in this chapter. 
South Africa has the largest population of PLWHA in Sub Saharan Africa (UNAIDS, UNAIDS 
fact sheet 2015). Consequently management of HIV and all related symptoms and co-
morbidities has become a priority for the South African Department of Health (UNAIDS, 
UNAIDS South Africa 2013, Department of Health 2014). Pain is commonly experienced by 
PLWHA around the world and is prevalent in the South African HIV/AIDS population (Norval 
D A, 2004; Harding et al. 2011; Bhengu et al. 2011; Farrant et al. 2012; Peltzer K, 2013). It 
has been shown that function; quality of life and productivity are affected in PLHWA who 
suffer from pain (Hughes et al. 2004; Astoro et al. 2007; Van As et al 2009; Balderson et al. 
2013; Merlin et al. 2013; Galantino et al. 2014). 
82 
 
Management of chronic pain in PLWHA has been mostly through pharmacological 
interventions which have been found to be ineffective or illegal in the case of cannabis 
(Finnerup et al. 2015; Kamerman and Mitchell 2011; Parker,Stein and Jelsma, 2014; 
Degenhardt et al. 2015; Dinat et al. 2015). This approach also does not follow the 
biopsychosocial approach usually recommended in the management of chronic pain 
(Marcus et al. 2000; Siddall and Cousins 2004; Cheatle M D 2016) and  leaves a gap in 
research with respect to the use of non-pharmacological management in this population. 
Non-pharmacological management has been shown to improve  pain intensity and 
interference (Evans et al. 2003; Trafton et al. 2012) health related quality of life (Mkandla, 
Myezwa and Musenge, 2016) , anxiety, energy and sleep (Henrickson M, 2001; Mulkins et 
al. 2014) as well as reduce symptoms (Gifford et al. 1998, Webel A R 2010). However, not 
all of these studies are in PLWHA who suffer from chronic pain. There is a paucity of 
research on non-pharmacological interventions in the HIV population globally and in South 
Africa. 
The current study was based on a previous study using the Positive Living self-management 
programme ( Parker, Jelsma and Stein 2016a) with the addition of a participant group that 
included therapeutic relationship alone as an intervention. This was done to establish if the 
therapeutic relationship played any part in the positive outcomes generated in the previous 
study, as positive results were reported for both the education alone and peer led groups by 
the previous study (Parker, Jelsma and Stein 2016a). 
Pain severity  
 
The study results showed there were no significant differences for pain interference, 
depressive symptoms, self-efficacy and health related quality of life. The earlier results of 
(Parker, Jelsma and Stein, 2016a) had shown a reduction in pain severity and interference 
as well as an improvement in self-efficacy, health related quality of life and depressive 
symptoms for all participants.  
Average pain severity was not included in my calculation of the pain severity score. A 
previous validation study of the BPI (Mpahlehle, Mitchell and Kamerman, 2008) showed that 
‘average’ pain intensity did not translate well in isiZulu and that the term average pain 
translated to ”medium”, “pain in between” or “mild” pain (Mpahlehle, Mitchell and Kamerman, 
2008). Thus the average pain severity reported by amaZulu participants would not be an 
accurate reflection of their average pain (where average is the patients rating of pain that is 
felt for most of the time) and this would impact on the validity of the pain severity score 
making it an unreliable measure. In my study I therefore excluded average pain intensity 
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when calculating the pain severity score to ensure a more reliable measure of pain severity. 
The participants in my study had a mild to moderate level of pain severity as shown 
graphically in figure 3.2 in the results chapter. Although there was a significant difference 
between the education and therapeutic relationship group over time this may not be clinically 
significant. The reason for this could be that the education group experienced significant 
attrition at week 8 and 24 with the largest overall number of loss to follow up coming from 
this group. This may imply that those participants who did not return for follow up may have 
been the individuals with a higher pain severity. The remaining group participants who 
returned for follow up may have had a reduced pain severity. The pain severity scores would 
thus be biased towards a lower level of pain severity as a result. These findings are unusual 
and there is no good reason that the researcher is aware of that could have been 
responsible for these results. This could be attributed to an erroneous finding in the study 
results. 
The study by Parker Parker, Jelsma and Stein (2016a) as well as the current study showed 
no differences between the intervention groups for self-efficacy, pain interference and health 
related quality of life when the intervention groups were compared with the exception of pain 
severity mentioned above. The differences found in the previous study (Parker, Jelsma and 
Stein, 2016a) and the current study over time were independent of the group allocation of 
participants with the exception of pain severity as discussed. The peer led self-management 
group has shown some efficacy in other chronic conditions including HIV and chronic pain 
(Gifford et al. 1998, Lorig et al. 2001; Gitlin et al. 2008, Kravitz et al. 2011 ), however, these 
results have not been replicated in randomized controlled trials and therefore may be 
questioned. The results from Parker, Jelsma and Stein’s 2016a study and the current study 
demonstrate that peer led self-management groups as a non-pharmacological management 
choice in this population requires further investigation. 
Self-efficacy and empowerment 
 
When the study results were compared for self- efficacy, the current study had a mean of 
nine out of ten at weeks 0 and 24. In the previous study by Parker, Jelsma and Stein (2016) 
athe mean at baseline was calculated at 7.09(SD1.58) at week 0 and 8.07(SD1.43) at week 
24 which was found to be statistically different (p=0.04). The self-efficacy scores from the 
current study demonstrated a possible ceiling effect when the data were analysed i.e. the 
scores were high at baseline so could not have been significantly improved upon. Ninety 
seven percent of participant’s scores at week 0 demonstrated a high level of self-efficacy 
which remained the case at week 24 for all participants in this study. This meant a clustering 
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of scores near the top end of the scale. The participants in Parker, Jelsma and Stein’s 
(2016a) study seemed to have a lower level of self-efficacy at week 0 and the scores were 
not clustering at the top end of the scale, thus the ceiling effect did not occur. Gifford (1998) 
also reported high levels of self-efficacy but did not seem to demonstrate a ceiling effect 
either. A cross sectional study that compared pain and depressive symptoms in spinal cord 
injury patients found that higher self-efficacy was linked to lower pain interference and less 
severe depressive symptoms (Pang et al.2009). The mean in this cohort (Pang et al.2009) 
was 6.5(SD1.6) which was significantly lower than the mean found in my study. It is possible 
that the higher level of self-efficacy found in my cohort is the reason that no other significant 
changes occurred. This could mean that my study population was quite empowered already 
which is possibly why this intervention did not really work with them. It could mean that these 
self-management interventions only work in people who have lower levels of self-efficacy 
who are thus more disempowered. Gifford (1998) also reported that their cohort was very 
empowered to begin with. 
Simmonds Battery Results 
 
Significant differences were found over time in my study for all participants for six 
components of the Simmonds battery. 
There was a significant reduction in preferred and fastest walking speeds over time between 
weeks 0 and 24 in the study groups. Due to logistical reasons these tests were carried out in 
a hospital corridor (the other tests were carried out in a private room) where passersby 
would occasionally stop to observe the test and ask the research assistants questions about 
the test. It is possible that the research participants would have felt more anxious about 
performing this test in a public space initially until they got used to the procedure and being 
observed by other people not involved in the study. Thus results could also be attributed to a 
decrease in anxiety at being tested, participants would have become more comfortable with 
research participants and the test procedure which may have led to a decrease in speed as 
they may have felt more relaxed. Like the findings on pain severity these findings are 
unusual and there is no other reason that the researcher is aware of (other than the one 
cited above) that could have been responsible for these results. This could be attributed to 
an erroneous finding. 
I compared the subjective data from the BPI reported by participants on walking interference 
using a student t test and found that there was no significant difference between week 0 and 
24 for walking interference. This infers that the participants did not feel that they were worse 
in terms of their walking but objectively reduced their walking speeds. Previous studies in 
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cohorts with pain such as total knee arthroplasty, lumbar spinal stenosis and ankylosing 
spondylosis have shown that participant’s subjective and objective data do not always 
correlate (Bolink, Grimm and Heyligers 2015; Tomkins-Lane et al. 2012; Van Weely et al. 
2012). This could be due to the fact that self-report measures do not measure the same 
specific aspects of physical function (Bolink, Grimm and Heyligers 2015; Van Weely et al. 
2012) as an objective physical test. This may be the case for the preferred and fastest 
walking speed data in this study as it does not correlate with the self-reported walking 
interference scores from the BPI. There may also be a risk of self-report bias from the study 
participants which could explain these results. 
There were significant differences for the loaded reach test and the unloaded reach test 
values over time. The participants reached further on the loaded reach test by week 24 than 
they did at week 0.  In addition all participants performed the sit to stand and belt tie tests 
faster by week 24. This could be due to improved physical function or the participants 
reaching further, sitting faster and tying the belt faster after having many opportunities to 
practice the tasks. This could also be attributed to the effect of mere participation in the 
research study. It has been demonstrated previously that participation in a research study or 
overt evaluation during a research study may influence the outcomes or study results (Cizza 
et al.2014; Wolfe and Micahaud, 2010; Robles-Garcia et al. 2015, Gazzi Macedo et al. 2012) 
and may result in an overestimation of functional improvement (Wolfe and Micahaud, 2010). 
These findings are unusual and could be an erroneous finding. Clinically this may mean 
what an individual reports on physical function may not be an accurate representation of 
their actual physical function thus it is important to use more than just self-report outcome 
measures for assessment in clinical practice in order to get a more accurate picture of an 
individual’s function. This would specifically apply to an individual who suffers from a chronic 
condition such as HIV as their own perception of their illness and symptoms may influence 
their self-report. The recent IMMPACT recommendations regarding the assessment of 
physical function recommend that self-report of function be combined with an objective 
physical function test which supports the above premise. In addition the authors note that 
physical function performance tests do not always reflect the everyday function that an 
individual engages in within their activities of daily living and may therefore not reflect their 
actual capacity (Taylor et al. 2016). This may also be true in my study and may be the 
reason the self-report conflicts with the actual physical performance of walking as the 
participants may be relating the interference question on the BPI to the distance they are 
required to walk on a daily basis which may include steps for example. 
86 
 
The role of the therapeutic relationship 
 
Parker, Jelsma and Stein’s (2016 a) participants were less empowered than my cohort due to 
the lower self-efficacy scores, however, they may have established a better therapeutic 
relationship with the research assistant, which then resulted in a positive effect from the peer 
led self-management programme and educational material provided. It is possible that the 
intervention worked better in her cohort due to this. My study used two research assistants 
thus the participants did not always see the same research assistant on follow up visits 
which may have hindered the development of a therapeutic relationship. My study sought to 
find out if the therapeutic relationship had the same effect as educational material or the self-
management programme. The previous study was not able to specifically report that the 
results seen could be attributed to the therapeutic relationship alone or the interventions 
supplied (Parker, Jelsma and Stein 2016a). Unfortunately the use of two research assistants 
may have resulted in interference in the development of a good therapeutic relationship 
which could account for the lack of changes seen over time in my study. 
Group differences and the inclusion of male participants 
 
The cohorts for Parker, Jelsma and Stein’s (2016a)’s study and my study did have some 
significant differences. The previous study included only Xhosa speaking, urban female 
participants while the current study included both urban male (n=12) and female (n=29) 
participants from various language backgrounds. Although the number of male participants 
was low, the addition of male participants may have influenced the study outcomes as male 
participants have been shown to report less pain (Deeny et al. 2015, Munce and Stewart, 
2007).  Thus the changes in pain severity and interference may have been less marked in 
my study due to the inclusion of male participants. During recruitment the research 
assistants reported that the male participants would not report pain in a public space such as 
the clinic waiting queue but would later report significant pain in a one on one interaction 
away from other people. This could explain the higher number of female participants 
recruited. Men are also reported to feel stigmatized by being seen as sick (Treves-Kagan et 
al. 2016) which may have contributed to the lower recruitment of men. This may mean that 
management of HIV related pain in men may be under recognized and subsequently under 
treated due to the lack of reporting by these men. In addition more male participants did not 
attend the first session of the self-management group and there was a higher dropout rate 
from the male group when compared to the female group. Those that did attend the group 
for the full duration participated just as enthusiastically as the female participants. 
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The participants in my study were mostly unemployed (59%, 24/41) and the majority had 
secondary school education (n=37) which was similar to the previous study (Parker, Jelsma 
and Stein 2016a). The majority of participants were in a relationship (59%, 24/41) with 3 
married and 14 single participants which included those divorced or widowed, while the 
study by Parker, Jelsma and Stein 2016 ahad a majority of single participants. This could 
possibly mean that those participating in the Parker, Jelsma and Stein (2016 a) study were 
less empowered than my study participants due to being more lonely and vulnerable.  My 
participants had more support systems due to being in relationships. 
Evaluation of the education manual and positive living programme  
 
The peer leader group in my study completed questionnaires regarding the Positive Living 
programme and the education manual they were given. The comments were positive and 
themes of self-management, interaction with others, motivation and self-confidence, 
empowerment and information were identified. All participants felt the manual and 
programme helpful. However, reporting of these comments may be biased as the education 
group were also given the Positive living manual but were not asked to comment on the 
manual, thus the comments may not be an accurate reflection of the manual itself and may 
have been influenced by group participation.  The participants did not objectively improve on 
the outcome measures that were self-report questionnaires but had all enjoyed the self-
management group and found it useful. It may be that the positive effects of participation in 
the group were short lived and did not last until the 24 week follow up when the final 
assessment of outcomes were done. Webel (2010) had similar results with the study 
participants reporting that they found the group beneficial but this did not translate into 
significant changes on the outcome measures. 
The results of (Parker, Jelsma and Stein, 2016a) had shown a reduction in pain severity and 
interference as well as an improvement in self-efficacy, health related quality of life and 
depressive symptoms for all participants. In comparison the current study did not have the 
same results thus no conclusions can be drawn at this stage about the role of a therapeutic 
relationship or the effects of the other interventions used in this study. Thus I believe that a 
change in current clinical practice is not warranted. 
Limitations 
 
The lack of efficacy in this study could be attributed to the small sample size. Although the 
possibility of drop outs was factored in to the initial power calculation with a possible dropout 
rate of 16%, the actual dropout rate was larger than expected at 58%. This was attributed to 
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various reasons such as loss of contact, moving to another city, ill health, obtaining 
employment and not arriving at the first session of the peer led self-management group. 
Possible reasons for non-attendance of the first group session were transport availability or a 
lack of understanding as to what the group participation entailed. Participation in the self-
management group required regular weekly attendance which may have been logistically 
difficult for some participants even though the transport costs were reimbursed. This resulted 
in an eventual 28 participants in total which was far lower than the anticipated 20 participants 
per group used for the sample size calculation. The study was thus likely underpowered and 
this possibly contributed to the lack of significance found in the results.  
It was found that participants who did come back for follow up were not consistent with 
attendance i.e. often missing appointments or follow ups and returning for the next 
appointment. This could be due to the fact that there were five time points at which the 
assessments were done and that the participants found it logistically difficult to return so 
often for follow ups. The attendance was therefore inconsistent. 
Several attempts were made to counteract the loss to follow up. Participants were sent 
reminder sms’s for appointments and called when they did not arrive on the day. In addition 
they were called afterward to allocate a second appointment date and time and two contact 
numbers were taken at recruitment stage to ensure that the researcher could contact the 
participants. The only avenue not explored was the use of home visits when the participants 
did not arrive or were not contactable by numbers provided. This is an option that should be 
considered for future research undertaken in this setting. 
There were several results that showed statistical significance initially but did not survive 
testing for multiple comparisons; these were pain severity and interference and depressive 
symptoms. It is possible that with a larger sample size these results may have remained 
significant with robust analysis. A longer follow up period of 12 months with follow up 
assessments spaced at 3 month intervals may have resulted in less sample attrition and 
provided data on the longevity of the study results. Another reason for the lack of significant 
results could be that the pain severity variable from the BPI was used in the power 
calculation of the sample size. The lack of significance in the other variables measured could 
be attributed to the fact that they were underpowered as the power analysis considered pain 
severity and not the other variables measured in the study. 
Self-report bias may have arisen as several of the outcome measures were self-report 
questionnaires and the objective physical function tests did not correlate with these results 
as discussed previously. The physical test may also not reflect the daily activity that the 
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participant engages in and uses as a frame of reference when answering the questions as 
discussed above.  
The reporting of the qualitative comments may also be biased as I did not obtain feedback 
from the education group who also received the positive living manual. The positive 
feedback received may not have been replicated by the education group as they had not 
received the peer led intervention. 
The development of a therapeutic relationship could also not be measured so there was no 
way to establish if a therapeutic relationship had developed between the research assistants 
and the study participants. In addition the participants did not see the same research 
participant for all follow up appointments which may have affected the development of the 
relationship. This is therefore a study limitation as it is not clear how successful the 
generation of a therapeutic relationship was in this study.  
The lack of a placebo group or intervention is a limitation of the study as the result cannot be 
compared to the effect of no intervention. Thus how significant the study results really are is 
difficult to ascertain. Placebo groups should be included in future research to ensure that 
results will be more robust. 
4.1 Recommendations for future research 
Future directions for research in management of chronic pain in PLWHA should focus on 
longer intervention and follow up periods to ensure longevity of any significant results 
obtained. Larger sample sizes need to be recruited to ensure that the sample is sufficiently 
powered despite any attrition that may occur. Based on the above attrition rates I would 
recommend a larger sample size to account for an approximate 60% attrition rate. I would 
also recommend home visits be included to try to keep participants in the study if they do 
default on follow up appointments. More studies should include the use of objective physical 
function data such as the Simmonds battery of physical tests so that this can be compared 
with self-reported physical function in this population. This is indicated by the fact that very 
few studies reviewed in the literature review chapter actually used physical performance 
tests to evaluate function. 
The effects of anxiety were not researched in this study and could possibly have contributed 
to the decreased walking speeds, thus anxiety should be added to future studies 
undertaken. The hospital anxiety and depression scale (HADS) is recommended. 
4.2 Conclusion 
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This research adds to the body of work done on non-pharmacological interventions in 
PLWHA and chronic pain. Although there were few significant findings, the study has 
demonstrated that physical function may be affected by non-pharmacological interventions. 
It is clear that self-reported physical function in this cohort did not match the physical 
function observed during the Simmonds battery of functional tests. Significant improvement 
over time in 4 components, indicate that the non-pharmacological interventions do indeed 
have a positive effect on function. It is clear from the study that self-report of physical 
function does not match with actual physical function scores. Clinically this is significant as 
healthcare providers often rely on a patient’s self-report of function when evaluating their 
level of function. Clinical practice should always include some form of objective physical 
function test so that a more accurate picture of the patient’s actual function is achieved. 
 The role that anxiety played in the study results is unclear and this would need to be added 
to future studies to establish the effect if any present. 
In this cohort as no differences were found between the intervention groups except for pain 
severity, which requires further investigation as discussed above. This may mean that by 
using a therapeutic relationship effectively, a health care provider might have the same 
effect, as providing other resource intense modalities such as patient education or self-
management groups. This could be a cost effective modality if all healthcare providers put 
more effort into creating a good therapeutic relationship with their patients which could 
improve patient outcomes especially in settings like the public healthcare system where 
patients are given limited attention due to limited resources in South Africa. If one takes the 
current results at face value it appears that the effect of the peer leader and education 
interventions when compared to the therapeutic relationship group did not have a significant 
impact on the variables measured. If this was not the case there would have been larger 
more significant differences between the groups. Therefore one can conclude that these 
interventions may not be as helpful as first thought when the study was initiated. Once again 
this theory would need to be tested in a larger cohort with a placebo arm. 
Several of the significant results obtained in this study are difficult to explain such as the 
between group difference in pain severity with the education group scoring lower than the 
peer led group, the slow performance of gait in the later follow up assessments and the 
seemingly unrelated improvement of physical function to the intervention (therapeutic 
relationship). I have attempted to explain these findings above through the effects of study 
participation, possible anxiety during the initial study phase and the possibility of anomalies 
or erroneous findings. These results need to be investigated further with a larger cohort and 
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a placebo group to establish if pain severity does improve and if objective physical function 
assessment differs from subjective physical function. 
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Appendix C Sample Calculation  
Sample Size Determination: 
Sample size calculations were based on the mean and standard deviation (SD) scores for the Pain Severity 
Scores (PSS) of the BPI from the study by Parker, Jelsma and Stein (2016
a
). The mean and SD scores for all 
participants at baseline were 5.32 ± 1.93, and the subsequent scores during data collection were: 5.55 ± 1.65 
(week 0), 3.81 2.89 (week 4), 3.1 ± 3.03 (week 8), 2.79 ± 3.38 (week 12), 1.81 ± 2.87 (week 16). Sample size 
calculations were therefore performed using standard deviations of 1.6, 2 and 3. 
A 3 point change in the PSS on the BPI is regarded as being clinically significant. The minimum specific 
difference of interest was therefore set at 3 points. Data will be collected at 5 different time points in this 
proposed study, namely at week 0, week 4, week 8, week 12 and 6 months. The total number of data 
collection time points will therefore be 5.  
The desired alpha level was set as 0.05 and the desired power was set at 0.9. 
 
Power Group Size Time Points Difference 
to be 
detected 
Standard 
Deviation 
Alpha Level 
0.92831 4 5 3 1.6 0.05 
0.91836 6 5 3 2 0.05 
0.90848 13 5 3 3 0.05 
 
The above shows that for a conservative estimate of the SD being 3, a group size of 13 participants per group is 
needed. This translates to 39 participants in total. However, due to a number of identified cultural factors 
relating to gender, two separate groups (one female and one male) for the experimental group is required. In 
order for groups to be effective in achieving a change in behaviour, they should be between 8 and 12 people in 
size. Therefore, in order to have functional peer-groups and to accommodate for drop out it was decided that 
a total number of 10 participants per gender group would be appropriate. This translates to a total of 20 
participants per group. The total sample size would therefore need to be 60 participants.  
 
Revised sample size calculations for groups of 20 would therefore result in power estimates of 100% for a SD 
of 1.6, 99.99% for SD of 2 and 98% for SD of 3. 
 
Power Group Size Time Points Difference 
to be 
detected 
Standard 
Deviation 
Alpha Level 
1.00000 20 5 3 1.6 0.05 
0.99998 20 5 3 2 0.05 
0.98310 20 5 3 3 0.05 
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Appendix F Information and Consent for research study 
INFORMATION SHEET 
Comparison of non-pharmacological interventions for managing 
symptoms in individuals living with HIV. 
Good day. I am Dershnee Devan, a student at Wits University.  People with HIV suffer from many 
symptoms that affect their daily lives and I am trying to find out what would be the best way to 
manage these symptoms. By helping me in this study you will help us find out if there are other ways 
to treat these symptoms other than using medicine. There will be no procedures like injections and 
you won’t be asked to take any extra medicines.  
If you agree to be part of the study, Flo or Tosh would like to ask you some questions. There will be 4 
question sheets. These question sheets will ask you how well you are doing in your day-to-day life, 
whether you feel sad and about your pain. There will also be a physical test which will include some 
simple physical tasks, for example, walking, reaching and tying a belt. These will test how physically 
fit you are and whether your physical fitness improves over the time of the study. We will need 
about 45 minutes. If you agree, we’ll talk in a private room in the HIV Clinic where it is quiet, and no-
one will be listening. None of the questions will be difficult to answer. You can tell us whether you 
want us to ask the questions in English, isiZulu or isiXhosa. 
After the questions we will find out which group you will be in. You have a 1 in 3 chance of being in 
each group.  
1. One group will come back to see Flo or Tosh every 4 weeks. She will go through the question 
sheets with you each time and wants to know how you are doing. 
2. The next group will have the same and also be given a book about living with HIV. 
3. The last group will also see Flo or Tosh, have the book and will be asked to come back every 
week for 6 weeks to take part in a course at the Occupational Therapy department at the 
University of Witwatersrand. The course will take 2 hours every week and be on Saturday 
mornings from 9 am to 11 am. There will be 10 people in the group.  
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When you come back for follow up, any questions you may have about the information in the book 
will be answered by me or your treating doctor or nurse. 
1. So, Flo or Tosh, will see everybody to go through the question sheets again 1, 2, 3, 6 and 12 
months from now.  
You will be given taxi fare for these follow up visits so that you do not have to spend any of your own 
money to come to the hospital. I will send you sms reminders to make sure you don’t forget your 
appointment for the follow up visit. At these follow up visits Flo or Tosh will ask you the same 
questions as before.  
I need people like you to help me with my research, but if you don’t want to be part of the research, 
you can just tell me no at any time. I’m part of the University, but I’m not part of the hospital. The 
doctors and nurses looking after you will look after you just the same, whether you agree to help me 
or not. I won’t tell them if you say yes or no. All the answers you give will be kept confidential and 
will be seen by me, the people helping me and yourself only. We will not show it to the doctors or 
nurses looking after you. I am going to give you a number like a PIN number so that people looking 
at your answers won’t know your name. When I finish my research I will combine everybody’s 
answers and show other researchers, doctors and nurses. However, your individual results won’t be 
seen by anybody. When the research is completed and if it is shown that one of the treatments was 
effective in helping people with HIV do better in their day-to-day activities you will be given a chance 
to have this treatment if you would like to have it. 
A group of staff at the University who look after patients’ rights have checked my study to make sure 
it is fair and treats patients well. If you want to know more about your rights when you are taking 
part in research you can contact Professor Cleaton-Jones on (011) 717 2301. 
Thank you for thinking about taking part in my research. Please read this sheet and have a think 
before signing to say that you agree to join in. If you have any questions, please ask me at any time. 
If I’m not in the clinic, please contact me, Dershnee on 011 717 3726, or you can visit me in my 
office: room no. 8, Occupational Therapy Department, Wits Education Campus, St Andrews Rd, and 
Parktown. 
Yours sincerely, 
 
Dershnee Devan 
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CONSENT FORM PARTICIPANT ID: 
A comparison of non-pharmacological interventions in reducing  
symptoms in individuals infected with HIV  
I, _______________________________________________, have been told about 
research that is trying to find out how effective different treatments that don’t use medicine 
for HIV positive people are.  
I understand that I shall be asked questions about how HIV affects my life.  
1. I understand that I will be asked to perform a set of physical tasks to see how fit I am.  
 
1. I agree to come back for 2 hours, once a week for 6 weeks on Saturday morning 
between 9 am and 11am if I am put in the course group. 
 
2. I agree to come back for appointments to see how I am doing 1, 2, 3, and 6 and 12 
months from now, whichever group I am put in.  
 
I agree to helping with the research by answering questions, performing a fitness test and 
participating in the groups offered as part of the research. I know that nobody is forcing me to do 
this and I can stop helping at any time, without anyone blaming me.  
 
_________________________    __________________ 
Signed (subject)      Date 
 
_________________________    __________________ 
Signed (researcher)       Date  
117 
 
CONSENT FORM: MULTIMODAL GROUP PARTICIPATION 
PARTICIPANT ID: 
A comparison of non-pharmacological interventions in reducing  
symptoms in individuals infected with HIV  
I, _______________________________________________, have been told about 
research that is trying to find out how effective different treatments that don’t use medicine 
for HIV positive people are.  
 
I understand that I shall be asked questions about how HIV affects my life.  
3. I understand that I will be asked to perform a set of physical tasks to see how fit I am.  
 
4. I agree to come back for 2 hours, once a week for 6 weeks on a Saturday morning 
between 9am and 11am. 
 
5. I agree to come back for appointments to see how I am doing 1, 2, 3, 6 and 12 
months from now.  
 
 
I agree to helping with the research by answering questions, performing a fitness test and 
participating in the groups offered as part of the research. I understand that all the 
information that is shared in the group sessions will remain confidential and restricted to 
those people who participate in the group. 
I know that nobody is forcing me to do this and I can stop helping at any time, without 
anyone blaming me.  
 
_________________________    __________________ 
Signed (subject)       Date 
 
______________________     __________________ 
Signed (researcher)       Date 
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Appendix G  ACSM Screening Questionnaire 
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Positive Living 
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Positive Living 
 
Welcome to “Positive Living”. This is a workbook designed to be used over 6 weeks which aims to 
help people develop self-management skills for living with HIV/AIDS. Using this workbook is not 
about sitting and reading or listening. In order to get the most out of this course you will be asked to 
share your experiences, you will need to set goals and share those goals with others and you will 
need to take part in activities. This workbook is NOT a substitute for any other medical care that has 
been recommended for the treatment of your condition. 
 
You will benefit most from this workbook if you commit yourself to completing all the sessions 
within a 6 week period of time. Scientific research tells us that these courses are of great benefit to 
people living with chronic diseases such as diabetes, arthritis and HIV/AIDS.  But to benefit from the 
course, using the workbook regularly over 6 weeks and participating in activities is essential. The 
workbook is divided into six sections: 
1. Week 1: Self-management and Exercise 
2. Week 2: Managing common symptoms of HIV/AIDS 
3. Week 3: Stress Management 
4. Week 4: Pain 
5. Week 5: Eating Well 
6. Week 6: Continuing as a successful self-manager 
 
Your course leader is                       . She/he has been trained in all the information you will be going 
through. She/he has also been trained by a physiotherapist or occupational therapist that specializes 
in HIV/AIDS in safe ways to exercise and in relaxation techniques.  
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Week 1: Self-Management and Exercise 
 
What do we mean by the term “self-management”? Self-management does not mean that you are 
expected to look after your health on your own with no help. No, someone who is a successful self-
manager takes responsibility for their health. This means that they choose to work with the health 
team, with their drugs and with themselves to live a healthy life (just like a manager in a business – 
they don’t do everything themselves, they work with a team).  
 
There are lots of things you can learn to do which will help you to be a successful self-manager. First 
of all it is important to understand HIV and AIDS. You need to understand about the virus and the 
disease, how it is transmitted, how it can affect you and about the medications used to treat it.  
 
The next step in being a self-manager is being able to think about this information in terms of how it 
affects you. The final step in being a self-manager is to think about what it is that you want to be 
able to do, decide how you are going to do it and then to learn and practice the skills you need to be 
able to do it. Some of the things you will learn about and practice every day when you do this course 
include exercising, relaxation techniques and healthy eating. 
 
Using this workbook you will learn about exercise and its benefits, in the second section you will 
learn a bit about the common symptoms of HIV/AIDS and how to manage these. The third section 
will focus on stress management, the final sections focus on pain, and eating well. Some people 
using this workbook may already know a lot about these topics, others may not know very much. It 
is important to share information and make sure that everyone has the knowledge they need to 
become a self-manager, even if you think you know a lot about these topics it is still worth your 
going through the workbook to make sure you have not missed out on any information. Scientific 
research tells us that people who are well informed about their health manage better and have a 
better quality of life. Using this workbook, you will also learn about and discuss the steps that are 
needed to become a good self-manager. Let’s look at these steps here.  
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Self-management steps 
Step 1: 
To be good at self-management you need to learn and practice several skills which you will practice 
through this course. The first step is to decide what it is you want to be able to do. This can be the 
hardest step to think about. For example you might be feeling very sad and depressed. First you 
need to think about why you are feeling that way. Perhaps one of the reasons you are feeling that 
way is that you have lost touch with your friends. Your first step might be to decide that you need to 
meet people to make friends. This will help you to feel less sad and depressed.  
 
Write down here three things that you want to be able to do:  
1)          
          
2)         
          
3)         
          
 
Step 2: 
But deciding that you are going to meet people and make friends doesn’t mean it will happen. You 
have to make it happen. The second step in being a self-manager is to decide how you are going to 
do it. Sometimes the thought of doing something new can seem too much and we don’t even try. If 
you want to meet people to make friends you need to think about all the different options you have 
to do this. For example you could invite your neighbours for tea, or you could decide you would 
meet people by going to church, by joining a support group or an exercise group. Never assume that 
what you want to be able to do is impossible. Always look for every option and look at it from every 
angle.  
 
Write down here three different ways that you could try to achieve what you want 
to do: 
1)          
   
2)             
3)             
 
Now that you have decided on how you can try to achieve what you want, you need to make an 
action plan. It is important that this plan is realistic otherwise it is likely you will not succeed. How do 
you do this? 
1. First decide what you are going to do this week 
2. Now make a specific plan  
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Saying that this week I’m going to try to meet some people is NOT a specific plan. To be specific, the 
plan must have different parts. It is useful to ask yourself some questions to help develop a specific 
plan. Questions like: 
1. What? 
Exactly what are you going to do? For example you could decide that to meet people you are 
going to invite your neighbour for tea. 
2. How much?  
Then you must decide how much you are going to do. For example are you going to invite one 
neighbour for tea or are you going to invite lots of neighbours over. Lots of people are much 
more tiring than one person. Or do you want to invite your neighbour for lunch? But lunch 
means a lot more preparation and time and will make you more tired. So you have to decide 
how much you can do. 
3. When will you do it? 
Then you must decide on exactly which day you are going to do the activity and at what time of 
the day. Maybe it is better to invite your neighbour for tea in the morning because you get tired 
in the afternoon. Or if you feel sick in the morning from your medicines maybe it is better to 
invite your neighbour for afternoon tea. Or maybe your neighbour works and you need to invite 
them for tea at the weekend.  
4. How often? 
This is always the hardest part. We all would like to be able to do more things every day. But we 
are human and this is not always possible. When people want to start exercising, we often say 
we are going to do it every day. But this is often just not possible and if we then miss a day we 
feel that we have failed and we give up. How often will you invite your neighbour for tea? Not 
every day but maybe once a week. You know that you won’t become friends immediately and 
that it will take time.  
5. Is it a good plan? 
To test whether you have come up with a good plan you need to ask yourself this 
question: 
“If I give myself a score from 0 -10 for how confident I am that I will achieve 
my plan this week, where 0 is not at all confident, and 10 is totally confident. 
What score will I give to show how confident I am that I can complete this 
plan?” 
If your answer is 7 or more out of 10 then this is probably a very good plan. If 
your score is less than 7 you need to think about why you are not confident. 
What are the problems or barriers? Can you change the plan or solve the 
problems to make yourself feel more confident? 
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Step 3: 
Now, write your plan down and put it somewhere you will see it every day. There is an action plan 
form at the end of this section and 5 more at the back of this book. Use them every week you are 
doing this course. You can always draw more of them to keep working on your plans in the future.  
 
 
 
 
 
 
 
 
 
 
 
 
Now you need to carry out your action plan. If it is a good plan then doing it is usually fairly easy. It 
helps to tell family or friends what your plan is and to report back to them on how you are doing. On 
this course you are going to make a plan every week and record how you get on. It helps to report 
back on things because you can then have an idea on how well you are doing. If you haven’t been 
able to keep to the plan you can discuss the problems you might have had and make plans to cope 
with them.  
 
Step 4: 
Always check your results and give yourself a reward for having achieved your plan. Also 
think about how achieving your plan is making you feel. In the example we talked 
about, you could congratulate yourself for having invited your neighbour for tea, you 
would also think about how you now feel. Is the plan helping you to achieve what you 
want?  
 
What about problems? 
What if your plan doesn’t work? Are you going to give up and decide you had a bad plan? There are 
seven steps to solving problems. These are: 
1. Deciding what the problem is (you might need friends and family to help here) 
2. List ideas to solve the problem 
3. Select one idea to try 
4. How did it go? 
5. If it didn’t work, try another idea 
6. If your ideas don’t work, ask friends, family, counsellors, professionals for ideas 
7. Finally you might have to accept that you can’t solve the problem now. 
 
 
 
A good action plan is: 
1. Something I want to do 
2. Something I can expect to do this week 
3. Is specific 
4. Answers the questions: What? How much? When? How often? 
5. I am confident that I can achieve with a score of at least 7 out of 10. 
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At the end of each section and at the back of the workbook there are “Action Plan Forms”. Use these 
forms to plan what you want to do and how you are going to do it. We are now going to discuss 
exercise – use the “Action Plan Form” at the end of this section to plan what exercise you are going 
to do this week. 
 
 
 
 
 
 
 
 
 
 
 
 
  
A successful self-manager is someone who: 
1. Sets goals 
2. Makes a list of ways to achieve those goals 
3. Makes action plans to achieve the goals 
4. Carries out the action plans 
5. Checks on their progress every week 
6. Can change the action plan if there are problems  
7. Gives themselves a reward for achieving their g als 
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Exercise 
 
Exercise is a very important way to keep healthy. Scientific research tells us that exercise has a lot of 
good effects on our bodies like helping our digestive system absorb and process 
food; it trains our hearts so that they are strong and healthy and keeps our lungs 
working well. Exercise makes our muscles and bones strong and our joints flexible so that 
we can keep moving. Exercise also helps to make us feel happy, improves concentration 
and memory, improves sleep and exercise helps to decrease the chances of developing 
chronic illnesses like high blood pressure and cancers.  
 
In the past, when people became ill with a chronic illness like high blood pressure or diabetes 
or HIV/AIDS, medical care focused on helping them when their symptoms became worse. Treatment 
focused on using drugs and people were often advised to rest or decrease their activity. Today we 
know that if we teach people who develop chronic illnesses about their disease and encourage them 
to do exercise we can prevent a lot of the problems which used to be treated with medicines. We 
also know that exercise can help to treat a lot of the symptoms which people with chronic diseases 
develop. Symptoms which may be caused by the disease or by the drugs used to treat the disease.  
 
You may be wondering if it is safe for you to exercise when you have an illness like HIV/AIDS. 
Research tells us that it is safe for people living with HIV/AIDS to do exercise. Not only is it safe, it 
also stimulates the immune system, improves endurance and decreases fatigue, improves strength 
and decreases body fat. We also know that strengthening exercises seem to help prevent or 
decrease lipodystrophy in people who are taking ARVs (Lipodystrophy means that your body stops 
storing fat in places where it normally stored it - like in your buttocks, and begins to store the fat in 
places like your chest or your stomach). We know that people who are physically fit get fewer colds 
and take fewer days off work because of illness. One of the biggest benefits of exercise is that 
exercising regularly makes you feel more in control of your life.  
 
Although exercise is good for you and safe for you to do, sometimes your 
body will give you clues that you need to cancel your exercise. If you 
have a fever, feel dizzy, have vomiting or diarrhoea, if your joints have 
suddenly become swollen, or if you have a pain which is new and you are 
not sure what is causing it, it is better to miss an exercise session until you 
can speak to a nurse or doctor.  
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Exercise is good for: 
1. Improving mood 
2. Strength 
3. Improving sleep 
4. Concentration and memory 
5. Heart and lung health 
6. Decreasing body fat 
7. Digestion 
8. Increasing confidence to self-manage chronic illness. 
Do not exercise if: 
1. You have a fever 
2. You are dizzy 
3. You have been vomiting 
4. You have diarrhoea 
5. Your joints have suddenly become swollen 
6. You have a new pain which you don’t know the cause of 
Miss one exercise session if you have one of these problems until you can speak to a 
nurse or doctor. This does not mean you should never exercise but you need to make 
sure you are not becoming ill. 
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What kind of exercise should you do? 
You do not have to join a gym or a club to get exercise. There are lots of ways of exercising from 
formal sports like running, playing football or netball, swimming or playing tennis. But, walking is 
also a very good way to exercise. Any activity which makes your heart beat faster and makes you 
breathe a little harder is exercise. Dancing is exercise, walking up the stairs is exercise, gardening is 
exercise. There are lots of ways that we can exercise every day without having to go to a class or join 
a club. You could walk a little further before catching the bus or the taxi or you could play with your 
children!  
 
There are three general kinds of exercise you can do. Endurance exercise; like walking, running, 
dancing or swimming. Endurance exercise is sometimes called aerobic exercise which means that 
you will be breathing faster and your heart will be beating faster too. We know that this kind of 
exercise is very important to keep healthy and we need to do 30 minutes of this kind of exercise 
three times a week to keep healthy. The second kind of exercise is strengthening exercise. This kind 
of exercise focuses on making us stronger. To make muscles stronger we have to do exercises which 
make the muscles work hard against a resistance, like weight training but you can also do strength 
training by working with heavy bags of shopping! The last kind of exercise is stretching exercise. 
Stretching exercises focus on keeping us mobile and flexible.  
 
 
 
 
 
 
 
 
 
 
 
Endurance   Strengthening   Flexibility 
 
  
Types of exercise: 
1. Endurance exercise which makes you breathe harder (sometimes called 
aerobic) 
2. Strengthening exercise which makes you stronger 
3. Stretching or flexibility exercise which makes you more mobile and supple 
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There is an extra reason for people living with HIV/AIDS to do strengthening exercise. Scientific 
research tells us that strengthening exercises seem to help to prevent or limit lipodystrophy. 
Lipodystrophy means that your body stops storing fat in places where it normally stored it (like in 
your buttocks) and begins to store the fat in places like your chest or your stomach. Lipodystrophy 
doesn’t just change the shape of the body, we also know that people who develop lipodystrophy 
tend to have high cholesterol and low insulin meaning that there is a bigger chance that they will 
have heart problems or develop diabetes. The exact cause of lipodystrophy is not clear but it seems 
to occur with certain HIV drugs, in older people and in people with a low T cell count who have been 
HIV+ for a long time. The most recent research tells us that if you do weight training (which builds up 
more muscle) you can limit lipodystrophy. This is a very good reason to make sure you do 
strengthening exercises in your exercise routine. 
 
We know one of the hardest things about exercise is not doing it once, but doing it again and again. 
There are several steps we can follow to make sure that when we start to exercise we stick to it. We 
all make lots of excuses why we can’t exercise. Let’s look at the most common excuses. 
 
“I don’t have time” 
It doesn’t take a lot of time to start exercising. Five minutes a day is a good start. 
We make time to take medicine because we know without it we would become 
ill. Exercise is as important as medicine to help us remain healthy (remember it 
can never replace your drugs). If we know that it is that important we can make 
time for it. 
 
“I’m too tired” 
When people become ill they often become less active. As you become less active, your body loses 
fitness and you become weaker, you may feel stiffer and you tire more easily. This means that 
exercising might feel harder and so you exercise less. This often results in a 
downward spiral of activity and people often get to the point where even walking 
down the street to visit the neighbour can feel like too much. Being active or doing 
exercise when you are feeling tired will give you more energy and make you feel 
less tired. 
 
“I’m too sick” 
You may be too sick to undertake very vigorous exercise but you can still aim to be 
more active. You can even break your exercise into one minute sessions which you 
repeat several times through your day. The fitter you get, the better you will be 
able to cope with your illness  
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“I get enough exercise already” 
You may be getting a lot of exercise already in your job or simply walking around doing your 
daily chores. But for most people if we add this time up, it still isn’t enough exercise to 
keep them fully fit. This kind of exercise also doesn’t include one of the most 
important components that make exercise good for us – fun!  
 
“Exercise is boring” 
You don’t have to do the exercises that everyone else does if they are boring. Choose 
something that is fun, exercise with a friend or with your favourite music or listen to 
the radio. You can also keep your exercises fun by changing them regularly. 
 
 
“Exercise is painful” 
Exercise may be uncomfortable but it shouldn’t be painful. If you have pain before you start to 
exercise, it should not get worse while you are exercising. If you do not have pain before you start to 
exercise and you start to feel pain while you exercise you need to stop exercising and evaluate your 
pain using the guidelines in Week 4: Pain. If you have muscle or joint pain for more than two hours 
after you exercise then you have probably done too much. Next time do a little less, either exercise 
for less time or less vigorously. 
 
 
“It’s too dangerous, it’s too hot, it’s too cold” 
There are always reasons like this not to exercise. Remember that exercise can be 
done anywhere and anytime. You can put on music in your home and dance, if it’s 
too hot you could walk around shops which have air-conditioning. Finding a group 
of people to exercise with will not only make it safer but also more fun! 
 
 
“I know I won’t stick to it so there is no point in starting” 
First review the steps we discussed on how to be a successful self-manager. If you set 
your exercise goals using these steps you have more chance of sticking to your exercises. 
Remember to the important step of rewarding yourself for achieving your goals, this 
makes it easier to move on to your next goal. We are now going to have a look at the 
important steps to take to be successful at putting your exercise plan into action. 
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Your exercise programme: 
An exercise programme should include the three different types of exercise; remember they were 
endurance, flexibility and strength exercise. Following the steps in the box “Steps to success with 
exercise”, you need to decide on what you want to be able to do and what exercise you would like to 
do. Now that you know what exercise you are going to do, you need to decide how much to do. The 
amount of exercise you are going to begin with will depend on a lot of different things. If you have 
not done any exercise for a long time or have been feeling unwell, have had difficulty breathing or 
been short of breath, if you have had stiffness or pain or weakness that interferes with your daily 
activities then you need to start your exercise slowly. You can begin slowly by starting with some 
flexibility and strengthening exercises. Do these exercises every other day for 5 minutes. Once you 
can do that comfortably and without feeling stiff or sore the next day, increase it to 10 minutes. 
Once you can do 10 minutes comfortably, you can start doing the exercises every day (when we say 
exercise every day, we usually mean exercise for 5 days of the week; it can be very hard to keep a 
routine to exercise on weekends when activities are different). Once you can do at least 10 minutes 
every day then you are ready to begin endurance exercises. Choose your exercises from the ones set 
out in the sections below. Follow the instructions in the box to make sure you get the most out of 
the exercises and do them safely. 
  
Steps to success with exercise: 
1. Set a clear goal using the steps outlined in “How to be a successful self-
manager” 
2. Choose exercise or activity that you want to do and that is fun 
3. Set a specific time and place to do your exercise 
4. Decide how long you are going to stick to the plan before you think about 
changing it (6 to 8 weeks is a good time to work on things) 
5. Keep an exercise diary to keep track of how you are doing (there is one at the 
back of this booklet for you to use) 
6. Keep track of your progress using the exercise diaries in this workbook. 
7. Start – don’t wait, start now. Begin gradually and proceed slowly 
8. Revise your programme. At the end of the 6 – 8 weeks make a new plan for the 
next 6 weeks 
9. Reward yourself. It is a reward to feel better and healthier but also give yourself 
a reward for achieving your goal, like eating a favourite meal, or visiting a friend 
or taking a walk somewhere special. 
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Flexibility Exercises: 
Remember, these exercises are aimed at improving your ability to move. There 
is a long list of exercises that could be included here and you might not be able 
to do them all every time you exercise. Try to ensure that you do flexibility 
exercises at least once a week.  
 
Strengthening Exercises: 
You do not need to go to a gym to do strength exercises, the exercises described 
here can be done at home. To make muscles stronger you must make them work 
against a resistance or a force – they have to push or pull. You should not do 
strength exercises every day, rather they should be done every second day. Your 
muscles need a day of rest to adapt and get stronger. To make a muscle stronger you 
need to repeat each exercise 5 times to start with. Once you can do an exercise 10 
times you will not get stronger by doing more exercises. Now you will need to add more 
resistance to the exercise to get stronger.  
 
  
Getting the most out of your flexibility and strength exercises: 
1. Move slowly and gently. Do not use jerking or bouncing movements as these 
will make your muscles shorter and tighter.  
2. Stretch to the point of tension in a muscle and hold for 20 seconds before you 
relax 
3. Don’t push until it hurts, stretch to tension not pain 
4. Start off with 5 repetitions of each exercise. After 1 week increase it to 7, after 
another week increase to 10.  
5. Always do the same number of exercises on the left side and the right side of 
your body 
6. Keep breathing; do not hold your breath when you exercise. Think about 
breathing out as you move to make sure you do not hold your breath. 
7. Use the two hour rule. If you have increased symptoms for more than two hours 
after you exercise you have probably done too much. Don’t stop doing the 
xerci es but decrease how much you do next time. 
8. If you find an exercise difficult this do s ot mean you should not do it at all. 
You should adapt it, do it as completely as you can. 
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Endurance Exercises: 
The most difficult thing for most people is deciding how much exercise to start with. The easiest 
starting point is to ask yourself the question: “how much do I think I can do without suffering for it 
tomorrow?” If you feel you can do 5 minutes, then do 5 minutes. Remember that any exercise is 
better than none. You don’t have to do 30 minutes from the first day. It is important to start slowly 
and increase very gradually. It is better to start off by doing less than you think you can and increase 
it from there.  
 
There are three things you need to think about when you do endurance 
exercise. These three things are frequency (how often am I going to do 
this exercise); duration (how long am I going to exercise for when I do 
exercise) and intensity (how hard am I going to work when I exercise).  
 
 
Frequency: 
Try to do endurance exercise 3 or 4 times a week. By doing this you can rest every second day and 
allow your body to recover. All athletes have at least one day a week when they rest. Rest does not 
mean that they lie in bed all day though, it means that they do not do their exercises. 
 
Duration: 
How much can I do without suffering for it tomorrow? That is your starting point. If you are starting 
with just a few minutes you can gradually increase it over time until you can do 30 minutes at a time. 
The easiest way to increase the time is to use intervals of exercise. For example to walk hard for 3 
minutes, then walk slowly for 2 minutes, then walk hard again for another 3 minutes. Slowly over 
time cut down the slow walking and increase the hard walking. You could also break your exercise 
into separate sessions. You could walk for 10 or 15 minutes in the morning and do it again in the 
evening. This would still count as 30 minutes of exercise.  
 
Intensity: 
How will you know that you are exercising hard enough to be doing some good? How will you know 
if you are exercising too hard? When doing endurance exercise the easiest way to check the intensity 
is to use the “Talk Test”. When you are doing moderate intensity exercise you should be able to talk 
comfortably but if you tried to sing it would be a little difficult and you would have to stop singing to 
take bigger breaths. Moderate intensity means you should feel that you are breathing a little faster 
and a little harder but you can still talk. It may take you a while to find the right intensity for you for 
the whole of your exercise session. This is normal; take your time to get to know how your body will 
respond.  
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How will you know you are improving in your exercises? For the flexibility and strength exercises it is 
easy to feel the improvements as you will feel that moving is easier and you are stronger and can lift 
heavier items. For some people it is harder to know if you are improving with the endurance 
exercises. One way to see if you are improving is to do a test. One of the easiest tests to do is a 
timed test. Decide on a route that you can walk near your home. Walk this route at a moderate 
intensity and time how long it takes. After several weeks of exercise walk the route again and time it 
again. You may see that you can walk the same route faster within 4 weeks, but it may take 8 to 12 
weeks before you see that you can do the route in a faster time. The goal is to complete the same 
route faster or in the same time but at a lower intensity (breathing much easier).  
 
Use the exercise diary at the end of each section to record your goals and your progress in achieving 
them. 
 
Exercise Routine 
This is a 20 minute exercise routine which is safe for people living with HIV. This routine includes 
exercises which make you stronger (strength exercises), more flexible (stretching exercises) and 
fitter (endurance exercises). 
 
1. Start by standing up straight and tall, feel your weight across your 
feet, relax your shoulders and open your chest, hold your head 
straight. Take a deep breath in and breathe out.  
 
2. March on the spot for 2 minutes. March at a steady pace – that is a 
pace which you can maintain for 2 minutes. Do not start fast and get 
slower or start slowly and get faster. Pace yourself, start and finish at the same speed. You 
should be marching so that you can feel you are breathing a little bit harder than normal, 
you should be able to talk but not be able to sing. 
 
3. Now stretch your neck – keep your shoulders relaxed and turn to 
look over your right shoulder – hold it for 20 seconds. Bring your 
head back to the middle, then turn to look over your left shoulder – 
hold it for 20 seconds and then bring your head back to the middle. 
Now put your left ear on your left shoulder - hold it for 20 seconds 
and then bring your head back to the middle. Repeat to the right. 
Now put your chin on your chest - hold it for 20 seconds and then 
bring your head back to the middle. Roll shoulders forwards 5 times, 
then roll your shoulders backwards 5 times.  
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4. March on the spot for 2 minutes – 30 steps normal, 30 steps lift your knees up as high as you 
can. Keep changing every 30 steps. 
 
5. Stretch your body – with your feet shoulder width apart, slide 
your right hand down your right leg so that you bend 
sideways. Bend as far as you can - hold it for 20 seconds and 
then stand up straight again. Repeat this to the left. Put your 
hands on your bottom; bend your body backwards as far as 
you can. Now bend forward and try to touch your toes.  
 
6. Sit on a chair – now stand up, keep sitting down and standing up for 2 
minutes. Stand up and sit down at a steady pace – that is a pace 
which you can maintain for 2 minutes. Do not start fast and get 
slower or start slowly and get faster. Pace yourself, start and finish 
at the same speed. 
 
7. Lie down on the floor with your knees bent and your arms 
crossed on your chest. Lift your head to put your chin on your 
chest, now lift your shoulders off the ground. Slowly lower 
down. Keep going for 2 minutes.  
 
8. March on the spot for 2 minutes – 30 steps normal, 30 steps lift your feet up as high as you 
can (try to kick your buttocks). Keep changing every 30 steps. 
 
9. Stand up straight. Take one big step forward with your right foot 
and bend your knees so that your left knee almost touches the 
ground (lunge). Push back with your right leg to bring your feet 
back together again. Repeat on the left. Do 10 lunges on each leg.  
 
10. March on the spot for 2 minutes – 30 steps normal, 30 steps lift your knees up as high as you 
can. Keep changing every 30 steps. 
 
Finish by standing up straight and tall, feel your weight across your feet, relax your 
shoulders and open your chest, hold your head straight. Take a deep breath in and 
breathe out.  
 
 Action Plan Form - Exercise 
 
Use this form to develop an action plan on exercise. What exercise would you like to do? 
Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three 
times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
How confident are you that you can complete this action plan? 
 
 
 
 
 
Keep a record of how you did: 
  
 I Plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
       ____________________________ 
Not at all      |     |     |     |     |     |     |     |     |      |       
Totally 
confident    1    2    3    4    5    6    7    8    9    10    confident 
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Week 2: Managing Common Symptoms of HIV 
 
When something that is happening to our bodies that is unusual or not right, we develop symptoms. 
Symptoms include things like having a fever or temperature, feeling nauseous, vomiting, feeling 
tired, having pain, having a skin rash, coughing or struggling to breathe, feeling depressed and many, 
many more. People living with HIV/AIDS are likely to have many different symptoms which need to 
be managed. In this section, you will learn about some of the more common symptoms which 
people living with HIV/AIDS experience. You will also learn how to manage these symptoms. If you 
start feeling a symptom which is not described in this section then it is best for you to go to your 
clinic to get your symptom checked by a doctor or nurse.  
 
The symptoms that people living with HIV/AIDS get can be put into one of three groups. The 
symptoms may be a side-effect of the medicines that you are using. Information on the side-effects 
of medicines can be obtained from your clinic and from other support and treatment literacy groups 
such as the Treatment Action Campaign (TAC). The second possible cause of symptoms is HIV-
related infections. You might have a cough because you have developed pneumonia or TB. The third 
possible cause of symptoms may be the HIV itself. People with chronic illnesses like diabetes, high 
blood pressure, arthritis and HIV will all get symptoms related to the illness. These symptoms tend to 
increase and decrease over time. Research tells us that all symptoms can be managed better by 
following a good programme for living well as using the steps described in this workbook.  
 
Symptom Management 
All of the different activities described in this workbook will help you to live well and manage 
different symptoms. Exercise, eating well, using relaxation techniques and managing stress are all 
important to help prevent new symptoms from developing. Before we go through the most common 
symptoms which people with HIV/AIDS experience, there are a few principles to keep in mind when 
you experience a new symptom. If it is a new symptom, it could be a sign that you are developing an 
infection or it might be a side effect of a drug. Use the information in this section to help you decide 
on what action you need to take for the new symptom. It might be something that is safe for you to 
manage to home, or it might be something that you need to go to the clinic for, or you might 
manage at home for a while but if it doesn’t get better then go to the clinic. Use the charts in this 
section to help you decide on how to deal with some of your symptoms 
 
If you start experiencing a symptom you need to take time to think about it. Is this a new symptom, 
one you have experienced before or a symptom you have had for a while which is getting worse? 
You can do a FAST check (as described in the box below) on any new or worsening symptoms.  
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Once you have done your FAST check you can then use the action charts in this section to help you 
decide what to do next. When you read the action charts, you need to start at the top and follow the 
arrows depending on your answers to the questions. Do not jump around the chart as this will lead 
to mistakes. You will see on the chart that some symptoms mean that you need to go to your clinic 
straight away (now), some symptoms you need to go to the clinic today, and some symptoms you 
can manage yourself at home until your next routine clinic appointment. If you have more than one 
symptom, check the charts for all the symptoms and follow the most conservative (safest) advice. If 
your symptom is not described in this workbook then go to the clinic today to get it properly 
assessed. We will now discuss some of the symptoms in alphabetical order. 
  
FAST check for new or worsening symptoms: 
 
Fever Do you also have a fever which 
started with the new 
symptom?  
(temperature of more than 
38°C) 
Having a temperature or fever can be 
a chronic symptom of HIV/AIDS. But if 
a fever starts with another symptom it 
can be an important clue that you 
have developed an infection. 
Altered 
mental 
status 
Have you also noticed a 
change in your mental state 
with the new symptom?  
 
The brain is a very sensitive part of 
the body. Altered mental status is the 
term used to describe feeling 
confused, dizzy, and very sleepy. It 
can also mean more severe problems 
like coma or experiencing seizures or 
fits. You may need your friends or 
family to help you assess this. 
Severe 
Is this symptom much more 
severe (worse) than anything 
you have had before? 
Symptoms come and go but if it is 
much worse than ever before you 
need to have it checked. 
Typical 
Is this symptom not typical for 
you? 
Anything that is totally new and you 
have never had before, it is best to 
discuss it with a health care 
practitioner. You can use the charts in 
this workbook to decide whether you 
need to go to the clinic immediately 
or if you can wait until your next 
planned visit.   
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Breathing problems and coughing 
Your body uses coughing to protect your lungs and to remove abnormal things 
from your lungs. Anything that irritates your lungs can cause you to cough. 
Coughing might bring up infected pus or mucous from the lungs which is useful. Coughing can be a 
side effect of medication used for high blood pressure too. 
 
Smoking is one of the most common causes of coughing as the smoke kills cells in the breathing 
tubes to the lungs. This can happen even in people who are not smoking themselves but are 
breathing in other people’s smoke. Other common causes of coughing are “colds” and “flu” which 
often cause yellow or white mucous. Infections of the sinuses (the 
passages of the nose), can cause coughing because the mucous drips 
down from the back of the nose into the throat and lungs which irritates 
them and makes you cough. This is usually worse at night. Another 
common cause of coughing is hay fever. Hay fever is more common in 
spring and when it is windy. Dust from tree flowers (pollen) and plant 
seeds in the air make it worse. If you are coughing because of hay fever, 
you will also have either itchy, red eyes and / or a bit of a sore throat with sneezing. The clinic can 
provide you with anti-histamine medicine to help with this.  
 
  Cough Action Chart: 
Are you also short of breath at rest or short of 
breath with walking around? 
Yes 
→ 
Go to the clinic now 
No ↓   
Is your cough dry and do you also have a 
fever? 
Yes 
→ 
Go to the clinic today 
No ↓   
Do you also have a fever and pain in your 
chest with your cough? 
Yes 
→ 
Go to the clinic today 
No ↓   
When you cough do you cough up thick, bad-
smelling brown or green mucous? 
Yes 
→ 
Go to the clinic today 
No ↓   
Have you had a fever for more than 4 days or 
has your cough lasted for more than 10 days? 
Yes 
→ 
Go to the clinic 
No ↓   
Treat your cough at home   
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People living with HIV/AIDS are also vulnerable to developing lung diseases which cause coughing. 
The first serious cause of coughing in people living with HIV/AIDS is TB. Tuberculosis of the lungs (TB) 
causes a cough which lasts a long time with a fever. If you have a cough which lasts for more than 10 
days then TB should be suspected and you should go to the clinic. The second serious cause is 
Pneumocystis pneumonia (PCP). PCP causes a dry cough (there is no mucous) with a fever and 
shortness of breath. Take a look at the “cough action chart” and you will see that any cough that also 
has a fever means you need to go to the clinic straight away.  
 
Home treatment for a cough: You can treat your cough at home by making sure you are not 
dehydrated. If you do not have enough fluid in your body it will make the mucous in your lungs dry 
and sticky and more difficult to cough out. Drinking a lot of water will help with this. If you have a 
shower then having a hot steamy shower may also help, or steaming with hot water or rooibos tea 
will help. If you have a dry cough with tickling in your throat, it may help to suck on cough lozenges 
or on a hard sweet.  
 
Depression: 
It is common for people living with HIV/AIDS to become depressed but this is often not picked up by 
the nurses and doctors at the clinic. It is important for you to tell your 
nurse or doctor if you think you have depression. Depression is an 
illness, it is not simply the shock, scared, lonely and stressed feelings 
you probably experienced when you first heard your HIV status. Those 
feelings are a normal reaction to learning about your status. Depression 
develops over a few weeks and is a general feeling of depressed mood 
which happens with physical symptoms. This is caused by an imbalance 
of chemicals in the brain. See the depression checklist below – if you think 
you have depression and you have many of these symptoms then you 
probably have some degree of depression. This can be treated with medicine 
and psychological support. It is not something to be ashamed of. Go to the clinic and tell the nurse 
or doctor how you are feeling so that they cans start you on treatment.  
 
Dementia is very different from depression. With dementia your thinking is affected so that you 
struggle to communicate, you may struggle to pay attention and forget things a lot. You may also 
find it hard to move, be clumsy, lose your balance or even find that you can’t move at all (paralysed). 
Your personality might also change. People who develop dementia generally do not feel depressed 
as they are usually not aware that they are unwell. Dementia is treated with ARV’s.  
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Home treatment for Depression: There are many things you can do to help manage depression. 
Make sure that you get help straight away if you feel like hurting yourself or someone else. Often 
talking to a person who understand or to a health professional will help you through this mood. Cut 
back on alcohol, although it might make you feel better in the short term. In the long term it affects 
the way your brain works and you will not be able to escape the depression. Keep active, make you 
sure you get up every day, get dressed and get out of the house. Even if you don’t feel like doing 
things, it’s important to keep active, visit friends, and join a group. If you start to lose contact with 
people and withdraw your mood will only get worse. Make plans for the future, for tomorrow, for 
next week, for next month. Make sure you do 20 to 30 minutes of exercise every day. As we said in 
Week 1, exercise is very important to keep us healthy and help our moods. Depression feeds on 
depression, when you believe that things will get better, they will start to change. Use the 
suggestions in the section on Week 3: Stress Management to help you manage your symptoms.  
Depression Check List: 
1. Do you feel down most of the time?  
2. Do you lack enjoyment with fun things like music, soccer or chocolate? 
1. Do you try to find peace by overeating? 
2. Or do you lack appetite and lose weight? 
1. Do you sleep badly at night? 
2. Do you struggle to get up in the mornings? 
1. Do you feel angry and agitated very quickly? 
2. Do you feel very passive?  
3. Do you lack energy every day? 
1. Do you struggle to concentrate? 
2. Is it difficult to make decisions about simple matters? 
3. Do you feel guilty? 
4. Do you feel worthless sometimes? 
5. Do you think of death a lot? 
6. Do you think of killing yourself? 
If you answer yes too many of these questions, then you may have some degree of 
depression. Speak to the doctor or nurse at the clinic about how you are feeling. 
If you answer yes to one or wo of these questions then you may have depressed mo d 
which you can manage with some of the echniques described in the section on stress 
management. 
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Diarrhoea (Running tummy) 
Diarrhoea can affect anyone. Diarrhoea means you have to go to the toilet often and / or your stool 
is watery or slimy. Sometimes diarrhoea comes with stomach pains or with vomiting or both. When 
you have diarrhoea your body is losing water all the time. Losing water is called dehydration and can 
be dangerous, especially for children.  
 
Diarrhoea can be because of infections, as a side effect of medicines or caused by poor absorption of 
food. Diarrhoea can be prevented by making sure that you are using clean drinking water, that you 
prepare food carefully (see the section for Week 5) and make sure that you wash your hands every 
time after going to the toilet.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Home treatment for diarrhoea: The most important thing 
with diarrhoea is to make sure that you are getting 
enough fluids so that you do not become dehydrated. Try 
to avoid drinks with caffeine in them as they can cause 
more dehydration (coca-cola, coffee and tea all have 
caffeine). Drink your fluids at room temperature, hot 
drinks or cold drinks can make your diarrhoea worse. 
Diarrhoea Action Chart: 
Do you have? 
1. Black or bloody stools 
2. Severe, steady stomach pain 
Yes 
→ 
Go to the clinic now 
No ↓   
Do you have any signs of dehydration? 
1. Extreme thirst 
2. Very dry mouth 
3. Dark urine 
4. Lightheadedness 
Yes 
→ 
Go to the clinic today 
No ↓   
Are you taking antibiotics? 
Yes 
→ 
Go to the clinic 
No ↓   
Has the diarrhoea lasted for more than 5 days 
without improving? 
Yes 
→ 
Go to the clinic 
No ↓   
Treat your diarrhoea  at home   
 
8 teaspoons 
of sugar 
½ teaspoon of 
salt 
1 litre 
of 
water 
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Making a glucose drink is the most effective treatment for diarrhoea. Make this by filling a clean 
one-litre bottle with clean water from a tap or boiled water if you are not sure that the water is 
clean. Add 8 teaspoons of sugar and half a teaspoon of salt to the water and mix it well.  You can add 
half a cup of orange juice if you find you don’t like the taste. Try to drink one to two cups (200ml) 
after each loose stool (bout of diarrhoea). Take small sips and drink it slowly. 
 
If you have diarrhoea you might not feel like eating but skipping food is not a good idea. Try plain 
foods like dry toast white rice noodles, mashed potatoes or white bread. Eat 
any food that doesn’t make you feel sick. Make sure you wash your hands 
before and after handling food. Usually diarrhoea will go away on its own 
within a week.  
 
 
 
Fever 
Fevers or having a high temperature are most commonly caused by infection. In people 
living with HIV/AIDS the fever can be caused by the HIV itself but it can also be caused 
by other infections or even by medications. If you have a fever you need to check that 
you do not have any other symptoms of serious illness warning you to take action 
straight away. Use the fever action chart to check for these. 
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Home treatment for fever: A high fever can be treated by sponging the body down to cool it down, 
or by using medicine. Sponging the body down with luke-warm water (not cold water) helps to bring 
the temperature down. Paracetomol (Panado) can also be used to lower a temperature.   
Fever Action Chart: 
 
Do you have a fever and? 
5. Neck stiffness (you can’t bend your 
neck to put your chin on your chest) 
6. Extreme tiredness or feel confused 
7. Fitting or seizures 
8. Severe irritability 
Yes 
→ 
Go to the clinic now 
No ↓   
Do you have a fever with a dry cough and 
severe shortness of breath? 
Yes 
→ 
Go to the clinic now 
No ↓   
Do you have a new skin rash or skin sores 
with this fever? 
Yes 
→ 
Go to the clinic 
No ↓   
Do you have any of the following with your 
fever? 
1. Headache 
2. Sore throat 
3. Cough 
4. Diarrhoea 
5. Urinary problems 
Yes 
→ 
See the action plan for 
that problem 
No ↓   
Treat your fever  at home   
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Headaches: 
Headaches are one of the most common symptoms experienced by people both with 
and without HIV/AIDS. Headaches can be caused by muscles becoming tense, they 
can also be caused by medication. Headaches with fevers can be more serious. If 
you have a headache with a fever and stiff neck – a neck so stiff that when you 
bend it forward you can’t put your chin on your chest, you may have meningitis. 
This is a serious infection of the lining of the brain which needs to be treated 
immediately. Use the headache action plan to decide how to manage your headaches.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Home treatment for Headaches: Paracetomol is very effective to treat a simple 
headache. This medicine works better if you take it as soon as you feel the headache 
rather than waiting until the pain is so bad you can’t take it anymore. If the headache is 
due to muscle tension and stress then rubbing the neck muscles and putting 
something warm on the neck (a hot water bottle wrapped in a towel) can help. 
Relaxation techniques and resting is also very effective to manage headaches.  
Eye problems: 
People living with HIV/AIDS can get many eye problems. All eye problems should 
be checked at the clinic. Eye problems can be caused by infection (CMV), but, eye 
problems can also be caused by medicines, high blood sugar (diabetes), 
headaches, eye strain and normal changes with ageing. If you develop eye 
problems suddenly then it is likely that this is caused by an infection and you need 
to go the clinic straight away. If your eye problems have come on slowly then you 
need to get your eyes checked the next time you go to the clinic.  
Headache Action Chart: 
Do you have a fever and neck stiffness with 
your headache? 
Yes 
→ 
Go to the clinic now 
No ↓   
Do you have any of these with your 
headache? 
1. Difficulty moving your arms or legs 
2. Difficulty with seeing 
3. Difficulty speaking (slurring) 
Yes 
→ 
Go to the clinic now 
No ↓   
Has your headache lasted more than 3 days? 
Yes 
→ 
Go to the clinic 
No ↓   
Treat your headache  at home and discuss it 
at the clinic at your next routine appointment 
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Nausea and Vomiting: 
Many of the worries about nausea and vomiting are the same as for diarrhoea. 
Medicines are the most common cause of nausea in people with HIV/AIDS but this 
can also be caused by viral infections. Dehydration is the biggest risk. Signs of 
dehydration may be dizziness, severe thirst, dry mouth and tongue, decreased and 
very dark urine, wrinkled and dry skin. Black or bloody vomit can be a sign that there 
is bleeding in the stomach.  
 
 
 
 
 
 
 
 
 
 
 
 
Eye Problem Action Chart: 
Did blindness (part or total) come on suddenly 
in one or both eyes or is the loss of vision 
severe?  
Yes 
→ 
Go to the clinic now 
No ↓   
Is your CD4+ count more than 200 
Yes 
→ 
Go to the clinic 
No ↓   
Have you had gradual loss of vision equally in 
BOTH eyes 
Yes 
→ 
Go to the clinic 
No ↓   
Go to the clinic NOW   
 
Nausea and Vomiting Action Chart: 
Do you have any of these? 
1. Black or bloody vomit 
2. Severe steady stomach pain 
3. Headache with a stiff neck (you can’t 
put your chin on your chest) 
Yes 
→ 
Go to the clinic now 
No ↓   
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Home treatment of Nausea and Vomiting: It is important to get as much fluid into your body as 
possible without vomiting again. Sipping the glucose drink described for diarrhoea is important. 
Don’t try to drink a whole glass all at once, sip it slowly so that you do not vomit again.   
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Shortness of Breath: 
It is normal to feel short of breath when you do strenuous activity or exercise. If you get short of 
breath when you are resting or when you do very little activity or if you wake up at night feeling 
short of breath then you need to go to the clinic urgently. The main cause for this kind of problem in 
people with HIV/AIDS is PCP. Shortness of breath can also be caused by lung infections you have had 
in the past and smoking. 
 
 
 
 
 
 
 
 
 
 
Home treatment for Shortness of Breath: If you are busy with something when you become short of 
breath you should not stop straight away or try to hurry up to finish. It is best to slow down what 
you are doing and see if your breathing settles down. Sometimes when we feel short of breath we 
worry about it which makes us afraid and can make our breathing even worse. If you have not been 
very active for a while, your shortness of breath might be a sign that you need to get fitter. You need 
to slowly increase your activity over time as discussed in the section on exercise. If you smoke and 
you are getting short of breath you need to try to stop smoking. If you are struggling with stopping 
smoking then speak to the nurse on your next visit to the clinic. If people smoke near you, try to 
avoid their smoke or ask them to smoke away from you. If you are short of breath it is helpful to 
practice the deep breathing exercises described in the section on relaxation. This kind of deep 
breathing helps to train the muscles for breathing and also helps your mind to manage your 
symptoms. 
 
  
Shortness of Breath Action Chart: 
Do you have shortness of breath at rest or 
with very little activity? 
Yes 
→ 
Go to the clinic now 
No ↓   
Do you have a dry cough or fever with your 
shortness of breath? 
Yes 
→ 
Go to the clinic now 
No ↓   
Treat at home and go to the clinic   
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Sore Throat and mouth: 
Sore throats are common in people with and without HIV. The most common causes of a sore throat 
are the cold viruses but a sore throat can also be caused by other infections. Most sore throats can 
be treated safely at home. A sore mouth and sore ears are also common. Patches in the mouth, 
white patches on the tongue or mouth or red burning patches which are itchy and sores in the 
mouth or down your throat can all be caused by thrush.  Pain in the mouth 
can be caused by teeth with holes. Teeth can get holes because of bacteria in 
the mouth. You can prevent these by brushing your teeth twice a day and 
after very meal. It does not take much toothpaste (a drop the size of a pea is 
enough) to keep your teeth clean. It is also important to cut down on sweets and 
fizzy drinks which cause teeth to rot. Use the sore throat and mouth action chart 
to decide on what you need to do. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Home treatment for a sore throat and mouth: Drinking cool liquids and taking painkillers like 
paracetomol can help. You can also treat a sore throat by gargling with salt water. It may also help to 
suck on ice cubes if you have access to ice.  
Sore Throat and Mouth Action Chart: 
Do you have severe difficulty breathing or 
swallowing? 
Yes 
→ 
Go to the clinic now 
No ↓   
Do you have a fever or pus in the back of your 
throat? 
Yes 
→ 
Go to the clinic 
No ↓   
Do you have pain in your teeth or swelling in 
your cheek? 
Yes 
→ 
Go to the dental clinic 
No ↓   
Do you have sores or white patches in your 
mouth, on your tongue or on your lips? 
Yes 
→ 
Go to the clinic 
No ↓   
Has your sore throat lasted more than 10 
days? 
Yes 
→ 
Go to the clinic 
No ↓   
Treat at home   
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Skin Problems: 
There are many skin problems which can affect people living with HIV/AIDS. Very few 
of these problems are dangerous but because they can be seen they can be very 
upsetting. Being able to see these might make you feel unattractive or have low self-
confidence, they often last a long time and can constantly remind you of your HIV 
status. The most common skin problems people with HIV/AIDS have are shingles, chicken pox, 
bacterial infections, warts, fungal infections and rashes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Home treatment for skin problems: It is important to keep the skin clean to prevent any infections 
developing. Wash your whole body with soap and water every day. Keep your fingernails short and 
clean. If you are scratching in your sleep, you can sleep with socks over your hands so that you do 
not damage your skin. If your skin is dry and itchy, it helps to wash with aqueous cream instead of 
soap.   
Skin Problems Action Chart: 
Do you have a rash which is painful on one 
side of your body or on your face? 
Yes 
→ 
Go to the clinic today 
No ↓   
Has the rash started after starting new 
medicines? 
Yes 
→ 
Go to the clinic today 
No ↓   
Do you have a rash or blisters on your body 
and a fever? 
Yes 
→ 
Go to the clinic today 
No ↓   
Do you have warts on your skin which are a 
different colour to your skin? 
Yes 
→ 
Go to the clinic 
No ↓   
Do you have a rash in a circle on your skin or 
white dying skin between your toes, in your 
groin, around your private parts or under 
your arms or is there pus in the rash? 
Yes 
→ 
Go to the clinic 
No ↓   
Treat at home   
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Urination problems: 
Urinary infections happen more often in women than in men, but men with HIV/AIDS are 
more likely to get these infections too. The most common symptom of a urinary infection is 
pain or burning when you pass water, frequent need to pass water and blood in the 
urine. These symptoms are not always caused by an infection; they can also be caused 
by too much caffeine (tea, coffee, cola); bladder spasms (when the bladder becomes 
overactive) and even anxiety. Bladder infection in women can also be caused by sexual 
activity. If you also have a fever, vomiting, back pain or teeth-chattering or body-shaking 
chills it is likely that the infection has spread from the bladder to the kidneys. Use the Urination 
Problems Action Chart to help you decide how to manage your symptoms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Home treatment of urination problems: The first step in managing these problems is to drink a lot of 
water. Drink several litres (4 to 5 litres) of water in the first 24hours after these symptoms start. This 
helps to wash out anything which might be causing the problem. Drinking fruit juices can also help as 
these change the chemical content of the urine. If you have a new vaginal discharge or pain in the 
abdomen it is important to go to the clinic as this means that the symptoms may not be coming from 
the bladder but from the vagina which needs medical treatment.  
  
Urination Problems Action Chart: 
Do you have a fever, vomiting, back pain, 
shaking chills as well as painful or frequent or 
bloody urination?  
Yes 
→ 
Go to the clinic today 
No ↓   
Could you be pregnant? 
Yes 
→ 
Go to the clinic today 
No ↓   
Do you also have a new irritating vaginal 
discharge? 
Yes 
→ 
Go to the clinic today 
No ↓   
Do you have pain in your stomach (abdomen) 
as well as a vaginal discharge?
Yes 
→ 
Go to the clinic today 
No ↓   
Treat at home and go to the clinic if it does 
not clear up in 2 days. 
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A final word on symptoms: 
Remember the steps described in this section and the action charts do not replace nurses and 
doctors. The information in this section is to help you work with 
your health team. Use the action charts to help with thinking 
about any symptoms you experience and to help you decide 
what you need to do about them. As you have read, some 
symptoms it is perfectly safe for you to manage at home. 
Some symptoms you need to go to the clinic straight away 
for. If you have any doubt or any worries about any of the 
symptoms you experience then it is best to go to the clinic to 
get them fully assessed. Remember what you learnt in the first 
section on how to be a good self-manager. Use the information 
in that section to help you get the most out of any visit to the clinic 
about any symptoms you experience.  
 
When you do visit the clinic for a symptom you may be treated by the nurse or doctor. Or may be 
referred to someone who specialises in the problem you are experiencing. In the next section, we 
will discuss how to communicate well with your health carer. No matter who you are seeing at the 
clinic, it is useful to use the steps on communication to get the most out of your clinic visit.  
 
Use the “Action Plan Form” at the end of this section to plan how you will manage a symptom which 
you experience. Use the “Exercise Diary” to keep track of the exercise plan you started last week. 
Remember these charts are designed to help you become a successful self-manager!  
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Action Plan Form – Managing Symptoms 
 
Think about a common symptom which you experience. Use this form to draw up an action plan of 
how you plan to manage this symptom the next time it occurs. 
Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three 
times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
How confident are you that you can complete this action plan? 
 
 
 
 
 
Keep a record of how you did, when I feel sick: 
  
 I Plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
       ____________________________ 
Not at all      |     |     |     |     |     |     |     |     |      |       
Totally 
confident    1    2    3    4    5    6    7    8    9    10    confident 
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Exercise Diary 
 
Use this exercise diary to keep track of the exercise goals and plan you drew up in week one. 
Start off by writing down your goal.  
Write down here what you want to be able to do:       
  
Now, what do you want to be able to do this week which will help you to reach your goal? 
Remember from your action plan to include:  
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before 
lunch (when) three times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
 
 Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 mins in a.m. after 
breakfast and in p.m. 
after supper 
 Very tired by the second session, I’m 
going to cut it down to morning only for 
this week. 
Monday    
Tuesday    
Wednesday    
Thursday    
Friday    
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Week 3: Stress Management 
 
In our society, we talk about stress a lot. We might say that it is stressful to live in 
South Africa. That it is stressful to worry about our children or our families, it is 
stressful to worry about money or it is stressful worrying about getting a job or coping 
with my job. We use the word stress a lot, but what does it mean? Stress is a feeling; it 
is a combination of feeling tense and worried. When we feel stressed we may be 
irritable, and find it difficult to concentrate or remember things, stress can affect our sleep, our 
appetite and our relationships. 
 
The most common reason why we feel stressed is a lack of control. We tend to feel that things are 
stressful if we don’t have any control over them. We feel stressed if we are going to be late for work 
because the trains are late – this is out of our control. We feel stressed about 
where we live if we don’t feel safe there – those who commit crimes against 
us are also out of our control. In the same way, we may feel stressed when 
we have a chronic illness like HIV/AIDS or diabetes or high blood pressure. If 
you feel that your illness is out of your control and there is nothing you can 
do to affect it, this makes you feel stressed.  
 
Stress is not always bad. We know that stress can be useful too. For many people if we feel some 
stress, we might feel under pressure to perform better. You might feel stressed because your family 
is coming to visit, but this stress makes you tidy up your home – a good effect of the stress. Students 
who are studying will only complete their studies if there are exams and deadlines for assignments, 
without the stress of the deadline, the students would not complete the work.  
 
Sometimes we wish for a “stress-free” life. But, we know that if there was no stress in our lives, if we 
did not have to do anything all day long, this would not be good for us either. If I lay in bed all day 
and did not do anything, my muscles would get weak, my joints would get stiff and I would become 
ill. We need some stress in our lives to keep us healthy. The important thing is to keep the amount of 
stress at a level that we feel we can manage. This is why we talk about stress management, not 
stress elimination! 
 
There are many different things we can do in our lives to manage stress. The first step is to 
understand why we are feeling stressed. There are usually three things which affect how stressed we 
feel. 
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1. The stressful situation:  
Usually the less you expect the situation and the less familiar you are with a situation, the more 
stressful it will be. If you needed to take the train to work but you knew the day before that the 
trains would be late, this would be less stressful than finding out after you have got onto the train 
that it is going to be late. If you think about having pain, if you know the cause of the pain is it more 
or less stressful? If you don’t know what is causing your pain and you are worrying that there is 
something seriously wrong, is this more or less stressful? 
 
2. How you see the situation and how you cope with it: 
If the situation you are in is not important, you are likely to feel less stressed about 
it. If you are on a train which is going to be late, but you are going shopping on your 
own, then you are likely not to get so stressed about it. If you are on a train which 
is going to be late and you are going to work this might be more stressful, but if 
you have a cell phone with you and you have airtime on the cell phone and you 
telephone your boss to explain why you will be late, then this might be less stressful. 
Your ability to cope with the situation, affects the amount of stress you feel. While it is stressful to 
live with a chronic disease like HIV/AIDS, diabetes or high blood pressure, if you thought you could 
cope with it and it would not interfere with your job and your life would it be more or less stressful? 
Having knowledge about your condition allows you to think about it in a different way and will 
change the way that you cope. 
 
 3. Support from family and friends: 
Friends and family who understand and support you will affect your levels of stress. Feeling 
alone and like you have no support will probably make you feel more stressed. If you think 
about living with HIV/AIDS, would it be more or less stressful if there were no one to support 
you? But, we do need to be careful about support from family and friends. If they take over 
doing everything for us (because they care about us and are trying to help), we might feel 
useless and like we don’t have a purpose. Support does not mean doing everything for me. 
 
 
Stress is not just the things that happen to us. The amount of stress that we feel depends on 
a lot of different things which can change every day. There are many different things we can do to 
manage stress every day. 
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Managing Stress: 
1. Dealing with the cause of the stress 
The first step in dealing with stress is to identify why you are feeling this way. Use 
the self-management steps to help you identify the problem. Once you know 
why you are feeling this way then you need to decide what you can do about it. 
Sometimes dealing with the things that stress us is easy, if you are friends with your 
neighbours and the noise from their television is irritating you it might be easy to 
ask them to turn down the volume. If you are not friends with your neighbours, or 
you are very shy it might be quite difficult to ask them to turn down the volume. 
Sometimes we can identify the things that stress us and do something about it. But, often we either 
cannot deal with it or it is out of our control. If you cannot deal with it or it is out of your control, the 
next step is to change the way you are looking at the problem. 
 
The second step is to look at the problem in a different way. Think about how you are feeling. Are 
your thoughts and feelings about the problem inaccurate? Maybe you are very worried about your 
health, this is stressing you. Are you worried that you will be very ill and unable to work soon? Are 
these thoughts and feelings accurate? On what information are you basing these thoughts and 
feelings? Have you spoken to experts about your health or are you basing your thoughts and feelings 
and stress on poor information? 
 
Step three is - plan your life. Do you get stressed by the same things over and over again? Or do you 
find yourself getting stressed because there are times when your life is very busy? If 
you are doing the same things over and over and getting stressed, you might want to 
look at how you are dealing with it and see if you can try a different plan. What 
about a busy life? This is also about planning, being very busy and having no time 
for ourselves, can be very stressful. Plan things over time carefully, make sure you 
have time to at least do some relaxation or exercise even when you are very busy. Do not leave 
things for the last minute.  
 
The last step to deal with stress is to get help. Family and friends and support 
groups are a great way to decrease stress. If we want support from people though, 
we have to tell them clearly what the problem is and what we would like from 
them. Often we do not communicate clearly and this might make the stress worse! 
If you find your family or friends are not very helpful or supportive, it might be 
worth sitting down with them when you are not feeling stressed to talk about these 
things. It might be that they see things differently to you, this does not mean they are right and you 
are wrong, or that you are right and they are wrong. It just means that you see things differently and 
you can discuss how to handle things better. If having a discussion like this is difficult, it might be 
useful to ask a counsellor to help with the conversation. You can ask for assistance at a clinic or you 
can go to an NGO like FAMSA who specialise in family and relationship counselling. 
 
2. Relaxation 
When we feel relaxed, we feel calm. Sometimes if we are relaxed and we are tired, we might feel 
sleepy. At other times we might feel relaxed and alert and be able to concentrate calmly on tasks. 
Relaxation can help us to concentrate and it can help us to unwind and go to sleep. Relaxation is a 
very useful way to manage stress and some of the symptoms of chronic diseases such as pain. 
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If we are stressed, this can make our muscles tense, our hearts beat faster and we breath faster, if 
we are also feeling unwell and have pain we will feel worse. Relaxation can decrease the tension in 
muscles and slow down our hearts and breathing and help to make us feel better. If we are stressed 
we often become irritable and moody, relaxation helps to calm you and make you feel more in 
control of your life. When we are stressed sometimes it is difficult to fall asleep as we 
are worrying about things out of our control, if you are also unwell, not sleeping will 
make you feel worse. Relaxation will help you get to sleep, this will help 
manage your stress and improve your health.  
 
Just like learning to play a new sport or doing exercise, relaxation takes practice. The specific way 
that you relax doesn’t matter; we are all different and might relax in different ways. The important 
thing is to practice it regularly. There are two different ways of relaxing described at the end of this 
section. You can do these at home in a quiet and comfortable safe place to begin with. But, once you 
get good at relaxation, you can relax in a crowded waiting room, on a train or a taxi. You can do 
relaxation anywhere! 
 
 
 
 
 
 
 
 
 
  
Good times to practice relaxing are when: 
1. You feel you are getting tense or irritable or you are worried 
2. You feel you are in pain 
3. You want to go to sleep 
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3. Sleep 
People with chronic illnesses often struggle to sleep because they are stressed and worried about 
their condition, they worry about what this means for them, for their family, for their future. People 
also often struggle to sleep because of the illness itself, perhaps you have pain, you 
feel sick or you may even be so tired you can’t sleep. Some people find it difficult to 
get to sleep and only fall asleep very late at night, others find that they fall asleep 
but then wake up during the night and can’t get back to sleep. Some people find it 
difficult to sleep at all at night and sleep during the day.  
 
Sleep is very important to keep healthy. We all need different amounts of sleep. Some people need 
8 hours of sleep a night, some may need 10 hours and some people only need 5 hours of sleep. We 
are all different. We have been learning how to fall asleep and sleep well since we were babies. If 
you do not sleep well, following these steps will help you to learn how to fall asleep and sleep well. 
Remember that like learning anything new, this will take time. It might take up to 3 months to learn 
to sleep well if you have been struggling with sleep for a while. 
 
Suggestions for Improving Sleep 
1. Have a bedtime routine: try to go to bed at around the same time every night 
and always do the same things before getting into bed. A bedtime routine 
could be to lock the house, get undressed, wash your face, clean your 
teeth, get into bed and do a relaxation session. 
2. You can’t sleep because of worrying: write down your problems or the things 
that are worrying you, then write down the next step that you think could help sort out the 
problem. If you wake up during the night worrying about the problem, remind yourself that 
you’ve gone over it and you have a plan. If you wake up with a new worry, 
write down that problem to deal with in the morning. Practice your 
relaxation to take your mind off the worry. If you still can’t sleep, it may 
be better to get up and do something relaxing like reading, watching TV, listening 
to relaxing music or doing relaxation.  
3. Your bed and bedroom are for sleeping: try not to use your bedroom during the day. Do not 
watch TV in bed. If you are not asleep within 30 minutes of going to bed, get up and do 
something else. Do not lie in bed and worry that you have not fallen asleep. 
This will only make you feel stressed and lessen the chance of falling asleep. 
4. Have a morning routine: get up at the same time every day, even if you don’t 
feel like it. Our bodies like to work on regular patterns to fall asleep and get 
up at the same time every day. 
5. Avoid drinks containing caffeine for at least 4 hours before going to sleep (drinks like coke, 
tea or coffee). 
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6. Never use alcohol to help you sleep. It might make you feel relaxed at first, but once this 
wears off it is likely to make you feel jumpy and you are likely to wake up during the night. 
 
 
 
 
 
 
 
 
 
 
7. Exercise 
Exercise is a very effective way of managing stress. People who exercise regularly 
doing at least 20 to 30 minutes of exercise, 3 times a week have less risk of 
suffering from stress related illnesses. Go back to the section on exercise for 
more on how to exercise safely and effectively. 
 
 
 
  
 
 
 
 
 
 
 
  
Good sleep habits: 
4. Go to sleep at the same time every day 
5. Have a bedtime routine 
6. Do relaxation before going to sleep 
7. Use your bed only for sleeping or relaxing 
8. Have a morning routine 
Exercise: 
9. Decreases stress 
10. Helps us sleep better 
11. Decreases pain 
12. Makes us healthy and decreases our chances of developing other 
illnesses 
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8. Communicating with your health carer 
Anyone living with a long term health problem, whether it is HIV or high 
blood pressure or diabetes will have to visit their clinic regularly. Visiting the 
clinic regularly can be stressful because it takes time, you have to plan ahead, 
you might not be sure how long you are going to have to wait, you might be 
worrying about what the health carers are going to tell you. One of the most 
important ways of managing the stress associated with visiting clinics and seeing health carers is to 
think about and plan how to communicate with them.  
 
 When visiting the clinic to see a health care practitioner it is important that you feel comfortable 
asking questions (any questions, even if you feel they are “silly” or “stupid” questions) and 
comfortable expressing how you feel. It is also important that you feel you can negotiate your 
treatment with your health care provider so that both you and the carer feel that you are receiving 
the best care for you. It is important that you not feel that your health care 
provider is ignoring you, “puts you down” or treats you like a child. We know 
that doctors and nurses have a lot of patients to see and they have little time 
to spend with each person. One helpful way to make sure that you get the 
most out of your appointments with the doctor or nurse is for you to take 
PART – Prepare, Ask, Repeat, Take action. 
 
Take PART: 
Prepare: 
Before your appointment at a clinic it is important to prepare. Think about the reason for your 
appointment and whether there are any issues in particular that are worrying you. Write down your 
questions or the things that are worrying you. You need to be realistic about the list you write down, 
there will probably only be time to answer one or two of the things on your list. Make sure the most 
important problems are at the top of the list. Take your list with you to your clinic appointment, then 
when the doctor or nurse asks if there is anything you want to ask, you can use your list.  
 
If there are particular symptoms or health issues you want to discuss, prepare for your appointment 
by writing down specific information the doctor or nurse will want to know. Things that 
are helpful are: when did it start, how long do the symptoms last, where are they 
in your body, what makes you feel better or worse, have you had a problem like 
this before and how was it treated; have you changed anything such as your diet, 
exercise, medicines. If you have already received treatment for a problem, be ready 
to report back on how well it has worked, or on whether it has not worked at all.  
 
Be open about how you are feeling and about the things that are worrying you. The more open you 
are, the more the health care provider can help you. Finally, give feedback. If you don’t like the way 
you have been treated you can tell the doctor or nurse. If you do not want to tell them directly then 
you can speak to someone else in the clinic or to someone in a support group. Remember too that 
doctors and nurses and other health care providers also appreciate being complimented. If 
you feel that you have been treated well and are happy with your treatment, it is 
acceptable to compliment the health carer. 
 
Ask: 
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Another important step in having good communication and decreasing stress is to ask questions. 
Having good information is essential to you being successful in self-managing your health. Ask 
questions about your diagnosis such as what is wrong, what has caused it, is it contagious and what 
is going to happen now? Then ask questions if you have had tests, what is the test for; what if I don’t 
have the test and what will the test involve? Remember to ask questions about your treatment 
options, what are the benefits of treatment and what are the risks and side effects? Finally ask 
questions about follow-up, when should you return to the clinic, what should you watch out for and 
what should you do next? 
 
If you find you have difficulty remembering information it is a good idea to write things 
down during your visit. Or you could ask someone you trust to come to the 
appointment with you to help with remembering.  
 
Repeat: 
One of the important things to do to help with remembering things is to repeat it. So if the nurse or 
doctor explains something to you, repeat back to them in your own words what you have 
understood. This is very useful to make sure there are no misunderstandings.  
 
Take Action: 
At the end of your appointment, it is important that you know exactly what you will need to do next. 
It might be that you need to make another appointment, or that you need to go home and change 
something or get new medicine from the pharmacy. Make sure that you are clear about what you 
need to do next, and then do it! 
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Relaxation 
Long relaxation: 
Find a comfortable position. Lie on your back or sit in a chair with your back supported. 
Place your hands at your sides, palms up. 
Close your eyes if you wish. 
Now begin to become aware of your breathing..... Focus on slowing down the rhythm of your 
breathing..... Your chest and tummy will expand outward with each breath, like a balloon gently 
filling with air.... 
Imagine your ribcage moving out to the sides when you breathe in.... and gently inward as you 
breathe out.... 
Slowly take a deep breath in.... Pause for a moment.... and then slowly breathe out. Let the tension 
melt away as you relax more deeply with each breath... 
Continue breathing slowly and gently.... 
Now think about the top of your head. Feel the skin on the top of your head beginning to relax, and 
spreading slowly downwards.... 
Even your ears are becoming relaxed and heavy.... Feel your eyebrows resting....  
Your forehead is becoming relaxed and smooth....all the lines on your face are becoming smooth.. 
Let your jaw relax by allowing your mouth to be slightly open.... Allow your tongue to relax... 
Feel your throat relaxing.... relax your cheeks, nose, and eyes.... Feel your eyelids becoming very 
heavy.... and very relaxed.... more and more relaxed.... 
Enjoy the feeling of relaxation you are experiencing. 
Now think about your neck.... allow a feeling of relaxation to begin at the top of your neck, and flow 
downward... 
Feel the relaxation as your shoulders become relaxed and loose.... Let your shoulders 
gently sink downward.... as they become relaxed.... and heavy.... very heavy.... and very relaxed.... 
deeper and deeper.... relaxed.... 
Feel your collar bones becoming relaxed as your shoulders move gently back, and your chest widens 
slightly.... 
Allow all the muscles in your shoulders to feel smooth... and relaxed.... as the muscles give up their 
hold completely... 
Notice your breathing once again... see how regular it has become... continue to take slow.... 
smooth.... deep breaths... Breathe in the feeling of relaxation... and breathe out any tension... your 
breathing allows you to become more and more relaxed.... deeply relaxed..... Now turn your 
attention to your right arm..... Feel the relaxation flowing down from your right shoulder.... allow 
your upper arm to relax... your elbow.... lower arm... and wrist become loose and relaxed.... 
Enjoy the feeling of relaxation as the muscles of your right arm give up their hold.... Feel the 
relaxation flowing into your hand... Let all the tension drain out of each finger tip and flow away.... 
the relaxation spreads to your thumb... index finger.... middle finger... ring finger... and little finger.... 
Feel the relaxation flowing down your left arm... Let the muscles of the left upper arm relax.... Relax 
your elbow.... lower arm.... and wrist....  
Enjoy the feeling of relaxation you are experiencing. 
Let the tension melt away.... imagine the tension flowing right out of your finger tips... Allow your 
left hand to relax completely.... relax your thumb... index finger.... middle finger... ring finger... and 
little finger.... 
Both of your arms are now totally relaxed... allow them to be free and limp... pleasantly relaxed... 
Enjoy the feeling of relaxation you are experiencing...  
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Allow the feeling of relaxation to continue to your chest and stomach....feel the relaxation there... 
becoming deeper with each breath.... 
Now turn your attention to your upper back... Feel the relaxation flow down your spine... Let all the 
muscles give up their hold.... relax your upper back... middle and lower back.... allow your back to 
relax completely..... Feel the relaxation in your whole upper body .... 
Relax more deeply with each breath.... more and more relaxed.... deeply relaxed and calm.... 
Let your hip muscles relax.... Relax all the way from your buttocks (bottom), down the back of your 
thighs... relax the muscles on the front of your thighs...Feel the relaxation in your upper legs moving 
down to your knees... your calves and shins.... your ankles.... and your feet.... allow all the muscles to 
relax and go limp.... 
Allow any last bits of tension to flow right out of the soles of your feet....Feel the relaxation flowing 
through your body... From the top of your head... down to the bottoms of your feet.... become more 
relaxed with each breath.... enjoy the feeling of total relaxation..... 
You are now as relaxed as you want to be.... Experience the feeling of deep relaxation... enjoy the 
feeling.... relaxed.... calm..... at peace 
Focus on the feeling of relaxation throughout your body.... Notice your breathing.... Your relaxed 
muscles.... Your calm thoughts... Memorize this feeling so you can re-create this relaxed state 
whenever you wish.... 
Enjoy relaxing for a few moments more.... 
When you are ready to return to your day, reawaken your body slowly... gently move your muscles... 
roll your shoulders slowly forward.... then slowly backward.... lean your head gently to the left... 
return to centre.... lean your head gently to the right... turn your head... 
Wriggle your fingers and toes.... 
Gently open your eyes.... Feeling alert... calm.... and full of energy. 
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Short relaxation: 
Deep breathing not only helps to cure anxiety and stress, it also triggers relaxation. Here's how to 
breathe deeply. 
 
Breathe in slowly to the count of four (count slowly; to the pace of one-one-thousand, two-one-
thousand....). Pause to the count of three. 
Breathe out slowly to the count of five. 
The breathing process goes like this: 
Inhale... two, three, four...pause...two, three....exhale...two, three, four five.... 
Inhale... two, three, four...pause...two, three....exhale...two, three, four five.... 
Repeat for a minute or two. 
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Action Plan Form – Stress Management 
 
Think about one thing that is causing you stress. Use this action plan form to come up with a plan of 
how to manage your stress this week. 
Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three 
times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
How confident are you that you can complete this action plan? 
 
 
 
 
 
Keep a record of how you did: 
 I Plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
  
       ____________________________ 
Not at all      |     |     |     |     |     |     |     |     |      |       
Totally 
confident    1    2    3    4    5    6    7    8    9    10    confident 
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Exercise Diary 
 
Use this exercise diary to keep track of your exercise goals and activities. 
Start off by writing down your goal.  
Write down here what you want to be able to do:       
  
Now, what do you want to be able to do this week which will help you to reach your goal? 
Remember from your action plan to include:  
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before lunch 
(when) three times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
 
 Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 mins in a.m. after 
breakfast and in p.m. 
after supper 
 Very tired by the second session, I’m 
going to cut it down to morning only for 
this week. 
Monday    
Tuesday    
Wednesday    
Thursday    
Friday    
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Week 4: Pain 
 
Many people living with HIV/AIDS experience pain and it is very often the symptom which 
bothers them most. We know this from lots of scientific studies conducted across South 
Africa, Africa and the rest of the world. There can be many reasons for someone living 
with HIV/AIDS to have pain. The pain may be caused by the virus, or the pain may be 
caused by the medicines used to keep you healthy or the pain might be for a reason 
that has nothing to do with HIV/AIDS.  
 
The pain may be caused by the disease, for example if the virus damages nerves you may feel pain. 
Pain may also be caused or made worse by tense muscles. When something hurts we tend to make 
our muscles tense to try and protect ourselves. Pain may also be caused by weak 
muscles or stiff joints. People with HIV/AIDS often become less active and their 
muscles and joints get weak and stiff. Then when they do use their muscles and joints 
these can hurt because they haven’t been used for a long time and they aren’t used 
to it. Finally stress, fear, anxiety and depression can cause pain and make pain worse. 
We know from research that when you are in pain your brain is very active. If you 
are also stressed, or afraid, worried or anxious, or depressed, your brain becomes even 
more active. This does not mean that your pain is not real, what it does mean is that 
activity in your brain can cause pain or if you are already in pain, it can make it worse.  
 
To properly treat pain we have to make sure that we check and treat all the possible causes of pain. 
 
Checking the cause of pain 
If you develop a new pain which you have not felt before it is important for you to pay attention to 
it. Pain is your body’s way of getting your attention that something might be wrong. It does not 
always mean that something is wrong; it may just be a warning. It’s like when you put your hand on 
something hot, it hurts and you pull your hand away. Often your hand is not burnt, but it was 
painful, the pain got your attention quickly and you moved your hand before you got burnt.  
 
If you have not felt the pain before it is important for a doctor or a nurse to examine you to find the 
cause of the pain. If they find the cause of the pain they may give you medication to treat the cause. 
If you have TB you might have pain, the doctors or nurses might give you medicine for the TB to 
treat the cause of the pain. They should also give you medicine for the pain itself. If they 
forget to give you pain medicine you must ask for it. Sometimes you may only be 
given pain tablets for a few days, if you know your pain lasts for the whole month 
you must tell the nurse or doctor this and they should give you medicine for the 
whole month.  
In up to one third of people with HIV/AIDS who have pain, the doctors or nurses might not find any 
reason or cause for the pain. This does not mean that the pain is not real or that it should not be 
treated. If they do not find a clear cause for your pain they should still give you pain medicine. 
 
What can you do for pain? 
There are lots of things you can do for yourself to help manage your pain. Because we know that the 
brain is very involved when someone is in pain, we also know that understanding your illness, being 
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a self-manager who understands about their treatment and, having support can help manage your 
pain. We are now going to talk about different things that you can do to help decrease pain. 
 
Exercise 
Doing any kind of exercise, stretching, strengthening or endurance exercise can all help to decrease 
pain. We also know that people who exercise regularly have less pain.  
 
Relaxation 
Managing stress and doing relaxation exercises also helps to decrease pain. This works because it 
decreases the activity in the brain. We also know that if you do regular relaxation it can help you to 
sleep better. People with pain often find that the pain is worse at night and that it is difficult to 
sleep. Bad sleep can also make pain worse. Doing relaxation and being able to sleep better will help 
to reduce the pain and help to prevent it getting worse. You can also help your pain by managing 
stress and anxiety. You can do this by talking to people and getting support, either from a nurse, a 
counsellor or a support group.  
 
Heat 
If your pain is being caused by tense muscles then heat can help to decrease it. 
You can warm up the muscles by having a warm bath or shower with the water on the affected area. 
If you cannot have a hot bath or shower, then keeping the muscles warm with clothes or a blanket 
can also help. There is one time when you should not use heat for pain. If you touch the painful area 
and it is already hot, this means it is inflamed and you should not make it hotter. If the area is 
infected or the skin is damaged then it is also better not to make it hot. In both these situations, it is 
better to use cold.  
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Cold 
Cold is a very good way to treat pain. When we make nerves that send messages warning 
us about damage cold, they slow down and send fewer messages. This means that we 
feel less pain. If you have a freezer then you could use a packet of ice or of frozen 
vegetables on the painful area. Only leave it on your skin for 10 minutes at a time. If 
you do not have a freezer then putting a damp cloth on your skin (if you have a fridge then use water 
from the fridge) will also work well.  
 
Massage 
Self-massage is a very simple but very good way to treat pain. You may have even been doing it 
without realising this is what you were doing. If you have ever rubbed a painful arm or leg then you 
have done some self-massage. You can use a simple cream or baby powder to do massage. Gentle 
rubbing of a painful area can relieve pain a lot. BUT, as with heat, if the painful area is hot or infected 
then it is better not to rub it. Rather use cold. If you have pain and the painful area is hot, red and 
swollen this may be a sign of an infection. If you have been using ice on this for a day and it is not 
getting better, visit the clinic. 
 
Support 
As we said before, when we feel pain, our brains become very busy. We often 
worry about the pain, we may feel scared about what is causing the pain or what 
the pain means (we often talk about this as stress – “I feel so stressed!”). We might 
wonder what we have done to be getting pain. The fear and worry we feel when we 
have pain can make the pain worse. This is why support is so important to help pain. It 
is helpful to talk to people that we trust about how we feel. It is also helpful to be reassured by a 
nurse or doctor about what is causing our pain. It may be that worrying about HIV is making your 
muscles tense and this is causing your neck to pain or causing headaches. It helps if the doctor or 
nurse can reassure you that the pain is caused by stress. This does not mean that you are making it 
up or that it is not real! It means that there is something you can do to help the pain. Talking to 
people, doing exercise and relaxation all help to manage stress and this will help the pain. 
 
Medicine 
If you have medicine to help your pain it is important that you take it regularly. Do not wait for the 
pain to start before you take the medicine, if you wait it will not work as well. If the doctor or nurse 
has told you to take the medicine several times a day then it is important that you do this, even if 
you are not feeling any pain at the time; not feeling pain means that the medicine is working. Do not 
wait for the pain to come back again before taking another pill, it won’t work as well.   
If your medicines are not helping the pain then you must go back to the nurse or doctor. You might 
need stronger medicine or you might need to take two different kinds of medicine at the same time.  
 
Common medicines used to treat pain are:  
9. Paracetomol (panado, dolorol, painamol, painstop) is a very 
good, very effective and safe medicine for pain. It is 
important not to take more than 10 tablets per day. 
10. Aspirin (disprin) is also very good but some people need to 
be careful with this medicine. If you use it for a long time you need to be careful of side-
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effects like ulcers, asthma or kidney problems. 
11. Anti-inflammatories like indomethacin (indocid), dicolfenac (voltaren or panamor) or 
ibuprofen (brufen or inza) are good if your pain is being caused by inflamed muscles or 
joints. These must be taken with food. These can also cause side-effects like ulcers. 
12. Paracetomol and Codeine is stronger than paracetomol on its own. If you have been using 
paracetomol on its own and taking it as the nurse or doctor told you but your pain is not 
getting better they may give you paracetomol with codeine. 
13. Dextropropxyphene (Doloxene) is a stronger pain medicine. This medicine is not easily 
available at clinics and the doctor or nurse would need to arrange for you to get it. 
14. Codeine phosphate is much stronger and can only be prescribed by a doctor. This medicine 
can make you sleepy and can cause constipation.  
15. Morphine is the strongest pain medicine. It can be taken up to 5 times a day. It also has to 
be prescribed by a doctor. If you are prescribed morphine make sure the doctor also gives 
you a laxative to prevent constipation.  
Remember that the most important thing about the pain medicines is to take them before the pain 
starts or as soon as the pain starts. Don’t wait for the pain to become severe before you take the 
pain medicine. It won’t work nearly as well. 
 
 
 
 
 
 
 
 
  
Pain 
13. Pain is one of the most common symptoms people living with HIV/AIDS 
experience 
14. Pain can be caused by the virus, by tense muscles, by weak muscles and stiff 
joints. 
15. Pain can be caused by and made worse by stress and worry 
16. Exercise, relaxation, cold, heat and massage are all good ways of treating pain 
17. Medication for pain works best if it is taken regularly and before the pain 
becomes very bad. 
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Action Plan Form - Pain 
 
Think about one pain which you commonly experience. Use this action plan form to develop a plan 
of how you are going to manage that pain. 
Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three 
times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
How confident are you that you can complete this action plan? 
 
 
 
 
 
Keep a record of how you did: 
  
 When I have pain I plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
       ____________________________ 
Not at all      |     |     |     |     |     |     |     |     |      |       
Totally 
confident    1    2    3    4    5    6    7    8    9    10    confident 
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Exercise Diary 
 
Use this exercise diary to keep track of your progress with your exercise goal which you set in week 
one. 
Start off by writing down your goal.  
Write down here what you want to be able to do:       
  
Now, what do you want to be able to do this week which will help you to reach your goal? 
Remember from your action plan to include:  
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how much) before 
lunch (when) three times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
 
 Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 mins in a.m. after 
breakfast and in p.m. 
after supper 
 Very tired by the second session, I’m 
going to cut it down to morning only for 
this week. 
Monday    
Tuesday    
Wednesday    
Thursday    
Friday    
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Week 5: Eating Well  
 
Eating well is important for everyone, eating well helps keep you healthy and if you are sick, either 
with HIV or any other illness, eating well is important to help you feel better. Treatment is not just 
taking anti-retroviral medicines; it is taking anti-retroviral medicines and eating well. When you are 
living with HIV, your body burns more energy than someone who does not have the 
virus. The virus makes your body use 10% more energy even when you are 
feeling well and between 20% and 30% more energy when you are 
feeling sick. This means that you have to eat more just to keep your 
weight the same. Losing weight is one of the most common 
symptoms of HIV. People with HIV mostly lose muscle weight, which 
makes them thin and also makes them weaker. So, how do you stop 
losing weight, or if you have already lost weight, how do you help your body recover? It is not 
difficult or complicated to eat well to stay healthy. We are going to discuss some simple steps to 
follow to eat well. 
 
What should I eat? 
Our bodies need energy to be able to do all the things we need to do every day. This energy comes 
from food and the best source of energy is food which has complex sugars in it. Complex sugars are 
not sweet, they are foods that many of us eat every day – the starch foods. Starchy foods like bread, 
pap, rice, potato and mngqusho are high energy foods (complex sugars). When our bodies 
run out of this high energy food, it will start to use energy stored in the 
body. Before you had HIV, your body would use fat to provide energy. But, 
now with the virus your body uses energy stored in muscles – protein 
energy. If you do not eat enough, your body will run out of complex 
sugars to give it energy and will start using protein from the muscles. This 
means that you will start to lose muscle and not fat – we call this wasting. If 
you eat foods with complex sugars (starchy foods - energy foods) regularly you can 
stop this happening. If you have already lost weight because of the virus, then you need to eat food 
with protein to help your muscles recover. Try to make sure you have high energy food (starchy 
food) with every meal. 
 
One of the important steps for eating well is to eat small meals or snacks often through the day. It is 
best to try and eat 3 meals a day and have another 2 snacks a day. This means that we should eat 5 
times a day; these meals do not all need to be big meals, a snack might be some fruit, nuts or sour 
milk. By eating 5 times a day we can make sure that we do not run out of energy. When we run out 
of energy, our bodies have to work harder, if we have pain the pain will get worse, if we are tired we 
will become more tired, if we are feeling sad we will feel sadder when we run out of energy and if 
are you are trying to concentrate then it is harder to concentrate when you run out of energy. Also, 
if you have HIV and you run out of energy your body starts to use the protein in muscle and you start 
to develop wasting. For these reasons it is important to eat at least 3 times a day and better to eat 5 
times a day.  
 
There is no single food which is good or bad. It is important to eat a variety of foods. We will now 
talk about the different food groups which we should be eating from every day. 
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Starchy Foods (also called carbohydrates or complex sugars) 
Bread-Potatoes-Pasta-Rice-Sweet Potatoes -Samp-Mealies-Sorghum-Pap-Porridge-Cereals 
 We need to have enough energy, so the starchy foods (complex sugars) should be the main part of 
our diets. Starchy foods should make up the main portion of all meals. Starchy foods can give us 
energy for a long time. In the shops or in magazines you might see food labelled 
“low GI”. “Low GI” foods are starchy foods which give us energy for a very long 
time compared to other starchy foods which are “high GI” which don’t give 
energy for as long. Both these kinds of starchy food are important for people 
living with HIV. 
 
 
Fruits and Vegetables 
Spinach-Morogo-Pumpkin-Green Peppers-Lettuce-Beans-Squash-Carrots-Tomatoes 
Peaches-Apricots-Oranges-Naartjies-Avocados-Paw Paw-Mango-Guavas-Watermelon 
The second most important groups of food which we need are the fruits and 
vegetables. We should eat at least one fruit and one vegetable with every meal 
and aim to have at least 7 portions of fruits and vegetables every day. Fruits and 
vegetables supply vitamins and substances which are important for keeping the 
immune system strong. Try to eat a variety of fruits and vegetables and include 
vegetables which are yellow, orange, red or dark green in colour. These fruits and vegetables contain 
a vitamin (vitamin A) which helps the lining of the stomach. Citrus fruits like oranges, 
lemons, grapefruit and naartjies are also important as they contain another 
vitamin (vitamin C) which helps the immune system to work. You can see in 
the picture below that the starchy foods and fruits and vegetables are the 
biggest sections of food. 
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Protein 
Beef-Pork-Chicken-Fish-Mutton-Lamb-Eggs-Milk products-Beans-Grains-Nuts 
People living with HIV need to eat protein every day. As we said before, this is important 
for your muscles and to help prevent weight loss. Protein is found in meats and milk 
based foods. You can also get protein from dried beans, peas, lentils, peanuts or soya. 
These foods can be a very economical way of getting enough protein, they are often 
much cheaper than meat or milk products.  
 
Fats and oils 
Butter-Lard-Margarine-Cooking oils-Cream-Mayonnaise 
Fats and oils are also an important part of a healthy diet. These foods provide energy, like 
the starchy foods. This does not mean you can eat as much as you like of these 
foods, but they should make up a portion of your diet. These foods can be used to 
increase your weight if you have been sick with an infection and lost weight. 
 
How do I put it all together? 
A balanced way of eating is for each meal to include two portions of starch + one portion of 
vegetables + one portion of fruit + one portion of protein. The fat portion of the food is included as 
part of the cooking (if you use oil) or if you put butter or oil on your food.   
 
 
 
A balanced meal 
“I find it hard to eat well!” 
Now that you know what you should be eating let’s talk about why people living with HIV may be 
struggling to eat enough. The reasons for not eating enough could be that they do not want to eat 
because they just don’t feel hungry or because they are too tired to eat or they are too worried to 
eat or they feel like they will vomit if they eat, or they have diarrhoea or they have sores in their 
mouth which hurt when they eat or food just doesn’t taste good any more. The next section gives 
ideas on ways to manage these problems.  
 
“I’m not hungry” 
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On the days when you feel like eating, make sure you eat well to make up for days when you might 
not be eating so well. On the days when you do not feel like eating try to eat small meals more 
often, maybe 6 times a day. Eat in a relaxing place, maybe with a friend. Keep small snacks with you 
in your bag or next to your bed so that if you wake up or suddenly feel hungry you can eat straight 
away. Make sure these snacks have lots of energy in them (are complex sugars). Make sure you have 
your favourite foods to eat, even if it’s just a little bit it helps.  
 
“I get full too quickly” 
You might be trying to get all your food at one meal. Try to eat five or six times a day. When you do 
eat, make sure its food with lots of energy and protein. Don’t eat foods without energy first and then 
feel too full for important foods. 
 
“Food doesn’t taste so good” 
Infections in the mouth or medicines can change the way food tastes. Sometimes you may have a 
bitter taste or a taste of metal in your mouth. If you have thrush, ask your doctor for 
medicine for this. You can also rinse your mouth with a mixture of 1 teaspoon of 
baking soda in a glass of water. DO NOT swallow this, rinse your mouth and spit it out. 
Try cleaning your teeth and your tongue before you eat. If you have a taste of metal in 
your mouth, try to drink orange juice or another tart drink.  
 
“Eating makes me want to vomit” 
Wanting to vomit when you eat can be because of an infection or a side effect of the medication. 
Eating smaller meals helps (5 or 6 meals a day) – it is important to know that nausea or the feeling 
that you are going to vomit is often worse when your stomach is empty. Food with lots of spices or 
fats and food or drink with caffeine can irritate your stomach and make you feel sick. Salty and dry 
food might help (bread or crackers). If the smell of food makes you feel sick, ask someone else to 
cook, and also make sure there is lots of fresh air where the cooking is being done so that the smell 
clears quickly. Don’t eat your favourite foods when you feel sick, you don’t want to start thinking 
that your favourite foods make you feel sick. If you think your medicine is making you feel sick, ask 
your doctor or pharmacist about the best time to take the medicines which might help. You can also 
ask your doctor for medicine which will help to stop the feeling of nausea.  
 
“I have diarrhoea”  
Diarrhoea can be caused by the virus, by the medicines or by stress or other infections. When you 
have diarrhoea, your body is not getting the food that it needs, even if you are eating it, your body 
cannot absorb it. When you have diarrhoea, your body is also not getting enough fluids. You need to 
make sure you are getting enough liquid when you have diarrhoea to make sure that you don’t get 
dehydrated. Go to the section on managing symptoms of HIV/AIDS for more information on how to 
manage diarrhoea. Remember, if you have diarrhoea for more than a week, you must go to your 
clinic for treatment. 
 
“I feel sick if I eat dairy products” 
Some people living with HIV find that drinking milk or eating milk products makes them feel sick. This 
is because the virus can affect a chemical in your intestine which you need to 
absorb milk. If this chemical is not present, you may feel bloated or get 
diarrhoea after eating milk products. This is called lactose intolerance. If this is 
happening to you, then you need to avoid eating milk products. Sometimes this 
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reaction will get better; you might find that in a few months you could try a milk product again and 
not have the same reaction. This would mean that your body now has enough of the chemical it 
needs and you can resume eating milk products.  
 
“My mouth is dry / I have sores in my mouth / chewing and swallowing hurts” 
A dry mouth might be a side effect of medications. Sores and pain in the mouth can be from 
infections. You can help this by avoiding smoking and drinking alcohol as these irritate your mouth 
and throat. Eat softer food, if you mash your food or make soup as this will be easier to swallow. Try 
not to eat food with a lot of spices or drink fizzy drinks if your mouth is sore. These can make your 
mouth burn more. Eating cold food like ice cream or sucking on an ice block can help to numb your 
mouth. If your mouth is sore, try to drink through a straw. Rinse your mouth often and keep a bottle 
of water next to your bed so that you can rinse your mouth during the night. 
 
 
 
 
 
 
 
 
 
 
Now that we have discussed how we should be eating and ways of managing eating problems, let’s 
look at how to keep our food safe.   
How do I keep my food safe? 
If we don’t pay attention to our food, where we get it from, how we store it 
and how we prepare and cook it, the food may become contaminated and 
make us sick. This is very important for the person living with HIV because you 
are more vulnerable to illness. There are simple ways to keep your food safe. 
 
 
 
  
Managing Eating Problems 
18. Try to eat at least 5 times a day – 3 meals and 2 snacks.  
19. Eat energy food first. 
20. Keep snacks with you to eat as soon as you feel hungry. 
21. Drink 6 glasses of juice and water a day. 
22. Drink rehydration fluid after every bout of diarrhoea. 
 
Storing and preparing food safely 
23. Read food labels carefully when you are shopping for food. Look for the “sell-by” and the 
“use-by” dates. Do not buy them if the “sell-by” date has already passed, do not buy if you 
are not sure that you will eat it before the “use-by” date. 
24. Don’t buy food if the packaging is damaged 
25. Storing food properly is important to keep it safe. Food that you buy from the fridge or 
freezer section of a shop needs to be put into a fridge or freezer as soon as possible unless 
you are going to cook or eat it straight away.  
26. Write on the packages of food the date you bought them so that you can keep track of how 
long you have had it. Remember food that can make you sick doesn’t always look or smell 
bad.  
27. If you want to keep leftover food, store it in a container with a tight lid and put it into a fridge 
or freezer immediately.  
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Action Plan Form 
 
Think about your eating habits. Use this form to come up with a plan to improve one thing about 
your nutrition. 
Be sure your action plan includes: 
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
 
For example: This week, I will walk (what) around the block (how much) before lunch (when) three 
times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
How confident are you that you can complete this action plan? 
 
 
 
 
 
Keep a record of how you did: 
  
 I Plan to….. I did….. 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
       ____________________________ 
Not at all      |     |     |     |     |     |     |     |     |      |       
Totally 
confident    1    2    3    4    5    6    7    8    9    10    confident 
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Exercise Diary 
 
Keep using the exercise diary to keep track of your exercise goals from week one. You may want to 
start increasing your exercise plan. 
Start off by writing down your goal.  
Write down here what you want to be able to do:       
  
Now, what do you want to be able to do this week which will help you to reach your goal? 
Remember from your action plan to include:  
What you want to do 
How much you are going to do 
When you are going to do it 
How many days a week you are going to do it 
For example: This week, I will walk (what) around the block (how 
much) before lunch (when) three times (how many). 
This week I will: 
          (what) 
          (how much) 
          (when) 
          (how many?) 
 
 Exercise Planned Exercise I did... How did I feel? Do you need to change 
anything? 
e.g. 20 mins in a.m. after 
breakfast and in p.m. 
after supper 
 Very tired by the second session, I’m 
going to cut it down to morning only for 
this week. 
Monday    
Tuesday    
Wednesday    
Thursday    
Friday    
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Week 6: Continuing as a Successful Self-Manager 
 
Over the last six weeks you have learnt many skills which will help you to live positively with your 
condition. Research tells us that people living with any chronic disease who follow these steps have 
better quality of life, have fewer sick days and have better disease control. This is true for people 
living with high blood pressure, HIV/AIDS, cancer or depression. You have learnt how to be a positive 
self-manager by being able to solve problems and set goals for yourself so that you can move 
forward with your life. You have learnt about the importance of exercise. How exercise can make 
you feel better, what exercises you should do and you have been doing those exercises too! You 
have learnt about the common symptoms that trouble people living with HIV and you have learnt 
how to manage these symptoms. You have learnt about pain, what might be causing pain and how 
to treat and manage any pain you may have. You have learnt about food and eating well and how to 
make sure that your food is safe. With all of these you have also had the chance to practice doing 
things differently and to think about how this has made you feel.  
 
Action Planning for the Future 
Now it is time to think about the future. People with long term illnesses often worry about what will 
happen if they get very sick, how they will manage their lives; how they will they look after 
themselves or their families. Worrying about these things can also make people feel sad, angry or 
depressed and helpless. These emotions may make everything feel even more difficult than they are. 
By working through this book you have already started to deal with these emotions. You have 
increased your knowledge and this is one of the main ways that we manage fear. If we are afraid of 
something, knowing more about it helps us to tackle the fear. If you know more about it, you can 
make a plan around it and making a plan helps us to get a sense of control over the very thing that 
we are afraid of.  
 
Planning for the future means thinking about the things that might happen to you in the 
future and planning for them. You may never ever need to use the plan as the 
things that you worry about may not happen, but, having a plan will help you 
to worry less about these things and stay in control should they happen. You 
can use the action planning forms you have been using in this workbook to 
think about the things which worry you about the future. You can then start 
making a plan about what you want to do if these things happen. If you are not 
sure about making a plan, you may want to talk to different people who might be 
able to help you with this. 
 
Step 1: 
To be able to plan for the future, you need to decide what it is that you are worried about 
happening. This can be the hardest step to think about. For example you might be feeling very sad 
and depressed. First you need to think about why you are feeling that way. It might be that you are 
worried about not being able to look after your family if you become ill, or you may be worried 
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about making someone else ill, or you may be worried about not being able to look after yourself, or 
you may be worried about dying. Once you have identified what it is that worries you and makes you 
feel sad, depressed, angry or afraid then you can start to make a plan to deal with it.  This will help 
you to feel less sad, depressed, angry or afraid.  
 
Write down here some of the things that might happen in the future that you worry 
about:  
1)         
         
  
2)         
          
 
Step 2: 
Now that you have identified some of the things which worry you, you can start to think about 
different ways to manage these things. If you were worried about becoming ill and not being able to 
look after yourself, write down a list of things that you would need help with. Then write down who 
you could ask to help you with those things. The people who can help might be family, friends, social 
workers, counsellors, nurses, physiotherapists, occupational therapists or doctors. If you are not sure 
who could help you, you may want to talk to someone you trust to help you identify who could help.  
 
Write down here three different things you could do to help plan for the things in the future that 
you worry about: 
1)             
2)             
3)             
 
There are many organisations and people who you can approach for help in planning for the future. 
These organisations include the Treatment Action Campaign (TAC), the Family and Marriage Society 
of South Africa (FAMSA), your church, the AIDS consortium; the Aids Law Project (ALP), the National 
Association of People living with HIV/AIDS (NAPWA) as well as the health care practitioners at your 
local clinic. The contact details for these organisations are included at the end of this section.  
Once you have completed Step 2 and written down three different things you could do to help plan 
for the things in the future that you worry about, choose the one which seems to suit you the best 
(this might be one which is easier or is cheaper or you know has worked for someone else). Now use 
this action plan form to work out what you will do if the thing which you worry about happening 
should happen. You can use this method to plan for any of the things which worry you.  
 
Action Plan Form for Future Worries 
 
I am worried that in the future I will not be able to: 
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My plan to manage this if it happens is to: 
             
           
         
         
         
         
         
          
   (what, who, how, when?) 
 
How confident are you that you can complete this action plan? (remember you are aiming for 7 out 
of 10 on the confidence line) 
 
 
 
 
 
  
       ____________________________ 
Not at all      |     |     |     |     |     |     |     |     |      |       
Totally 
confident    1    2    3    4    5    6    7    8    9    10    confident 
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Changes I have made in my life: 
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
           
Moving forward: 
Over the last 6 weeks you have learnt many things about how to live with a chronic illness like 
HIV/AIDS. You have learnt about the disease and how to be a successful self-manager. This does not 
mean that you should be managing your health on your own. What it does mean is that you now 
have the ability to manage your health and your life as part of the health team. Remember you are 
not alone but are part of a team of people whose aim is to help you get the most out of life. We 
encourage you to keep using the skills you have learnt in this workbook to live positively. There are 
extra “Action Plan Forms” and “Exercise Diaries” in the back of the workbook for you to use. Try to 
keep using these forms to help you remain active and give you a sense of purpose and 
accomplishment in your life. Being active and involved, using the skills you have learnt in this 
workbook are important steps in helping you achieve the best quality of life you can. In the box write 
down some of the important changes you have made in your life over the past few weeks. 
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Things that are still missing in my life: 
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
           
Now, your final task is to think about changes you still want to make in your life. Remember, this is 
about getting the most out of life, increasing your quality of life. Are there still some things missing 
in your life, things that you would still like to be able to do? In the box below, write down some of 
the things that are still missing. You can use this list to keep working on your goals from now on.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
You have now completed this workbook. By working through this workbook you made an important 
commitment to yourself. You have chosen to spend time looking 
after yourself and you have taken steps to overcome the many 
challenges that people living with HIV/AIDS face. Do not put this 
workbook away; keep it somewhere safe where you will be able to 
review it from time to time. We all forget things at times and it is 
useful to be able to look back and remind ourselves of things we 
may have forgotten. We can also look back and see how far we 
have come. We hope that the knowledge and the skills you have 
learnt by using this workbook will continue to have a positive 
effect on your life.   
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Useful Organisations: 
Treatment Action Campaign (TAC) (http://www.tac.org.za) 
Johannesburg  011 872 1405 
 
Family and Marriage Society of South Africa (FAMSA) (http://www.famsa.org.za) 
Johannesburg 011 892 4272 
AIDS consortium (http://www.aidsconsortium.org.za/) 
 (011) 403-0265 
 
Aids Law Project (ALP) (http://alp.immedia.co.za/) 
 (011) 356-4100 
 
National Association of People living with HIV/AIDS (NAPWA) (http://www.napwasa.org.za/) 
Johannesburg  0846964964 
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Additional Reading 
 
The information is this workbook is based on several sources of information. If you would like to 
read more on any of these topics we suggest you explore these: 
 
Living Well with HIV & AIDS; Gifford A.L.; Lorig K; Laurent D; Gonzalez V (3rd edition) Bull Publishing 
Company, Boulder Colorado2005 
 
Self-management of Long-term Health Conditions: A handbook for people with chronic disease. 
Expert Patients Programme Community Interest Company . Bull Publishing Company, Boulder 
Colorado 2007 
 
Manage your pain. Nicholas M, Molloy A, Tonkin L, Beeston L ABC Books, Sydney 2000 
 
HIV in our lives: a book of information sheets for clinics. Treatment Action Campaign, Cape Town, 
2007 
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Appendix I Brief Pain Inventory 
BRIEF PAIN INVENTORY 
1. Throughout our lives, most of us have had pain from time to time (such as minor headaches, sprains, and 
toothaches). Have you had pain other than these everyday kinds of pain during the last week? 
Yes No 
2. On the diagram, shade in the areas where you feel pain. Put an X on the area that hurts the most. 
3. Please rate your pain by circling the one number that best describes your pain at its worst in the last week. 
 
0  1  2  3  4  5  6  7  8  9  10 
No                       Pain as bad as 
Pain                       you can imagine 
4. Please rate your pain by circling the one number that best describes your pain at its least in the last week. 
 
0  1  2  3  4  5  6  7  8  9  10 
No                       Pain as bad as 
Pain                       you can imagine 
 
5. Please rate your pain by circling the one number that best describes your pain on the average. 
 
0  1  2  3  4  5  6  7  8  9  10 
No                       Pain as bad as 
Pain                       you can imagine 
 
6. Please rate your pain by circling the one number that tells how much pain you have right now. 
 
0  1  2  3  4  5  6  7  8  9  10 
No                       Pain as bad as 
Pain                       you can imagine 
 
16. What treatments or medications are you receiving for your pain? 
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8. In the last week, how much relief have pain treatments or medications provided? Please circle the one percentage 
that most shows how much relief you have received. 
 
0%  10%  20%  30%  40%  50%  60%  70%  80%  90%  100% 
No           Complete 
Relief           Relief 
 
9. Circle the one number that describes how much, during the past week, pain has interfered with your: 
A. General Activity 
 
0  1  2  3  4  5  6  7  8  9  10 
Does not          Completely 
interfere          interferes 
 
B. Mood 
 
0  1  2  3  4  5  6  7  8  9  10 
Does not          Completely 
interfere          interferes 
 
C. Walking Ability 
 
0  1  2  3  4  5  6  7  8  9  10 
Does not          Completely 
interfere          interferes 
 
D. Normal Work (includes both work outside the home and housework) 
 
0  1  2  3  4  5  6  7  8  9  10 
Does not          Completely 
interfere          interferes 
 
E. Relations with other people 
 
0  1  2  3  4  5  6  7  8  9  10 
Does not          Completely 
interfere          interferes 
 
F. Sleep 
 
0  1  2  3  4  5  6  7  8  9  10 
Does not          Completely 
interfere          interferes 
 
G. Enjoyment of life 
 
0  1  2  3  4  5  6  7  8  9  10 
Does not          Completely 
interfere          interferes 
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Scoring: 
Pain Severity Score = Mean of items 3–6 (pain at its worst, pain at its least, average ) 
Pain Interference Score = Mean of items 9A–9G (interference of pain with: general activity, mood, walking, normal work, relations, sleep, 
enjoyment of life) 
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Appendix J Becks Depression Inventory II 
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Appendix K Euroquol 5D  
 
 
 
 
 
 
 
 
 
 
Health Questionnaire 
 
South African English version 
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By placing a tick in one box in each group below, please indicate which statements 
best describe your own state of health TODAY. 
 
 
Mobility 
I have no problems in walking about  
I have some problems in walking about  
I am confined to bed  
 
Self-Care 
I have no problems with self-care  
I have some problems washing or dressing myself  
I am unable to wash or dress myself  
 
Usual Activities (e.g. work, study, housework, family or 
leisure activities) 
I have no problems with performing my usual activities  
I have some problems with performing my usual activities  
I am unable to perform my usual activities  
 
Pain/Discomfort 
I have no pain or discomfort  
I have moderate pain or discomfort  
I have extreme pain or discomfort  
 
Anxiety/Depression 
I am not anxious or depressed  
I am moderately anxious or depressed  
I am extremely anxious or depressed  
 
Compared with my general 
level of health over the past 12 months, 
my state of health today is: 
 
Better   PLEASE TICK 
Much the same  ONE 
Worse  BOX 
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To help people say how good or bad their state of health is,  
we have drawn a scale on which the best state you can imagine  
is marked 100 and the worst state you can imagine is marked 0. 
 
We would like you to indicate on this scale, in 
your opinion, how good or bad your own health 
is today. Please do this by drawing a line from 
the box below to whichever point on the scale 
indicates how good or bad your state of health is 
today. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Your own 
state of health 
today 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
Worst 
imaginable 
state of health 
0 
Best  
imaginable 
state of health 
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Appendix L Self-Efficacy for Managing Chronic Disease 6 item Scale  
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Appendix M Simmonds Battery  of Physical tests 
Simmonds Battery of Functional Tests 
 
1.  15 metres (m) walking at preferred speed. For this test, subjects are timed as they walk  
     7.5 m turn around, and walk back to the starting position at their preferred walking speed. 
 
2.  15 m walk at fastest speed. Subjects are again timed as they walk 8 m, turn around, and  
     walk back to the start as fast as they can. 
 
3.  Unloaded forward reach. For this test, subjects stand adjacent to a wall on which a tape 
measure is positioned horizontally at shoulder height. Subjects reach forward as far as 
they can and the distance reached is measured in centimetres (cm). 
 
4.  Timed, repeated sit-to-stand. Subjects sit in a standard chair and are then timed as they  
     stand up and then sit back down, twice. The test is repeated after a brief rest and the  
     average time of the two trials is used.  
 
5.  Sock test. Subjects sit in a standard chair. They are timed as they put on one loose-fitting  
     sock.  
 
6.  Loaded forward reach.  For this test, subjects stand adjacent to a wall on which a tape 
     measure is positioned horizontally at shoulder height.  They hold a weighted bar (4.46 kg) 
with both hands close to their body and at shoulder height. They then reach forward as     
far as they can with the bar in a horizontal position, maintaining their hands at shoulder 
height. The reach distance is recorded in centimetres.   
7.  Timed, repeated reach-up. For this test, subjects stand facing a wall and reach up as high  
as they can with both hands. A mark is placed on the wall at the reached distance. 
Subjects then reach up and return their hands to their sides three times, as fast as they 
can. 
 
8.  Distance walked in 6 minutes. Subjects walk as far and as fast as they can for 6 minutes.  
The distance walked is measured in metres at 6 minutes. (Subjects are allowed to rest if 
and  as necessary during the 6-minute period.)  
 
 
9. Timed belt tie. Patients sit in a standard chair and are timed as they wrap a standard 
    wrap bandage (approximately 1 meter long) around their waist and tie it in front of them. 
 
Reference: 
Simmonds MJ,  Novy D, Sandoval R. The Differential Influence of Pain and 
Fatigue on Physical Performance and Health Status in Ambulatory Patients 
with Human Immunodeficiency Virus. Clinical Journal of Pain 2005;21:200-206. 
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Appendix N  Feedback questionnaire for peer leader participants 
  
1. What did you like about the course? 
 
 
2. What didn’t you like about the course? 
 
 
3. Was there anything more you would like to learn that wasn’t in the course? 
 
 
4. What did you like about the workbook? 
 
 
5. What didn't you like about the workbook? 
 
 
6. Is there anything you would like to add or change in the workbook? 
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Appendix O – Graphs demonstrating modelling of data 
Graphs of all histograms and quantile-quantile plots done during modelling of data 
Depressive Symptoms 
The data from the three intervention groups for BDI scores were tested for normality and found to 
be slightly skewed to the right as shown in the histogram below.  
 
Figure 3.4. Histogram of BDI scores 
On a quantile-quantile plot, the data had a heavy upper tail due to the right skew as shown below.  
 
Figure 3.5 Plot of BDI scores  
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The data were transformed using a square root transform which helped to make the tail less heavy 
and normalise the data. 
 
Figure 3.6 Plot of BDI scores after square root transformation 
 
HRQOL Data 
The data from the three intervention groups for health related quality of life was tested for 
normality and found to be slightly skewed to the left as shown in the histogram below. 
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Figure 3.7 Histogram of EQ5D VAS 
Normality was also tested with a quantile-quantile plot, which showed the data had a heavy lower 
tail as shown below. 
 
Figure 3.8 Plot of EQ5D VAS 
As the data were not normal they were analyzed using a general additive mixed-model (GAMM) with 
inflated beta distribution.  
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Preferred walking speed 
The data from the three intervention groups for preferred walking speed was tested for normality 
and found to be slightly skewed to the right as shown in the histogram below. 
 
Figure 3.12 Histogram of preferred walking speed 
 
This resulted in the data having a heavy tails due to the right skew in data as shown below. 
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Figure 3.13 Plot of preferred walking speed 
The data was transformed using a square root transform which helped to make the tail less heavy 
and normalise the distribution to account for the right skew in data. 
 
Figure 3.14 Histogram of preferred walking speed with square root transformation 
 
Fastest walking speed 
The fast walking speed data was examined for normality and found to a have a slight right skew as 
shown below. 
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Figure 3.9 Histogram of fastest walking speed 
Although the tails were slightly heavy this was not significant and no further adjustment of data was 
undertaken.  
 
Figure 3.17 Plot of fastest walking speed 
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6 minute walk test 
The distance walked in 6 minutes data was examined for normality and found to a have a slight right 
skew as shown below. 
 
Figure 3.19 Histogram of 6min walk test 
Although the tails were slightly heavy this was not significant and no further transformation of data 
was undertaken.  
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Figure 3.10 Plot of 6 min walk test 
 
 
Unloaded reach test 
The unloaded reach test data was examined for normality and found to a have a right skew as shown 
below. 
 
Figure 3.22 histogram of unloaded reach test 
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This resulted in a heavy upper tail as shown below.
 
Figure 3.23 Plot of unloaded reach test 
A log transformation was used to normalize the data . 
 
 
 
Figure 3.24  Plot of unloaded reach test after log transformation 
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Loaded reach test 
The data for the loaded reach test was fairly normally distributed as shown below. 
 
Figure 3.26 Plot of loaded reach test 
However a log transformation was used so that the data matched the data from the unloaded reach 
test.  
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Appendix P Plagiarism declaration 
